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PREFACE
As I look back over the last five years the convolutions that my program has 
taken are absolutely amazing to me. After completing a residency in Equine Medicine 
here at LSU, I began working full time in Dr. Horohov*s laboratory. I had completed 
the majority o f my course work during my residency and so I expected that, working full 
time in the laboratory, I would complete my Ph.D. in approximately two to three years. I 
struggled initially to find a project that held my interest. Evie Vandergrifft had recently 
cloned equine IL-2 and IL-4 in our laboratory and interferon-y was available from the 
laboratory of Dr. Doug Antczak, thanks to the efforts of his graduate student Gabriel 
Grunig. With the unique availability of these three reagents, my idea was to determine if 
horses exhibit cytokine patterns consistent with the T-helper (TH)1/TH2 paradigm. 
Because of my background in equine medicine and familiarity with the work o f other 
investigators in the School o f  Veterinary Medicine, I proposed to explore the TH1/TH2 
paradigm in three equine diseases that had immunologically well characterized mouse 
and human corollaries, influenza virus infection, Strongylus vulgaris infestation, and 
Summer Pasture Associated Obstructive Pulmonary Disease (SPAOPD). There was, and 
remains to this day, no easy way to identify helper cell phenotypes. There is no magical 
surface marker that warns the investigator of a TH1 or TH2 response and so I began, a 
veterinarian whose greatest asset is her power of observation, on the road to quantify 
messanger RNA in the realm o f  the unseeable.
After reviewing the literature I hoped to utilize Northern blotting so as to avoid 
the pitfalls of the polymerase chain reaction (PCR). PCR (dubbed ‘polymerase chain
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
rubbish’ by some) with it's Iogrhythmic expansion whose efficiency is limited by mis- 
priming, primer dimer, secondary structure, magnesium concentration, annealing and 
extension times, pH, and entering the dreaded plateau phase, was something that as a 
practicing veterinarian, I surely wanted to stay away from. Besides, people who knew 
far more about molecular biology then I said they knew graduate students that spent 
years just standardizing their PCR reactions. And so I forged into the land of Northerns, 
dot blotting, end-labeling, and random priming, ribo-probing with fluorescent dyes and 
radioactive poisons determined to avoid PCR. When dot blotting didn't provide a signal, 
I tried solution hybridization northerns (RNase protection) to tap into their 'greater 
sensitivity' and stability. But this too did not work. That assay required tremendous 
amounts o f RNA (more than 10 pg of RNA per cytokine), had unlimited opportunities 
for RNase contamination, and would never be adaptable to large sample numbers. So 
after almost two years o f Northern blotting it was time to try a PCR based method. 
Southern blotting using fluorescently-labeled random-primed probes was sure to give 
results. But the blots again had too much background and were too insensitive. So there 
I was, two years o f  intense work and no hope of any data. Frustrated and on the verge 
of quitting, I decided to clone equine IL-10 and P-actin so that I would have something 
to show for my time, maybe someone would give me my Masters degree if all else failed. 
Luckily I did manage to clone these genes but expression and bioassay of the cytokine 
was a little less fruitful. And then it happened, the black box that was to revolutionize 
quantification o f PCR products arrived - the Perkin-Elmer QPCR System 5000.
Still reticent about PCR I abdicated that I would have to perform a PCR based 
quantification but by now some data was better than no data. And it didn't look as
viii
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though I would ever have data. So into the land of quantitative PCR (QPCR) I forged. 
The company literature and initial presentation made the QPCR System 5000 seem like 
a Red Rider BB gun. Little did I know just how proficient I would come to be at 
understanding the functioning and interpretation of luminosity values from the QPCR 
System 5000. One year after the machine's arrival I finally understood how it really 
worked (which is actually quite powerful but not exactly in line with my initial 
understanding) and with the exception of three months for the birth of my daughter, I 
was ready to 'generate data'.
From my proposal four years earlier, many changes had occurred in the samples 
I was to analyze. In fact, as I complete my final writing, samples that I collected to 
answer many of the questions that I have formulated sit dormant at -80 °C as the 
development of this assay came together too late for me to learn the answers. As for the 
original questions of a TH1 response for protection against equine influenza virus, which 
has been documented in other species, I initially proposed looking at changes in the 
cytokine profile of peripheral blood mononuclear cells derived from horses both before 
and after vaccination and stimulated in vitro with influenza virus. Though I initially 
suggested to, I did not believe that we would be allowed to nebulize equine influenza 
virus to horses in the facilities as they exist at LSU. I noted in my original proposal that 
this killed virus vaccine, by virtue o f it's induction of the humoral immune response, was 
actually more likely to induce a TH2 response and that our best hope for detecting a 
TH1 response with equine influenza hinged on assaying the cytokine profile of 
lymphocytes from the portal o f infection (draining the respiratory tract) and comparing 
this profile to that of a distant lymph node following a live influenza virus challenge.
ix
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Though I will not personally get to answer these questions, I have not only collected and 
frozen RNA to address the vaccination question, but also collected peripheral and 
respiratory associated lymphocyte samples from ponies challenged with equine influenza 
virus, and been co-investigator on a funded research proposal to address this question o f 
TH1 responses in live equine influenza challenge of ponies.
My second disease state of interest, Strongylus vulgaris infestation, became a 
focus of this dissertation. My initial proposal sought to characterize the cytokine 
response of peripheral blood mononuclear cells (PBMC) from parasite free and 
chronically S. vulgaris parasitized ponies in response to stimulation with a crude S. 
vulgaris antigen. As I addressed my committee I noted that data from mice indicated that 
a protective TH2 response to gastrointestinal nematodes was sometimes restricted to the 
GI tract and not detectable in PBMC, indicating that lymphocytes draining the GI tract 
might be more useful in our assays. Over the next few years I managed to collect 
lymphocytes from blood, as well the peripheral and colonic lymph nodes of close to a 
hundred ponies with a variety o f parasitic conditions. In a moment of humor I suggested 
that following the cytokine response of parasite free ponies to nematode parasite 
infestation could be accomplished using serial surgeries. Little did I know this comment 
would come to fruition as a funded USDA grant and a whole new set of freezer samples 
that would become the focus o f my dissertation.
Being a clinician at heart, my greatest interest lay in the study of horses with 
SPAOPD. Horses with this disease suffer immensely and factions studying the disease 
stand divided as to how to determine its cause. My original proposal for these horses 
was to examine cytokine production from PBMC's collected monthly from horses with
x
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SPAOPD. I further proposed that bronchoalveolar lavage (BAL) lymphocytes be 
evaluated similarly. My first samples were tracheal aspirates (TTA) and had the copious 
mucous characteristic o f tracheal aspirates from SPAOPD horses. Unfortunately, after 
developing a method to separate the mononuclear cells from the TTA mucous, the 
procedure was only repeated once on a limited number of horses. These samples were 
collected and frozen. However, as of this writing, I am aware that a proposal submitted 
by Dr. Horohov and Dr. Beadle examining some of the above issues has been funded and 
hopefully will provide some direction for therapy in this disease.
It is hard to finish when you feel you are finally ready to embark upon your goals 
of six years prior. This preface is to those who secretly wondered what was taking so 
long and those who will benefit from my work, ideas, and ‘my legacy’ o f frozen RNA 
samples, so that you will know their origins.
xi
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ABSTRACT
The effect o f oral vaccination with radiation-attenuated Strongylus vulgaris 
larvae on the cytokine responses o f ponies to oral challenge with S. vulgaris was 
examined. Message was quantified using RT-PCR by interpolation against a plasmid- 
derived standard curve. PCR product was detected using the Perkin-Elmer QPCR 
System 5000. Standard curves were analyzed with a two parameter exponential rise to 
maximum fit of the data. By altering the cycling parameters to maintain P-actin 
amplification within it’s exponential phase, P-actin was used as a normalization factor. 
The assay resolves 2 fold changes in message, has a linear dynamic range on the order of 
3 logs, and is precise with errors in the range of 10% for replicate amplifications from 
the same sample. The error between replicate RNA samples from separate extractions of 
the same cell population, following P-actin normalization, was 13-27%. Equine 
Interleukin(IL)-6 , IL-10, and P-actin were cloned and sequenced for use in this assay.
1 0  ponies were reared parasite-free. Four received 500 attenuated S. vulgaris L,
9 and 6  weeks prior to challenge with 1000 nonirradiated L,. Four nonvaccinated ponies 
were also challenged. Control ponies were neither vaccinated nor challenged. Four days 
prior to challenge, and on days 4, 9, and 14 post-challenge, peripheral blood 
mononuclear cells (PBMC) and colonic lymph nodes (CLN) were collected. Prior to 
necropsy on D14, CLN were obtained surgically. PBMC and CLN cells (CLNC) were 
assayed for EL-2, IL-4, EL-5, IL-10, and EFN-y. Vaccinates and nonvaccinates 
demonstrated TH2-like cytokine patterns with significant elevations in EL-4 and IL-5 in 
response to S. vulgaris challenge. Vaccinates produced more IL-4 and IL-5 than
xvi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
nonvaccinates prior to challenge (not statistically significant), and significantly more EL-4 
in response to challenge, first in CLNC at D4 and then PBMC at D9. IL-4 in CLNC of 
nonvaccinates increased significantly by D9. Thus, ponies appear to generate TH2-like 
responses to gastrointestinal nematodes and anamnestic IL-4 production may be one 
component of the protective immune response generated by vaccination. Strongylus 
vM/gora-specific antibody isotypes and lymphoproliferative responses were also 
examined.
xvii
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INTRODUCTION
Cytokine production by helper T-lymphocytes has been divided into two 
categories based on the relative balance of the cytokines that are produced (Mosmann et 
al., 1986). T-helper (TH)1 responses, characterized by a predominance of interferon- 
gamma (IFN-y), interleukin (EL)-2, and tumor necrosis factor-alpha (TNF-a) 
production, have been shown to be integral to delayed-type hypersensitivity reactions 
(DTH), graft rejections, and to the protective immune response to intracellular 
organisms such as viruses (reviewed in Abbas e ta i, 1996). TH2 responses, which are 
characterized by a predominance o f IL-4, IL-5, and IL-13 production (as well as EL- 6  
and EL-10 in the mouse), are integral to the protective immune response to some 
extracellular organisms including gastrointestinal nematode parasites (reviewed in 
Finkelman et al., 1997). Because these cytokine profiles have been identified in cell 
populations that are not composed purely of helper T-cells (Robinson et al., 1992), the 
terms Type I and Type II responses, respectively, have been coined to describe TH1 and 
TH2 cytokine profiles in non-T-cell populations or cell populations that are not purely 
CD4+ T-cells.
The purpose of this dissertation was determine the contribution of Type I and 
Type II responses to vaccine induced resistance to Strongylus vulgaris infections. S. 
vulgaris is a highly pathogenic gastrointestinal nematode of horses whose life-cycle, 
which takes 4 to 6  months to complete, causes severe inflammation in arteries that 
perfuse the intestine (Ogboume and Duncan, 1985). These lesions can compromise 
intestinal perfusion resulting in a syndrome, known as verminous arteritis, that is
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2characterized by ischemic infarctions o f the bowel which result toxemia, abdominal pain, 
and death in severe cases (White, 1985). However, clinical signs of infection including 
pyrexia, anorexia, depression, and colic appear within the first week following ingestion 
of third-stage infective larvae (L3) and are near maximal by 14 days post infection (Klei 
et al., 1982). Oral immunization with radiation-attenuated L3  produces a strong 
protective resistance to challenge infection which prevents classical lesions of verminous 
arteritis and eliminates clinical signs o f infection (Klei etal., 1982).
Natural and experimental infections with S. vulgaris result in eosinophilia and 
eosinophilia is known to be an IL-5 (Type II) dependent phenomenon in murine models 
(Coffman et al., 1989). Furthermore, when compared to parenteral vaccination with 
adult or larval somatic antigen homogenates which did not confer resistance to challenge 
infection, the protection observed in ponies vaccinated orally with radiation-attenuated 
L3  correlated to both pre-challenge anti-5, vulgaris antibody titers specific for surface 
antigens of late L3  stages, and to induction o f a post challenge anamnestic-like 
eosinophilia (Monahan et al., 1994). Infections by S. vulgaris have also been shown to 
activate eosinophils in vitro (Dennis etal., 1988), and eosinophils from S. vulgaris 
primed but not unprimed ponies kill S. vulgaris L3  in vitro in an antibody-dependent 
manner (Klei et al., 1992), indicating that an antibody-dependent phenomenon involving 
eosinophils may contribute to the resistance seen in immune ponies. In addition, a 
cytokine or combination of cytokines which exhibits chemotactic activity for eosinophils 
has been found in the supernatant o f S. vulgaris stimulated peripheral blood 
mononuclear cells (PBMC) from immune but not nonimmune ponies (Dennis et al.,
1993). A synthesis o f these findings suggests that differential cytokine production,
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3perhaps similar to that seen in classical Type n  responses to helminth parasites may play 
a role in immunity to S. vulgaris.
The underlying hypothesis of this study was that in the equine, as in murine 
species, Type II responses confer protective resistance to gastrointestinal nematode 
infection. Identifying Type I and Type II cytokine responses requires cytokine 
quantification and so two major portions of this study were devoted to cloning and 
sequencing IL- 6  and IL-10, which are Type II cytokines in the murine system, and 
developing a method for quantifying equine cytokine messenger ribonucleic acid 
(mRNA). This latter step also necessitated the cloning and sequencing of equine P-actin 
for use as an internal standard in the cytokine quantification assay. Using this assay, the 
cytokine responses in both peripheral blood mononuclear cells and colonic lymph nodes 
taken from a region o f parasite invasion were examined to elucidate the nature of the 
cytokine responses in both vaccinated and nonvaccinated ponies
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LITERATURE REVIEW
The TH1 and TH2 Paradigm
The clinical response to infectious organisms, most notably Mycobacterium 
leprae, provided early and convincing evidence of a dichotomy in the immune response. 
Patients with the tuberculoid form of the disease demonstrated reduced numbers of 
organisms in association with strong delayed-type hypersensitivity reactions (DTH) and 
low levels of antibody, while patients with the lepromatous form displayed large 
organism burdens, high antibody titers, and a relative lack of DTH (Turk and Bryceson, 
1971). Recognition that CD4+ helper T-cells were required for both antibody and DTH 
responses raised questions as to how a helper T-cell subset that appeared phenotypically 
homogenous based on surface staining characteristics could present such differing 
functional capabilities as antibody production and DTH.
The recognition o f at least two distinct helper T-lymphocyte responses originated 
in murine studies o f T-cell help for antibody production. Tada et. al. (1978) first used 
the term "Th[" cell to describe a subset of carrier-specific mouse Lytl+,2-,3- helper T- 
cells which did not adhere to nylon wool, did not express the class II major histocompat- 
ability (MHC) antigen la, and provided help for anti-hapten antibody production by B- 
cells, only if the hapten was linked to a sensitizing carrier on the same molecule. Tada 
termed this cognate interaction or 'linked' help. In contrast, Tada's "Th2" cells were nylon 
wool adherent, Ia+, and did not depend upon the relevant carrier being coupled to the 
hapten in order to provide help for B-cell anti-hapten antibody production (nonlinked 
help). Studying cloned Lytl+,2- L3T4a+ helper T-Iymphocytes, Kim et al. (1985) also
4
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5determined that helper T-cell subsets could be identified by characteristics o f the help 
provided for antibody production. Based on their activity in bulk cultures with B-cells, 
Kim defined 4 types o f helper T-cell clones. "Type 3" clones were unable to provide help 
for antibody production and some actually suppressed the ability o f other clones to 
provide help, while "Type 4" clones were specific for antibody directed at class II (la) 
antigens. When compared to clones he defined as "Type 1" helper T-cells, Kim's "Type 
2" clones resulted in 15 fold greater antibody production, which was predominately of a 
single idiotype. Limiting dilution analysis determined that this idiotype specificity 
resulted from both a higher precursor number and greater clonal expansion o f the 
idiotype specific B-cell precursors. Such differences in precursor frequency for a single 
idiotype could not be attributed to the B-cells which bear the same germ-line encoded 
idiotype. This lead Kim to postulate that "Type 2", not "Type 1" helper T-cell clones 
delivered a critical activation signal for the B-cell in the form o f either enhanced affinity 
receptors or more likely via secreted molecules. He suggested that such a molecule from 
"Type 2" helper T-cells, now known to be interleukin(IL)-4, could act by increasing 
MHC class II expression on B-cells, thereby allowing B-cells with low MHC II 
expression to become activated. Collectively these and other early studies indicated that 
despite fairly uniform surface distribution of CD3 and CD4 antigens, when assessed by 
functional criteria, at least two types of helper T-cells exist whose activities might be 
linked to differing patterns o f secreted molecules (Waldman, 1977; Swiekosz et al.,
1979; Asano et al., 1982; Imperiale etal., 1982; Melchers eta l., 1982).
The description by Mosmann et al. (1986) of two classes of antigen-specific 
mouse helper T-cell clones that could be identified not only by differing modes of B-cell
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6help, but more significantly by distinct patterns o f cytokine production was an 
immunologic milestone. Mosmann's "TH2" clones, which secreted IL-3, EL-4, and EL-5, 
bound nylon wool, were Ia+, enhanced the production of IgGl and IgE by LPS 
stimulated B-cells, and stimulated the expression of la antigen on B-cells. In contrast, his 
"Th1" clones which secreted EL-2, interferon-Y (EFN-y), granulocyte-macrophage 
colony stimulating factor (GM-CSF), and EL-3, did not bind nylon wool, were la-, and 
did not possess IgGl, IgE, or la  enhancing activities. A second major finding o f this 
paper was that the "Th" phenotype was dependent upon the antigen used for clonal 
stimulation. Chicken RBC-specific T-cell clones (200 in all) from three different mouse 
strains exhibited the "TH1" phenotype, while fowl y-globulin stimulated clones from the 
same mice all exhibited the "TH2" phenotype. Interpreted together, these findings 
suggest that antigens which induce substantial IgE responses may do so by preferentially 
inducing the "TH2" phenotype; whereas antigens that induce high IgM and low IgE titers 
may do so by preferentially activating the "TH1" phenotype, which aids in IgM 
production and suppress IgE production.
Recognition of distinct cytokine phenotypes in mouse Thl and Th2 clones lead 
to attempts to characterize cytokine production by helper T-cells in experimental animals 
and humans in response to a variety of antigenic stimuli, both in vitro and in vivo.
Cloned helper T-cell subsets with characteristic cytokine patterns have been described in 
humans (Del Prete et al., 1991; reviewed in Del Prete et al., 1994; Romagnani, 1994), 
rats (Druet and Pelletier, 1996), and cows (Brown et al., 1995). However, initial studies 
of existing mitogen induced and alloreactive human T-cell clones indicated that most 
clones produced combinations o f the Thl and Th2 cytokines (Maggi et al., 1988;
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7Paliard et al., 1988; Umetsu et al., 1988), leading to scepticism regarding the functional 
significance of Thl and Th2 clones in mice (Kelso, 1995). In sharp contrast to the early 
human clones which were derived from unimmunized or mildly immunized individuals, 
Mosmann's clones originated from strongly immunized mice which were stimulated for 
prolonged periods in vitro. Further analysis of cytokine patterns from alloreactive mouse 
T-cell clones, T-cell clones maintained for a short period in vitro, and T-cell clones from 
unimmunized mice indicated that these clones also exhibited the unrestricted cytokine 
patterns of early human T-cell clones (Kelso and Gough, 1988; Mosmann and Coffman, 
1989a). Mosmann also observed that the generation of distinct Thl and Th2 phenotypes 
was most rapid with cells from mice that had been immunized with antigens that 
stimulated strong Thl and Th2 responses in vivo. In support of this observation, the first 
human Thl and Th2 clones were generated from normal humans in response to purified 
protein derivative (PPD) of Mycobacterium tuberculosis and exceretory/secretory 
antigen of Toxocara canis, respectively (Del Prete et al., 1991). These antigens, as will 
be discussed, originate from classes of infectious organisms, namely intracellular bacteria 
and helminth parasites, that classically evoke Thl and Th2 responses, respectively, in 
vivo. Together these findings indicate that polarization to a Thl or Th2 response is 
dependent not only upon the nature o f the inciting antigen, but also the duration of 
exposure to the antigen, with polarization toward the Thl or Th2 response increasing 
with the chronicity o f exposure. Unrestricted cytokine patterns, termed ThO, therefore 
reflect an earlier step in the maturation of the antigen-specific immune response, while 
distinct Thl and Th2 responses become more pronounced in chronic disease states. The 
occurrence of clear helper cell phenotypes in association with persistent infections, Thl
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8(reviewed in Kaufmann, 1993) in association with leishmaniasis (Reiner and Locksley, 
1995), listeriosis (Hsieh et al., 1993b), and mycobacterial infections (Yamamura et al.,
1991), and Th2 in association with helminth infections (Sher and Coffman, 1992), 
substantiates this hypothesis.
The characterization o f distinct classes of CD4+ helper T-cells whose functions 
are determined by their cytokine repertoire, termed the Thl/Th2 paradigm, provided an 
explanation as to how a T-cell subset that appeared phenotypically identical based on 
surface staining characteristics could present such differing functional capabilities as 
immunoglobulin production and DTH. Several questions raised by Mosmann's 
characterization of Thl and Th2 cytokine phenotypes have lead to an explosion of 
research in order to elucidate the relationship between antigen stimulation, secretion of 
defined patterns of cytokines by helper T-cells, and generation of the protective antigen- 
specific immune response. These are: 1) What cytokines define the TH1 and TH2 
phenotypes? 2) What is the ontogeny of the TH1 and TH2 phenotypes? 3) How are they 
differentially regulated? 4) Is selection of the helper T-cell phenotype by antigen real 
and what determines it? and 5) What is the role of each subset in normal in vivo 
responses?
Cytokine Phenotypes of Thl and Th2 Responses
Continued investigation into the cytokine repertoires of Thl and Th2 cells has 
confirmed that in both human and murine systems, production of EFN-y, IL-2, and tumor 
necrosis factor-P (TNF-P) is unique to Thl cells, while only Th2 cells produce EL-4, EL- 
5, and IL-13 (Mosmann et al., 1986; Cherwinski e ta i, 1987; Janeway et al., 1988; 
Mosmann and Coffinan, 1989b; Romagani, 1991; Romagnani, 1994). However, IL- 6
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9(Romagnani, 1992) and IL-10 (Del Prete et al., 1993), which segregate exclusively with 
Th2 cells in mice, are produced by both Thl and Th2 cells in humans.
The nature of the pathogens which incite Thl and Th2 responses, as well as the 
immunologic activities of the cytokines produced by each helper cell subset, suggest that 
Thl responses provide protection against intracellular pathogens through phagocyte 
mediated mechanisms, while Th2 responses protect from extracellular pathogens 
primarily via phagocyte independent mechanisms. EFN-y has been termed the signature 
cytokine of the Thl response (Abbas et al., 1996) and its functions have been reviewed 
(Trinchieri and Perussia, 1985). Produced by CD8 + T-cells, CD4+ Thl cells, and NK 
cells, EFN-y was initially recognized by its ability to inhibit viral replication in fibroblasts 
(Wheelock, 1965). IFN-y is now recognized as a potent activator of macrophage 
function, greatly augmenting oxidative and nitrogen dependent microbicidal activities 
(Murray, et al., 1985; Belosevic et al., 1989; Nacy and Meltzer, 1991; Beaman et al.,
1992). IFN-y also modulates expression of class I and IIMHC antigens on a variety o f 
cells, potently upregulating class II expression on classical APC and inducing de novo 
synthesis on a variety of other cells (reviewed in Trinchieri and Perussia, 1985). As will 
be discussed in more detail, IFN-y is involved in the differential regulation of Thl and 
Th2 responses, augmenting induction of Thl cells while impeding the induction, 
proliferation, and effector function of Th2 cells (Mond et al., 1986; Belosevic et al.,
1989; Gajewskief al., 1989; Swain e ta l, 1991). In the murine system, IFN-y stimulates 
the production of complement fixing IgG isotypes, IgG2a and IgG3 (Snapper and Paul, 
1987; Coffman et al., 1993), which also bind to the high-affinity Fey receptors of 
phagocytes, making them integral to osponization and phagocytosis of pathogens. In
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addition, IFN-y augments cytotoxic immune mechanisms by directly activating natural 
killer (NK) and cytotoxic T lymphocytes (CTL) (reviewed in Trinchieri and Perussia, 
1985).
IL-2, whose functions have been extensively reviewed (Smith, 1988; Swain,
1991), is well recognized as an autocrine growth factor for T-ceils which is especially 
significant in the development o f antigen-stimulated cytotoxic T-Iymphocyte precursors 
into functional cytotoxic effectors, and augmentation of NK responses. However, IL-2 
also activates most cells o f  the immune system. EL-2 is produced primarily by activated 
T-cells, though B-cells have been induced to secrete IL-2 in vitro. IL-2 activates 
monocyte mediated cytotoxicity, and increases phagocytosis. In conjunction with other 
cytokines, IL-2 induces B-cell differentiation and immunoglobulin secretion (Coffinan et 
al’, 1988; Loughnan and Nossal, 1989).
The activates o f TNF-P have been reviewed (Paul and Ruddle, 1988) and mimic 
those of TNF-a. Though the two proteins display only 30% amino acid homology, TNF- 
P can activate both o f the TNF-P receptors (Aggarwal and Eessalu, 1987) (whose 
expression is upregulated by EFN-y), making TNF-P a mediator of inflammation and 
graft rejection, able to recruit and activate inflammatory leukocytes. In addition to 
production by CD4+ T-cells, TNF-P is also produced by activated CD 8 + T-cells 
(Ruddle et al’, 1987), and B-cells (Aggarwal e ta l, 1994). TNF-P was first described as 
a cytotoxic activity in culture supemates of activated lymphocytes and is one of the 
cytotoxic mediators involved in CTL, CD4+, NK, and LAK cell killing. TNF-P is 
directly cytotoxic toward tumors, both in vitro and in vivo, and has been shown to kill 
antigen presenting B-cells, while also functioning as a B-cell growth factor.
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The collective actions of the TH1 cytokines which induce macrophage cytocidal 
mechanisms, the generation of opsonizing, complement fixing antibodies, and induce 
lymphocyte mediated killing mechanisms support the notion that Thl responses are 
designed to destroy host cells which have been altered either by infection or malignant 
transformation. Cytokine induced mononuclear phagocyte recruitment and activation 
lead histologically to inflammatory reactions that are characteristic of delayed type 
hypersensitivity reactions. In contrast, the signature cytokines of the Th2 response, IL-4 
and IL-5, support the destruction of extracellular invaders, primarily via phagocyte 
independent mechanisms.
IL-4 and EL-13 share many, though not all, functions and will therefore be 
discussed together. To date at least two mechanisms for this cross reactivity have been 
documented. Both cytokines utilize the IL-4 receptor-a (IL-4 Ra) subunit in signal 
transduction (Kotowicz et al., 1996; Andersson et al., 1997, Orchransky et al., 1997), 
and EL-13 binding to its low affinity receptor induces the expression of a high affinity IL- 
13 receptor capable of binding IL-4 (Hilton etal., 1996). However, the receptor system 
for these two cytokines still requires study. Both IL-4 (Howard et al., 1982; Isakson et 
al., 1982) and IL-13 (McKenzie et al., 1993) stimulate the proliferation of activated B- 
cells and provide help for immunoglobulin production. In addition to production by Th2 
cells, IL-4 is also produced by CD4- CD8 - splenic T-cells (Zlotnick et al., 1992), 
CD3+CD4+ CD 8 - Thymocytes (Fischer et al., 1991; Bendelac and Schwartz, 1992), 
some CD8 + clones (Yamamura et al., 1991; Seder et al., 1992a), as well as basophils 
and mast cells (Plaut et al., 1989). IL-13, in addition to production by T-cells, is 
produced by mast cells (Krishnaswamy et al., 1997), basophils (Dahinden et al.,, 1997),
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and certain B-cell lines. IL-4 (reviewed in Paul, 1992; Paul and Ohara, 1987) and IL-13 
(Defrance et al'., 1994) have stimulatory effects on both resting and activated B-cells, 
including increasing MHC H , and Fee receptor expression. Two prominant roles of IL-4 
which have been substantiated in vivo are the augmentation of IgE production via 
induction of isotype switching (Kuhn et al., 1991; also reviewed in Finkelman et al.,
1990; Schultz and Coffinan, 1992), a function demonstrated in vitro by EL-13 in an EL-4 
independent manner (Punnonen et al., 1993), and the ability to drive the Th2 response 
(Zlotnick et al., 1987; Swain et al., 1990) while inhibiting the generation o f the Thl 
response (LeGros et al., 1990; Swain et al., 1990). Inhibition of Thl responses by EL-4 
also applies to IL-2 stimulated B-cells whose proliferation is inhibited by IL-4 (reveiwed 
in Paul, 1992). IL-4 also augments the production of non-complement fixing IgG 
isotypes (Bruggemann et al., 1987; Dangl e ta l, 1988), IgGl in mice, and IgG4 in 
humans. Augmentation of IgG4 production by human B-cells has also been 
demonstrated by IL-13 (Punnonen et al., 1993). Both IL-4 and IL-13 have also been 
shown to act as cofactors in the inhibition of B cell apoptosis (Lomo et al., 1997).
Though IL-4 and IL-13 do enhance MHC II expression on monocytes 
(McKenzie et al., 1993), both cytokines also exhibit potent inhibitory effects on 
monocytes (Figdor and te Velde, 1992; de Waal Malefyt et al., 1993; Doherty et al.,
1993; Bogdan et al., 1997; Mijatovic et al., 1997). IL-4 and IL-13 inhibit monocyte 
cytotoxicity by decreasing production of monocyte derived cytotoxic metabolites, such 
as nitric oxide (Doherty et al., 1993), as well as inhibiting the production of a wide range 
of monokines, including IL-l, EL-6, IL-8 , IL-10, EL-12, GM-CSF, granulocyte colony
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stimulating factor (G-CSF), IFN-a, and TNF-a (de Waal Malefyt et al., 1993). Both 
IL-4 and IL-13 also increase production of the EL-1 receptor antagonist (IL-IRa).
Both IL-4 and IL-13 have unique attributes. IL-4 is a growth factor for mast 
cells (reviewed in Figdor and te Velde, 1992) that also enhances CTL differentiation 
(Widmer et al., 1987) and has demonstrated potent anti-tumor activity in vivo. EL-4 
induces tumor infiltration by cytotoxic eosinophils, followed by a long lived immunity 
that is mediated by CTLs (Tepper et al., 1989; Bosco et al., 1990; Golumbek et al.,
1991; Tepper et al., 1992). In contrast to EL-4, IL-13 does not inhibit production of 
EFN-y, RANTES (regulated on activation, normal T expressed and secreted), 
macrophage inhibitory proteins l-a  and 1-p, or perforin by IL-2 stimulated T cells 
(Minty et al., 1997). IL-13 functions as a cofactor for dendritic cell differentiation 
(Piemonti et al., 1995) and like EL-4 induces the expression of VCAM-1 (vascular cell 
adhesion molecule-1) on endothelial cells (Ying et al., 1997). IL-13 also induces MCP-1 
(monocyte chemoattractant protein-1 ) release from endothelial cells (Goebeler et al., 
1997), which in coordination with VCAM-1 upregulation results in recruitment of 
inflammatory cells including eosinophils, monocytes, and T-cells.
Recent studies have indicated that IL-4 and IL-13 can exhibit paradoxical effects 
on monocytes, inducing both activation and suppression of monocyte functions 
(Kanbayashi et al., 1996; Minty et al., 1997). To date the differences in action o f these 
two cytokines have related to the timing of monocyte exposure to IL-4 and IL-13. When 
monocyte exposure to IL-4 or EL-13 preceded LPS or SAC stimulation, monocyte 
activation, characterized by increased monokine production, ensued whereas 
cotreatment with IL-13 or IL-4 and LPS inhibited monocyte activation. This differential
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effect is an area o f  ongoing interest which may have significant ramifications for the 
modulation of the inflammatory response in the face of ongoing infection.
In vivo neutralization experiments indicate that IL-5 is the predominant regulator 
of eosinophilia (Coffinan e t al., 1989; Sher et al., 1990b; Korenaga etal., 1991; Urban et 
al, 1992) stimulating mature eosinophil progenitors to proliferate and differentiate into 
mature effector cells (reviewed in Sanderson, 1992). IL-5 was originally described as a 
B-cell stimulatory factor (reviewed in Takatsu, 1991) and has demonstrated growth and 
differentiation activities in the murine system, including differentiation o f antigen 
stimulated B cells to plasma cells, and expression of the IL-2 receptor. However, the 
role of EL-5 in human B-cell growth and differentiation remains controversial (Azuma et 
al, 1986; Yokota et a l, 1986; Clutterbuck et al., 1987).
IL- 6  is a Th2 cytokine in the murine system. However, this polarization is not 
always clear in human CD4+ subsets (Romagnani, 1992). EL- 6  was initially described in 
separate experiments as an antiviral, hybridoma/plasmacytoma growth (Nordan and 
Potter, 1986; Van Snick et a l, 1986), hepatocyte stimulating, and B-cell stimulating 
factor (Hirano et a l, 1985). The biology and functions of EL- 6  have been extensively 
reviewed (Akira eta l., 1990; Van Snick, 1990; Hirano, 1992). IL - 6  is produced by 
macrophages, T-cells, B-cells, fibroblasts, and a variety of transformed cells (Hirano et 
al, 1985; Kawano et al., 1988; Tsato et a l, 1988). It is an inflammatory cytokine that 
demonstrates a broad spectrum o f actions, overlapping those of TNF-a and IL-1. Unlike 
TNF-a and IL-l, which amplify their own production as well as the production of EL- 6  
(Shalaby et a l, 1989), IL- 6  suppresses production of both TNF-a and EL-1 by 
macrophages (Schindler et a l, 1990). EL- 6  functions in an endocrine manner, traveling
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via the blood stream to induce systemic events collectively termed the acute phase 
response and characterized by fever, and the hepatic synthesis of proteins including C3, 
haptoglobin, serum amyloid A, alpha^macroglobulin, and fibrinogen (Ramadori et al., 
1988). IL- 6  induces monocytopoesis (Jansen et al., 1992) and synergizes with IL-3 in 
the induction of pleuripotent stem cell differentiation (Ikebuchi et al., 1987). IL- 6  
exhibits a late effect on both B-cell and CTL function, augmenting IgM secretion in 
proliferating B-cells (Hilbert et al., 1989), and IL-2 expanded CTL function (Takai et al., 
1988; Uyttenhove et al., 1988), presumably via induction of serine esterase, and perforin 
(Liu et al., 1990). IL- 6  has exhibited characteristics of a costimulator for T-cells by 
permitting a growth response to EL-2 ( Garman et al., 1987; Stein and Singer, 1992). IL- 
6  appears to play an important role in the mucosal immune response, functioning as a 
cofactor in IgA production (Rafferty and Montgomery, 1995; Okahashi et al., 1996; Van 
Cott et al., 1996; Yamamoto et al., 1996), but does not appear to function as an IgA 
heavy chain switch factor (Kawanishi and Joseph, 1991).
EL-10 was first characterized independently by two research groups as a factor 
from murine Th2  clones that inhibited EFN-y production by Thl clones (Fiorentino et 
al., 1989), as well as a factor in B-lymphoma supemates that enhanced the proliferation 
of murine thymocytes in response to IL-2 and IL-4 (Suda et al., 1990). These activities 
were later confirmed to be EL-10 (MacNeil et al., 1990). The biologic activities of EL-10 
have been reviewed (Moore et al., 1993). IL-10 inhibits cytokine synthesis by murine 
and human Thl cells, human Th2 and ThO cells, NK cells, and macrophages. IL-10 
inhibition of cytokine production by Thl and NK cells is indirect, being macrophage 
dependent. Similarly, IL-10 also inhibits macrophage dependent T-cell proliferation. The
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macrophage cytokine profile inhibited by IL-10 (de Waal Malefyt et al. 1991; Fiorentino 
etal., 1991; D’Andrea etal., 1993) parallels the inhibitory actions previously described 
for IL-4 and IL-13, inhibiting TNF-a, EL-1 , IL-6 , IL-8 , GM-CSF, and G-CSF 
production, while also increasing EL-lRa production (Pajkrt et al., 1997), and decreasing 
reactive nitrogen and oxygen intermediates (Bogdan et al., 1991; Cunha e ta l, 1992; 
Gassinelli et al., 1992). The effects o f EL-10 on macrophages that lead to inhibition of 
IFN-y synthesis by T cells are multiple. EL- 1 0  inhibits production of the p40 component 
of IL-12, which is produced by macrophages primarily in response to bacterial products 
and has been shown to be required for optimal EFN-y production in vitro (Trinchieri et 
al., 1992; D’Andrea et al., 1993). IL-10 also inhibits production of EL-1, which 
functions as a co-stimulatory molecule for EFN-y production by T cells (D’Andrea et al.,
1993). EL-10 inhibits upregulation of B7 expression, which is significant in macrophage 
costimulation (Ding et al., 1993). EL-10's inhibition of TNF-a production by 
macrophages also eliminates a necessary costimulatory factor for IFN-y induced 
macrophage activation (Oswald et al., 1992). There is also evidence that EL-10 plays a 
role in the paradoxical activation and suppression of monocytes induced by both IL-4 
and EL-13, with EL-10 levels being elevated in association with antigen/cytokine timing 
manipulations that result in monocyte suppression and decreased in association with 
those manipulations that result in macrophage activation (Kambayashi et al., 1996). In 
vivo experiments support the in vitro findings that IL-10 is a modulator of the 
inflammatory response. IL-10 protects mice from lethal endotoxic shock mediated by 
inflammatory cytokines, including TNF-a and IL-1 (Howard etal., 1993a), and
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neutralization of IL-10 in vivo results in elevated IFN-y, TNF-a, and IL- 6  (reviewed in 
Howard etal., 1993b).
One o f IL-10's earliest documented activities was the ability to augment the 
growth and proliferation o f  murine mast cells lines in response to EL-3 and IL-4. IL-10 
also augments the proliferation, differentiation, and immunoglobulin secretion of 
activated B-cells. In conjunction with EL-6 , IL-10 appears to play a significant role in the 
generation of IgA responses, though not via isotype switching (Jackson et al., 1996; 
Okahashi et al., 1996; Van Cott et al., 1996; Yamamoto et a l, 1996). In addition, IL-10 
depleted mice also have decreased serum IgM and IgA depletion of peritoneal B-cells, 
and fail to develop in vivo antibody responses to bacterial antigens, highlighting the role 
of IL-10 in B-cell function.
Ontogeny of T h l and Th2 Responses
It is now clear that T hl and Th2 cells originate from antigen naive CD4+ T-cells, 
termed pre(p)TH (Swain et al., 1991). Upon receptor engagement and costimulation, 
pTH produce IL-2 but little or no EL-4 or IFN-y. Upon priming, pTH cells can develop 
into cells that make IL-4 or IFN-y, termed effector(e)THl and eTH2, respectively. 
Generally, IFN-y producers retain IL-2 production while IL-4 producers loose it. pTH 
cells may traverse through a ThO like state in which both EFN-y and EL-4 are produced 
prior to differentiation into eTH phenotypes, but it is not clear if this state is obligatory. 
Early support for this single cell progenitor came from 48 hour mitogen stimulated single 
cell cultures which were split into culture pairs and cultured under conditions favoring 
IFN-y or EL-4 production (Rocken et al., 1992). Upon restimulation, twin cultures from 
the same parent cell produced EL-2 or IL-4, depending upon the culture method.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
18
Differentiation o f  the naive CD4+ T cells into EFN-y producing TH1 or EL-4 
producing TH2 phenotypes is driven primarily by cytokines which reflect the 
environment and nature o f  the inciting antigen. EL-12 drives differentiation into the IFN- 
y secreting Thl phenotype (Hsieh et al., 1993), while EL-4 is the primary driving force 
for the differentiation o f naive CD4+ T cells into IL-4 secreting Th2 phenotypes (LeGros 
etal., 1990; Hseih etal., 1992; Seder etal., 1992b).
EL-12, which is produced primarily by activated macrophages and dendritic cells, 
is potently induced by intracellular pathogens (reviewed in Scott, 1993). IL-12 activates 
three transcriptional factors: signal transducer and activator o f transcription (STAT)l, 
STAT3, and STAT4, of which STAT4 is exclusively activated by EL-12 (Jacobson et al., 
1995). EL-12 (Magram et al., 1996) and STAT4 knock out mice (Kaplan et al., 1996; 
Thierfelder et al., 1996) display markedly reduced Thl responses. Prior to the 
characterization of EL-12 there was some evidence that EFN-y was the driving force for 
Thl differentitation. IFN-y induced substantial EFN-y production in polyclonally 
stimulated mouse CD4 + spleen cells, but unlike IL-4, which potently induced both IL-4 
and IL-5 production, EFN-y only supported low to moderate IL-2 production (Swain et 
al., 1991). However, more reductionist experiments using murine T-cells with antigen- 
specific transgenic T cell receptors (TcR) indicated that IFN-y was not sufficient for 
IFN-y priming (Seder et al., 1992b), suggesting that while EFN-y augments Thl 
expansion and possibly differentiation, it is not itself sufficient to bias the immune 
response toward the Thl phenotype. EL-12 itself is a primary mediator of IFN-y 
production from T-cells and NK cells (Chan et al., 1991; D’Andrea et al., 1992) and 
EFN-y promotes TH1 development by enhancing macrophage IL-12 transcription (Hayes
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et al., 1995; Ma et al., 1996) and by maintaining the expression o f IL-12 R P2  subunit on 
CD4+ T-cells (Gollob et al., 1997; Szabo etal., 1997). IL-10 ( D'Andrea et al., 1993) 
and IL-11 (Leng etal., 1997) inhibit IL-12 production by macrophages, and EL-12 can 
induce IL-10 production by human T cell clones (Meyaard et al., 1996). Though the 
significance of this latter finding has not been substantiated, collectively this suggests a 
Thl induction loop. Cytokines induced by intracellular pathogens facilitate pathogen 
destruction by activating macrophages and then induce negative feedback in the form of 
IL-10, which downregulates the reaction after the inciting agent is eliminated.
IL-18 is a newly characterized cytokine (Okamura etal., 1995), also termed 
EFNy-inducing factor, which like IL-12 may be important in the development of the Thl 
response. Studies are limited at this time and have been restricted to the murine system. 
Like IL-12, EL-18 has been produced by activated macrophages in response to bacterial 
products (Okamura et al., 1995) and shares IL-12's capacity to induce IFN-y production 
by Thl cells, as well as to induce the production of IL-2 and GM-CSF, while inhibiting 
IL-10 production (Ushio et al., 1996). IL-18 has been shown to serve as a costimulatory 
factor for established Thl clones activated in a variety of manners, as well as antigen 
stimulated T cell lines, augmenting their proliferation and production of IFN-y, whereas 
IL-18 failed to support EL-4 production or proliferation from similarly stimulated Th2 
clones (Kohno et al., 1997). IL-18 is a more potent inducer o f IFN-y production than 
IL-12 and appears to utilize a separate induction pathway (Kohno et al., 1997). Though 
the role of IL-18 in driving pTh to Thl cells has not been fully elucidated, recent 
evidence suggests that IL-18 is dependent upon IL-12 mediated upregulation of the EL-
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18 receptor for its activity, making it likely that IL-12 remains the pivotal Thl inducing 
cytokine (Ahn et al., 1997).
The mechanisms involved in the generation of Th2 cells are not as clear as those 
that drive Thl differentiation. EL-4 is considered to be the primary driving force, though 
its signaling pathway and origins remain enigmatic. Two transcriptional factors are 
currently known to be activated by IL-4, STAT6  and insulin response substrate (IRS)-2 
(Hou et al., 1994; Ryan et al., 1996). Though the mechanism by which STAT6  induces 
IL-4 production is not clear, a multimeric STAT6  binding site does exist within the IL-4 
promoter (Lederer et al., 1996), suggesting that IL-4 may participate in an 
autoregulatory mechanism. Prolonged activation of STAT6  is characteristic of 
populations undergoing Th2 differentiation, and STAT6  is activated in an autocrine 
manner when differentiated Th2 populations are stimulated by antigen receptor ligation 
(Lederer et al., 1996). Furthermore, IL-4 (Kuhn et al., 1991; Kopf et al., 1993) and 
STAT6  knock out mice (Kaplan et al., 1996; Shimoda et al., 1996; Takeda et al., 1996) 
exhibit deficient Th2 responses. Other transcription factors including NFAT, which is 
activated in both eThl and eTh2 cells but only supports IL-4 production by eTh2 cells 
(Rincon and Flavell et al., 1997), and NIP45, which has been shown to synergize with 
NF-AT and proto-oncogene c-Maf to drive IL-4 production in B lymphoma cells 
(Hodge et al., 1996), suggest that the control of IL-4 upregulation is complex. In light 
of the potent suppressive effects of IL-4 and its associated Th2 cytokine congeners, 
intricate regulation of Th2 induction is not so surprising.
Because IL-4 appears to be the earliest signal for TH2 differentiation and it 
appears to be autoregulated, many theories have been proposed to explain the original
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source of IL-4 that drives Th2 differentiation. Naive T cells produce small amounts of 
JQL-4 upon initial activation (Schmitz et al., 1994), and it is proposed that Th2 induction 
may result from a threshold effect, with IL-4 levels necessary to drive the Th2 response 
resulting from a collective increase in lymphocyte activation at the local site of antigen 
presentation. Along these lines, it has been suggested that antigens stimulating Th2 
responses may act as superantigens (Paul and Seder, 1994) or be presented in 
association with nonpolymorphic molecules (Yoshimoto and Paul, 1994) inducing the 
production o f small amounts o f  LL-4 from a large number of CD4+ T-cells with diverse 
TcR specificities. Other cells have also been implicated, including mast cells and 
basophils (Plaut et al., 1989), and NK 1.1T cells (reviewed in Bendelac et al., 1997). 
Mast cells and basophils have been discounted by some because immunoglobulin 
mediated triggering requires prior exposure to the antigen for B-cell priming. However, 
there is ample evidence that mast cells and basophils can be triggered via 
nonimmunologic mechanisms as well as via the induction of products o f the complement 
cascade, C3a, and C5a (Rockoff et al., 1970; Findley et al., 1981; Sheflfer, 1983; 
Eggleston et al., 1984).
Though cytokines appear to be the major driving force that determines which Th 
response will be generated, a number o f  other factors including co-stimulation by 
accessory molecules, the dose o f  the antigen, and the type of antigen presenting cell have 
been shown to influence pTh differentiation. However, there is conflicting data regarding 
the role that each of these factors plays in determining the Th phenotype. The best 
defined co-stimulators are B7-1 and B7-2, whose kinetics have been characterized on B 
cells and dendritic cells cultured in vitro (Hathcock et al., 1994), but not on traditional
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antigen presenting cells during in vivo immune responses. B7-2 expression, which tends 
to exceed B7-1 by as much as 100 fold (Inaba et al., 1994), is induced early during 
activation, followed later by B7-1 expression. However, alterations in the course of B7-2 
and B7-1 expression have been characterized (Hathcock et al., 1994; Lenschow et al., 
1994; Constant et al., 1995). Both molecules bind to their T-cell receptors, CD28 and 
CTLA4, with differing avidity (Kariv et al., 1996) and CD28, which is constitutively 
expressed on all T cells, has a 20 fold lower binding avidity for B7 molecules than 
CTLA4, which is expressed following activation (Linsley et al., 1991b).
CD28/B7 interactions are required for early IL-2 production during activation of 
naive T-cells, thereby complicating interpretation of the effects of B7 interactions on Th 
differentiation (Seder et al., 1994). Blocking of CD28/B7 interactions in Thl clones, 
which inhibited IL-2 production but did not affect cytokine secretion by Th2 clones, 
provided the first evidence o f a possible B7 mediated costimulatory effect (Mcknight et 
al., 1994). Since that time studies of B7 mediated signals have yielded conflicting results. 
A number of studies using antibodies to B7-1 and B7-2 indicate that B7-1 mediated T- 
cell stimulation provides co-stimulatory signals for TH1 differentiation, while B7-2 helps 
to drive TH2 differentiation (Freeman et al., 1995; Kuchroo et al., 1995, Lanier et al., 
1995 and reviewed in Constant and Bottomly, 1997). However, there are also conflicting 
studies that report the reverse effect (Lenshow et al., 1995; Levine et al., 1995; Natesan 
et al., 1996) or no effect (Lanier et al., 1995 and reviewed in Constant and Bottomly, 
1997) on Th differentiation. In contrast to the aforementioned studies which examined 
the immune responses to systemically administered protein antigens, B7-1 and B7-2 
neutralization experiments in a mouse model of gastrointestinal nematode infection in
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which Th2 responses are protective showed that blocking both molecules was required 
to decrease Th2 responses, but there was no elevation in Thl cytokines (Gause et al., 
1997).
The variable effects of anti-B7 antibodies in different disease states have been 
postulated to reflect the significance of different antigen presenting cells and 
concentrations of antigen at different stages of an infection (reviewed in Constant and 
Bottomly, 1997). Differing characteristics of the antigen, including low dosage and/or 
other characteristics that result in weak TcR signaling, could increase the requirements 
for costimulation which may be mediated primarily by B7-2 because it is more rapidly 
upregulated. Whereas, in the case o f high antigen density or antigens that for other 
reasons potently signal via the TcR, the need for co-stimulation may be limited or even 
bypassed, such that exogenously added blocking antibodies would have little effect on 
the response. Other authors have suggested that differences in neutralization studies with 
B7-1 and B7-2 reflect differences in the nature of the immune response to intact 
pathogens, as compared to protein antigens, withB7-l being able to provide both a co­
stimulatory and a down-regulatory signal (Gause et al., 1997).
Equally confusing and interrelated are the effects of differential B7 signaling 
through the CD28 and CTLA4 receptors on T cells. However, unlike B7 mediated 
signaling experiments, a variety o f in vitro and in vivo systems suggest that CTLA-4 
mediated signaling is integral to the generation of Th2 responses in naive T-cells 
(reviewed in Gause et al., 1997). Blocking CTL-4 mediated signaling at the beginning of 
the immune response inhibits the generation of Th2 responses but has no effect if 
administered following the initiation of the immune response (Corry et al., 1994; Lu et
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al., 1995, 1995). Taken together with the dependence of Thl clones and naive T-cells on 
TcR and CD28 mediated signaling for activation and IL-2 production (Linsley et al., 
1991a; Reiser et al., 1992), and the ability o f some Th2 clones to utilize EL-4 as an 
autocrine growth factor (McArthur and Raulet, 1993) or to utilize IL-1 as a cofactor 
with TcR crosslinking without CD28 costimulation (Lichtman et al., 1988; Weaver and 
Unanue, 1990; McArthur and Raulet, 1993), CD28/CTLA-4 signaling appears to be 
required for IL-2 and IFN-y production in vitro and for the differentiation of naive T- 
cells into Th2 cells, but not for the activation of differentiated Th2 cells, which appear to 
be able to utilize other co-stimulatory molecules (reviewed in Gause et al., 1997). 
Differential Regulation of T h l and Th2 Responses
Shortly after characterization of Thl and Th2 clones it was discovered that IFN- 
y could inhibit proliferation and cytokine synthesis of Th2 clones (Femandez-Botran et 
al., 1988; Gajewski and Fitch, et al., 1988) and search for a Th2 derived cytokine that 
inhibited cytokine synthesis o f Thl cells lead to the discovery of IL-10 (Doherty et al.,
1993). Continued interest in the differential regulation o f these two populations has 
indicated that cytokines from each Th population inhibit functions of the opposite 
phenotype. The cross-regulatory mechanisms appear to be quite complex with co­
stimulatory molecules and a variety of cytokines being capable of exerting inhibitory 
roles. Significantly, IL-13 has been shown to inhibit IL-12 production by macrophages 
(de Waal Malefyt et al., 1993). However, this discussion will be limited to cross- 
regulatory mechanisms mediated by IL-4, EL-10, IFN-y and IL-12.
IL-4 has been shown to prevent the generation o f IFN-y producing Thl cells 
from accessory cell stimulated TcR transgenic (Hseih et al., 1992; Seder et al., 1992b;
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Tanaka et al., 1993) and polyclonally stimulated naive CD4+ T cells (reviewed in Swain 
et al., 1991). There is also ample evidence that IL-4 inhibits effector functions of Type I 
populations in vivo. IL-4 inhibited delayed type hypersensitivity reactions and IFN-y 
production by lymphocytes draining the site of antigen challenge as effectively as IL-10 
(Powrie et al., 1993). In the murine model of Leishmania major infection in which 
susceptibility is associated with a Th2 cytokine profile and resistant mice exhibit a Thl 
cytokine profile, exogenous IL-4 blocks the generation of the IFN-y producing 
protective Thl phenotype in resistant strains (Chatelain et al., 1992), while neutralizing 
EL-4 at the time of/,, major challenge converts susceptible mice to a resistant Thl 
response (Heinzel eta l., 1989;; Saddick et al., 1990; Chatelain etal., 1992). Unlike IL- 
4 neutralization, neutralizing IL-10 does not change the course o f L. major infection in 
susceptible strains (Coffinan et al., 1991), suggesting that IL-4 may be more potent than 
EL-10 in the differential regulation o f Th phenotype. However, unlike IL-10, IL-4 does 
not inhibit proliferation or cytokine production by Thl clones .
Despite the intense interest in Thl and Th2 responses, the mechanisms by which 
IL-4 inhibits Thl differentiation and EFN-y production are poorly characterized. IL-4 has 
been shown to down regulate expression of the IL-12 R P2  subunit during Th2 
differentiation, thereby inhibiting IL-12 signaling that drives Thl differentiation (Gollob 
et al., 1997; Szabo et al., 1997). IL-4 is also a potent down regulator o f macrophage 
function and has been shown to reduce CD40 mediated IL-12 secretion by dendritic cells 
(Kelsall et al., 1996). EL-4 inhibition o f IL-2 production and associated priming for 
IFN-y production may also play a factor (reviewed in Seder and Paul, 1994), though
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IFN-y does not appear to be essential for the generation of Thl responses in all systems 
(Seder etal., 1993; McKnight et a l, 1994).
EL-10 was first recognized as a cytokine produced by mouse Th2 clones that 
inhibited cytokine synthesis by, but not proliferative responses o f  Thl clones 
(Fiorentino etal., 1989). However, human IL-10, which is clearly not exclusively a Th2 
cytokine, has been shown to inhibit both proliferation and cytokine production by Thl as 
well as Th2 cells (Del Prete et al., 1993). In the face of conditions that usually propagate 
a Th2 response, including in vitro cultures of TcR transgenic mouse T cells (Coffinan et 
al., 1991), as well as in vivo models of murine gastrointestinal nematode infection 
(reviewed in Urban et al., 1991b), neutralization of IL-10 changes the cytokine pattern 
to Thl-like. However, as previously noted, IL-10 neutralization is not sufficient to alter 
the course of L. major infections in susceptible hosts, while IL-4 neutralization will 
(Coffinan et al., 1991).
Early on it was recognized that IL-10's inhibitory effect on cytokine production 
by Thl clones required antigen presenting cells and had a delayed onset ( 8  hours) 
(Fiorentino et al., 1989), suggesting that IL-10 acted via an indirect APC dependent 
mechanism. Consistent with these early findings, EL-10 has been shown to inhibit 
expression of co-stimulators, such as B7-1 on antigen presenting cells (Ding et al., 1993) 
that are required for up regulation of IFN-y production by some Thl clones, and to 
inhibit the induction of Thl development from naive T-cells by inhibiting IL-12 
production by antigen presenting cells (D* Andrea et al., 1993; Kennedy et al., 1994; 
Murphy et a l, 1994; Minty et a l, 1997).
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IFN-y and IL-12 have both been shown to play a role in the down regulation of 
Th2 responses. IFN-y inhibits the proliferative response of Th2 cells (Femandez-Botran 
et al., 1988; Gajewski and Fitch, 1988; Maggi et al., 1992), as well as their generation 
from naive CD4+ cells (Femandez-Botran et al., 1988; Noble et al., 1993). However, 
this latter effect is dependent upon the degree of IL-4 priming present (Seder et al., 
1992b). With optimal levels o f  EL-4, EFN-y is not sufficient to inhibit the generation of 
the Th2 phenotype. However, in the presence of suboptimal IL-4 concentrations, IFN-y 
inhibits the generation o f IL-4 producing Th2 cells. In vivo findings in the mouse L. 
major model using IFN-y supplementation (Scott, 1991) and neutralization (Reiner and 
Locksley, 1995) substantiate the findings that IFN-y decreases IL-4 production in 
susceptible strains, but unlike IL-4 neutralization, IFN-y administration is not sufficient 
to induce the protective Thl phenotype (Sadick et al., 1990; Reviewed in Scott, 1991; 
Reiner and Locksley, 1995).
The mechanisms by which IFN-y inhibits Th2 differentiation and effector 
functions are not clear. CD28 mediated co-stimulation of Th2 cells has been 
demonstrated to induce IL-4 responsiveness in an EL-1 dependent manner, and IL-1 
receptors, which are expressed on T-cells only after primary stimulation (Luqman et al.,
1992), are upregulated on Th2 cells following EL-4 exposure (Koch et al., 1992). 
Accordingly, a growing number o f experiments indicate IFN-y inhibits Th2 proliferation 
by inhibiting EL-1 co-stimulation (Gajewski and Fitch, 1988; Oriss etal., 1997). 
Differentiation to Thl is also associated with loss of the IFN-y RP chain which is 
maintained on ThO and Th2 cells (Pemis et al., 1995), and Th2 cells have been shown to 
transduce signals via this receptor that are lacking in Thl clones (Pemis et al., 1995;
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Groux et a l, 1997), suggesting that IFN-y may provide negative signals that inhibit Th2 
differentiation. However, the significance of the IFN-y receptor on Th2 cells remains 
enigmatic. Studies o f rIL-12 mediated suppression of Th2 responses in murine 
leishmaniasis (Heinzel et al., 1993) and murine graft vs host disease (Via et al., 1994) 
indicate that IFN-y is required for inhibition of IL-4 priming. Accordingly, IFN-y KO 
mice on a resistant Thl background switch to the susceptible Th2 phenotype when 
challenged with L. major (Wang et al., 1994a). However, IFN-yR KO mice effectively 
mount Thl responses to pseudorabies (Schijns et al., 1994) and L. major (Swihart et al., 
1995), even in the presence of IFN-y neutralizing antibodies.
While it is well accepted that IL-12 inhibits Th2 responses (Manetti et al., 1993), 
factions stand divided as to the IFN-y dependence of this inhibition. As previously 
indicated, IL-12 mediated Th2 inhibition has been shown to be EFN-y dependent using 
EFN-y neutralization experiments in a number of murine Th2 models, including graft vs 
host disease (Via et al., 1994), the egg granuloma stage of S. mansoni (Finkelman et al., 
1994; Oswald et al., 1994; Wynn et al., 1994), anti-IgD stimulation (Morris et al.,
1994), and leishmaniasis (Heinzel e ta l., 1993). However, the leishmaniasis model 
presents a paradox. IL-12 adminstration at the time of infection protects susceptible 
strains in an IFN-y dependent manner (Heinzel et a l, 1993), but other experiments 
support direct inhibition of IL-4 production by IL-12. Exogenous EL-12 decreases EL-4 
transcription and protein production, converting susceptible strains to resistant if 
administered during the first week o f infection (Seder et al., 1993; Sypek et al., 1993), a 
time when both resistant and susceptible strains produce equivalent amounts o f IFN-y 
(Morris et al., 1992; Reiner et al., 1994). Furthermore, experiments with EFN-y
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neutralization in Balb/c and IFN-y KO mice indicate that IL-12 can directly inhibit EL-4 
transcription independent o f  IFN-y (McKnight eta l., 1994; Wang e ta l, 1994b). As 
with all cytokine treatments, timing appears critical in that rIL-12 cannot suppress 
established Th2 responses (Heinzel e ta l, 1993; Finkelman eta l., 1994; Via et a l, 1994; 
Wang et al., 1994b), due to a  lack of the IL-12R signaling chain on ThO and Th2 cells 
(Szabo et al., 1995; Gollob et a l, 1997; Rogge et a l, 1997). However, the finding that 
early exposure of Th2 cells to EFN-y maintains the EL-12RP subunit (Szabo et al., 1997) 
suggests a mechanism by which some CD4+ subpopulations can exhibit IFN-y 
independent EL-12 mediated suppression of IL-4 production.
In Vivo Significance of the Thl/Th2 Paradigm
Studies o f L. major in mice were especially significant because they 
demonstrated for the first time that susceptibility or resistance to disease are attributable 
to the specific Thl or Th2 phenotype that is generated during interaction with the 
pathogen and that endogenous cytokines produced as a result o f interaction with the 
pathogen not only determine the Th phenotype that is generated, but can be manipulated 
to direct the development o f  a protective or resistant Th phenotype (reviewed in Reiner 
and Locksley, 1995). Thus, lymphocytes draining the lesions of disease resistant 
C57BL/6 and C3H/HeN mice produced Thl cytokines, while lymphocytes draining the 
lesions of Balb/c mice, which develop a chronic and eventually lethal systemic disease, 
produced Th2 cytokines. Furthermore, treatment of resistant mice with anti-EFN-y or 
anti-IL-12 ablated Thl development resulting in a susceptible Th2 expressing phenotype, 
whereas treatment of susceptible mice with anti-IL-4 or IL-12 supplementation inhibited 
Th2 differentiation and conferred a resistant Thl phenotype. Interestingly, IFN-y
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supplementation was not sufficient to drive conversion of susceptible mice to the 
resistant phenotype, though it did substantially reduce IL-4 production. Further 
investigation has substantiated a major role for IFN-y in protection from Leishmania in 
that resistant C57BL/6 mice with disruption of the EFN-y gene converted to the 
susceptible Th2 phenotype (Wang et al., 1994a). However, other non-IFN-y dependent 
mechanisms for control of Leishmania appear to exist as IL-12 has been shown to 
suppress IL-4 transcription even in the absence of IFN-y (McKnight et al., 1994; Wang 
etal., 1994b).
Since the original characterization of Thl induced resistance to L. major, a 
growing number o f studies have supported the notion that Thl responses, by virtue of 
their EFN-y and TNF-a mediated potentiation of macrophage cytocidal activities, play a 
crucial role in defense against a wide variety of intracellular pathogens, including 
parasites, bacteria, and viruses (Sher and Coffinan, 1992; Kaufman, 1993). Thl 
responses have been associated with protection in human leprosy (Yamamura et al., 
1991b), human lyme disease (Yssell et al., 1991), human leishmaniasis (Pirmez et al., 
1990; Pirmez et al., 1993), Toxoplasma gondii (Suauki et al., 1989), Plasmodium sp. 
(Sedegah et al., 1994; Stevenson et al., 1995), Cryptosporidium parvum  (Ungaar et al., 
1991; Urban et al., 1996), Listeria monocytogenes (Buchmeier and Schreiber, 1985; 
Hsieh et al., 1993), and murine cytomegalovirus (Orange et al., 1996) infections (From 
Finkelman et al., 1997). However, macrophages are certainly not the sole mediators of 
resistance in Thl dominated responses in vivo, with NK cell, CTL, and cytotoxic 
antibody responses all being induced or augmented by Thl cytokines.
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Thl responses by virtue of their activation and recruitment o f macrophages to 
the site o f infection result in delayed type hypersensitivity reactions. This is especially 
true for slow growing, persistent organisms, such asM  leprae, for which resistance has 
been associated not only with the development of Thl responses but also the presence of 
granulomatous inflammation (Yamamura etal., 1991). However, Thl responses, by 
virtue of the toxic side effects o f TH1 cytokines and inflammatory mediators from 
recruited cells, can result in pathological inflammatory reactions. In particular, Thl 
cytokines have been linked to diseases characterized by organ-specific autoimmunity 
(reviewed in Romagnani, 1994), including autoimmune thyroiditis, Crohn's disease, 
experimental autoimmune uveoretinitis (Dubey et al., 1991), experimental allergic 
encephalomyelitis (Beraud et al., 1991), insulin-dependent diabetes mellitus (Hahn et al., 
1987), and multiple sclerosis (Benvenuto, etal., 1991; Brod et al., 1991). It is certainly 
tempting to attribute such disease to faulty Th2 cross-regulatory mechanisms, especially 
in light of the association of lethal exacerbations of pathogen induced inflammatory 
reactions with disruption o f the IL-10 gene (Gazzinelli et al., 1996).
In contrast to intracellular pathogens, studies of parasitic helminths in rodent 
models indicate that Th2 responses provide protection from extracellular pathogens 
primarily via phagocyte independent mechanisms. Though many parasites have been 
studied to determine the Th phenotype induced in susceptible versus resistant hosts, four 
models are primarily responsible for establishing that Th2 responses are important for 
protective immunity to nematode parasites. These are Trichinella spiralis, 
Heligmosomoides polygyrus, Nippostrongylus brasiliensis, and Trichuris muris 
(reviewed in Urban et al., 1992; Finkelman et al., 1997).
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The lifecycles o f these four parasites have been briefly reviewed (Urban et al., 
1992; Finkelman et al., 1997). H. polygyrus and T. muris have strictly enteral lifecycles. 
H. polygyrus third-stage larvae (L3 ) invade the wall of the small intestine, then enter the 
gastrointestinal lumen approximately 7 days after infection, mature to adults, and remain 
alive for a period o f several months in susceptible (Balb/c) strains. Challenge infections, 
however, are eliminated more rapidly in immune hosts, especially in rats where the effect 
is extremely rapid, occurring within 1 hour of challenge. T. muris, which infects as Lj in 
a resistant egg, parasitizes the large intestine. Infections are chronic in some strains 
(B10.BR) and more short lived in most inbred mouse strains (Balb/k), which expel the 
parasite before it develops into egg laying adults.
In contrast to H. polygyrus and T. muris, the lifecycles o f T. spiralis and N. 
brasiliensis have visceral migration phases. T. spiralis infects its hosts as Lt, matures 
and mates within 2  days of infection, and then resides within the wall o f the small 
intestine, where females release larvae beginning 4-7 days after ingestion. Larvae migrate 
through the body via intestinal lymphatics and venules, settling primarily in striated 
muscle where they encapsulate. Adults are generally expelled from rodents less then 2 
weeks following ingestion. N. brasiliensis penetrates the skin o f hosts as L3  and migrates 
to the lungs by 36 hours, where the parasite causes eosinophilic granulomas before being 
coughed up, swallowed, and maturing to egg laying adults in the small intestine. N. 
brasiliensis have been mouse adapted. In the mouse the prepatent period is 5-6 days. N. 
brasiliensis are expelled by 1 0  days after inoculation, and challenge infections are 
characterized by a decrease in the number of larvae that reach the intestine, and 
markedly reduced or obliterated egg production.
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Protective immunity to each o f these parasites has been shown to be CD4 
dependent (reviewed in Finkelman et al., 1997). Anti-CD4+ mAh treatment causes 
increased fecundity in primary H. polygyrus infections, blocks immunity to H. polygyrus 
challenge infections (Urban et al., 1991a), prolongs primary infections in T. muris 
resistant mice (Koyama et al., 1995), prevents expulsion of N. brasiliensis (Katona et 
al., 1988), and prevents the rapid expulsion of T. spiralis in previously infected rats (Vos 
eta l., 1983).
IFN-y and IL- 1 2  have been shown to inhibit protective immunity to 
gastrointestinal nematodes. These effects are most evident in T. muris and N. 
brasiliensis infections (reviewed in Finkelman et al., 1997). Mouse strains that develop 
chronic T. muris infections produce strong IFN-y responses as compared to resistant 
strains which produce a strong EL-4 response (Else and Grencis, 1991; Else el al., 1992). 
IFN-y neutralization at the time o f T. muris inoculation shortens the duration of 
infection (Katona et al., 1988). IFN-y (Urban et al., 1993) or IL-12 (Finkelman et al.,
1994) supplementation during M. brasiliensis inoculation enhances egg production and 
prolongs the duration o f infection. IL-12 administered in this manner will also retard, but 
not inhibit the Th2 response leading to rapid clearance of challenge infection (Finkelman 
eta l., 1997). IL-12 also increases the susceptibility of resistant hosts to T. muris 
(reviewed in Finkelman e ta l., 1997). EL-12's effects in enhancing susceptibility have 
been shown to be IFN-y dependent using IFN-y mAB and IFN-y KO mice (Finkelman 
et al., 1994). Though IFN-y was once thought to contribute to T. spiralis resistance 
because of the more rapid expulsion from mouse strains expressing higher IFN-y (Pond 
et al., 1989), subsequent studies using IFN-y neutralizing antibodies (Finkelman et a l,
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1997) and adoptive transfer o f immune T cells expressing Thl or Th2 phenotypes 
(Ramaswamy et al., 1994) now indicate that Th2 phenotypes are significant in protection 
immune responses directed against this parasite.
Studies of the effect o f IFN-y supplementation on immunity to nematode 
parasites were also enlightening because they suggested that strongly polarized Thl or 
Th2 responses could interfere with the ability to generate the opposite response in vivo. 
Heat killed Brucella abortis injected intravenously, a strong inducer of IFN-y 
production, increased N. brasiliensis adult worm survival and fecundity in a manner 
similar to that of exogenous IFN-y (Urban et al., 1993). These parasite sparing effects 
were reversed by the administration of anti-EFN-y and anti-EFNa/p, suggesting that 
animals with systemic IFN responses may be more likely than healthy animals to develop 
severe nematode infections. This finding was also consistent with observations from 
Eimeria spp. infected mice, which have enhanced IFN-y production but demonstrate 
depressed eosinophil and mast cell responses and increased fecundity in response to 
infection with N. brasiliensis (Upton et al., 1987). Similarly, ongoing Th2 responses 
induced by helminth parasite antigens have been shown to alter the Thl phenotype of 
purified protein derivative (PPD)-specific Th cells to include EL-4 and EL-5 production 
(Pearlman et al., 1993).
Several other key characteristics of helper T cell phenotypes originated in studies 
of nematode infections. First, the nature of the helper T-cell response to a given 
pathogen is, at least for some pathogens, a local phenomenon (Svetic et al., 1993). 
Perhaps reflecting the totally enteral lifecycle, H. polygyrus infected mice displayed large 
increases in Th2 gene expression in gut wall, Pyefs patch, and mesenteric lymph nodes,
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while only minor changes were seen in the splenic expression of these cytokines. A. 
second finding was that the kinetics of Th cytokine expression are not always the same 
with different pathogens (reviewed in Urban et a l, 1992). IL-3, EL-5, and IL-9 were 
rapidly expressed within 24 hours of infection, followed by IL4, IL-10, and IL- 6  at day 3 
post-infection in H. polygyrus, whereas IL-3, IL-4, and IL-9 were expressed 3 days post 
and IL-5 at 8  days post infection with N. brasiliensis. H. polygyrus infected mice 
exhibited slight increases in EL-2 and IFN-y production followed by an IFN-y decrease 
below baseline levels, while N. brasiliensis infected mice failed to show increases in IL- 
10 or EL-2 and only exhibited a decrease in IFN-y production.
Though IL-4 production is a characteristic of nematode infections, its protective 
effects are best demonstrated in H. polygyrus and T. muris infections. Neutralization of 
EL-4 or the IL-4R blocks immunity to challenge infections with H. polygyrus (Urban et 
al., 1991b), and IL-4R neutralization converts T. muris resistant to susceptible hosts 
(Else et al., 1994). However, immunity to H. polygyrus appears to be more EL-4 
stringent than immunity to T. muris in that EL-4 KO mice fail to expel H. polygyrus but 
efficiently expel T. muris (reviewed in Finkelman et al., 1997). Thus, IL-4 appears 
necessary for immunity to H. polygyrus, but EL-4 alone has been shown to be insufficient 
for complete immunity in H. polygyrus infected SCID mice (Urban et al., 1995).
EL-4 appears to play a less crucial role in protective immunity against N. 
brasiliensis and T. spiralis. EL-4 and IL-4 R neutralization do not significantly alter the 
course of N. brasiliensis infection (Madden et al., 1991; Ungar et al., 1991) but 
sustained EL-4 stimulation via IL-4C (IL-4 complexed 2:1 with it's Mab to increase its 
half-life) cures CD4 depleted and SCID mice (Urban et a l, 1995). (This treatment also
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cures established T  muris and H. polygyrus infections in immunocompetent mice (Else 
et al., 1994; Urban, et al., 1995)). Studies in T. spiralis are limited by a lack o f IL-4 
neutralizing reagents for rats, but IL-4 R neutralization in the mouse model modestly 
exacerbated T. spiralis infections (Finkelman et al., 1997). IgE depleted rats have 
increased T.spiralis larval numbers (Dessein etal., 1981) and rapid expulsion can be 
transferred with purified IgE (Ahmad et al., 1991), suggesting a protective role for IL-4 
or IL-13, since as previously discussed, these cytokines are responsible for IgE isotype 
switching. The apparently unnecessary but protective effects o f  IL-4 in T. muris, N. 
brasiliensis, and T. spiralis have lead to the summary that while IL-4 is required for 
protective immunity to H. polygyrus infections, it appears to provide a redundant 
mechanism that becomes critical for some parasites when CD4 dependent mechanisms 
are blocked (Finkelman et al., 1997).
In addition to IgE production, nematode infections are characteristically 
associated with eosinophilia that is mediated by IL-5 (Coffinan et al., 1989; Sher et al., 
1990a, b) and mucosal mastocytosis that is mediated primarily but not exclusively by the 
combined effects o f IL-3 and IL-4 (Takeda et al., 1997). Though eosinophils are known 
to kill some parasites in vitro, IL-5 neutralization experiments which obliterate in vivo 
eosinophilia have failed to indicate a necessary role for eosinophils in the immune 
response to T. muris (reviewed in Finkelman et al., 1997), N. brasiliensis (Coffman et 
al., 1989), and H. polygyrus (Urban et al., 1991b). However, there is evidence that IL-5 
dependent mechanisms may be significant outside the confines o f the intestinal tract. 
Anti-eosinophil serum has been shown to increase T. spiralis muscle larval recoveries 
(Grove et al., 1977), and transgenic mice expressing elevated IL-5 levels exhibit
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increased killing of M. brasiliensis in lung tissues (reviewed in Finkelman et al., 1997). 
Additionally, ablation of the eosinophil response with anti-IL-5 enhanced the survival o f 
Angiostrongylus cantonensis (Sasaki etal., 1993) and Strongyloides venezuelensis 
(Korenaga et al., 1994) in mouse brain and lung, respectively.
In order to determine how IL-4 controls H. polygyrus and T. muris infections, 
studies have focused on the physiological effects of this cytokine that could limit 
infection (reviewed in Finkelman et al., 1997). Early evidence that IL-4 might have 
physiological effects came from studies of T. spiralis infections in immune rats in which 
mast cells (Woodbury et al., 1984) and IgE (Ahmad et al., 1991), both regulated by 
IL-4, have been shown to be strongly associated with the rapid expulsion phenomenon.
A localized anaphylactic reaction in which chemical mediators of anaphylaxis, including 
serotonin, leukotrienes, and prostaglandins released through IgE or IgG mediated mast 
cell degranulation cause increased smooth muscle contraction and increased fluid 
secretion may be one mechanism which inhibits larval penetration of the mucosa. 
Unfortunately, the role o f IL-4 in this phenomenon has not been elucidated because EL-4 
neutralizing antibodies and IL-4 knockout rats are not available. Like T. spiralis, specific 
antibodies can promote T. muris expulsion though mast cells do not appear to be 
necessary. The role o f IL-4 (or IL-13) in T. muris expulsion has not been well 
characterized.
In H. polygyrus infections of mice, mAb to the IL-4 R has been shown to block a 
mast cell and leukotriene dependent, parasite induced, increase in small intestinal fluid 
influx and smooth muscle contractility during challenge infections. These changes can 
also be induced in non parasitized mice treated with IL-4C. Though these findings
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suggest a mechanism by which EL-4 could be directly responsible for immunity in H. 
polygyrus, there are a number o f discrepancies. Changes in smooth muscle contractility 
with IL-4C treatment lag behind, by 3-5 days, the treatment induced decrease in 
fecundity. In addition, in the natural immune response to H. polygyrus, endogenous EL-4 
appears to eliminate early parasite stages, while mechanisms mediated by exogenous IL- 
4 are directed against adult worms. Studies of IL-4's role in other immune mechanisms 
including antibody-mediated defenses and alterations in cellular adhesion molecules such 
as VCAM-1 are an area of continued investigation.
Primary N. brasiliensis infections have also been shown to induce changes in 
intestinal smooth muscle contraction and fluid dynamics, though these changes are B 
cell, T cell, Ieukotriene, and mast cell independent. The role of EL-13 in protective 
immunity to nematodes is an area of great interest at this time because STAT6  KO mice 
fail to expel N. brasiliensis (Finkelman et al., 1997) and STAT6  is only known to be 
involved in EL-4 and IL-13 receptor transduction (Yssell et al., 1991). Other IL-4 
independent mechanisms that induce expulsion oiN . brasiliensis are an ongoing focus of 
study and include mucous trapping, antibody dependent mechanisms, and lipid 
peroxidation (Finkelman et al., 1997).
Like Thl responses, Th2 responses have also been linked to a number of human 
diseases (reviewed in Romagnani, 1994). Allergen specific T-cells from atopic 
individuals preferentially express TH2 profiles, while those from nonatopic donors 
express Thl/ThO profiles. Th2 but not Thl cytokines have been found via in situ 
hybridization at the site of late phase reactions from atopic patients, bronchial biopsies 
and BAL fluids from asthma patients, allergen challenged nasal mucosa of allergic
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rhinitis patients, and in the BAL fluids of allergic asthmatics. Over production of Th2 
cytokines and an associated decrease in Thl cytokines has also been documented in one 
person with Omenn's syndrome, a rare immunodeficiency characterized by 
hypereosinophilia and increased serum IgE.
In the eleven years since the cytokine profiles of mouse helper T cell clones were 
first characterized, continued study of the in vivo cytokine responses to a variety of 
stimulating antigens has confirmed that Thl and Th2 responses are true in vivo 
phenomena which determine the resistance or susceptibility to pathogens. Noting that 
some Th2 mediated functions are required for immunity to certain parasites while being 
redundant for other parasites (eg IL-4 for H. polygyrus vs N. brasiliensis immunity), it 
has been suggested that Th2 mediated immune mechanisms are generalized responses 
initiated by attributes that are common to Th2 inducing pathogens (Finkelman et al., 
1997). Proteolytic enzymes are one potential common thread among Th2 inducing 
extracellular pathogens which tend to traverse integumentary surfaces, but the 
immunologic role of these enzymes has been poorly studied. In the case of Thl inducing 
attributes, lipopolysaccharide (LPS) is known to induce IL-12 production (Ozmen et al.,
1994) and is common to a number of Thl inducing organisms. Therefore, it is likely that 
for both Thl and Th2 responses, certain attributes are common to the organisms that 
evoke the respective response. It has further been suggested that the Thl pathway which 
protects against intracellular pathogens can be summarized as simply an EL-12/EFN- 
y/iNOS mediated pathway, sharply contrasting the diverse mechanisms identified for the 
control of nematode pathogens. Given the rapid rate of genetic mutations in single celled 
organisms, it would seem that redundancies in Thl responses are even more critical to
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the survival o f the host than Th2 redundancies. Furthermore, redundancies in the Thl 
response have been identified. For example, in addition to nitrogen-dependent 
mechanisms, macrophages possess potent oxidative metabolic pathways which are 
known to kill pathogens (Jones, 1993). At the cytokine level EL-18, which like IL-12 is 
also induced by bacterial pathogens, potently induces IFN-y production, in an IFN-y 
independent manner (Kohno et al., 1997). Antibodies induced during Thl responses may 
also have phagocyte independent effects, such as virus neutralization and complement 
mediated cytotoxicity. Thus, it appears that Thl and Th2 responses are more like sides 
of the same coin. Each response being induced by pathogen attributes that relegate the 
pathogen to one of two immunologically relevant groups, with diverse effector mech­
anisms in each response being redundant for some pathogens but required for others. 
Strongylus vulgaris a Potential Model for the TH2  Paradigm in Horses
Because of the clear association between TH2 responses and nematode parasite 
infections, a nematode parasite of horses was studied to determine if cytokine profiles 
suggestive of the TH2 phenomenon are evident in the equine species. Strongylus 
vulgaris is considered the most pathogenic nematode parasite of horses due to the 
severe arterial lesions it causes in the cranial mesenteric artery during larval 
migration. The life-cycle has been extensively reviewed (Enigk, 1950, 1951; Duncan 
and Pirie, 1972; Ogbourne and Duncan, 1985). Infective third-stage larvae (L3 ) 
ingested from contaminated pasture penetrate the mucosa primarily of the cecum and 
ventral colon where they migrate for 4-7 days reaching the submucosa. There, larvae 
molt to the fourth-stage (L4) and then proceed along arterioles and arteries that supply 
the intestine toward the root o f the cranial mesenteric artery. Upon reaching the
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regions of ileo-ceco-colic and cranial mesenteric arteries, larvae cease migration and 
molt to become immature adults (Ls), causing severe arteritis before returning, again 
via the vasculature, to complete their life cycle in the large intestine. Arterial lesions 
include the formation o f tortuous subintimal tracts, thrombi, and in severe cases, 
verminous aneurysms, which can compromise perfusion of intestinal vascular beds. 
This syndrome, known as verminous arteritis or thromboembolic disease, is 
characterized by ischemic infarctions of the bowel which result in toxemia, abdominal 
pain, and death in severe cases (White, 1985). Though the life cycle is prolonged, 
taking 4-6 months to complete, signs associated with large innoculae of virulent L3  
including pyrexia, anorexia, depression and abdominal pain appear within the first 
week following L3  ingestion and are near maximal by 14 days post infection (Klei et 
al., 1982).
Though the importance of S. vulgaris as an equine pathogen has decreased 
(Herd, 1990) due to regular use of ivermectin, which is efficacious against adult and 
migrating larval forms o f the parasite (Slocombe et al., 1982; Klei et al., 1984), S. 
vulgaris provides several advantages as a model in the study of the equine immune 
response to nematode parasites. Horses can acquire an incomplete resistance to further 
infection from natural exposure to S. vulgaris L3  (Amborski et al., 1974; Duncan, 
1975; Klei et al., 1986), indicating that immune modulation in order to limit S. 
vulgaris infestations is likely to be an attainable goal and that elucidation of the 
mechanisms that limit natural infection could serve as a model to define some aspects 
of the equine response to nematode parasites that may have more universal 
applications. Singular infections can be produced by surgical implantation of adults
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
42
into parasite free ponies (McClure et al., 1994) and late L3  and early L4  have been 
successfully cultured in vitro (Chapman et a l., 1994). This provides both a ready 
source of feces for collection of infective S. vulgaris L3  and a  source of late L3  and L4  
for characterization of the host immune response to these forms. While mature L5  
forms can be procured fairly easily from necropsy specimens, the availability of late 
L3  and early L4  forms provides an invaluable tool for the characterization and 
manipulation of the host immune reponse to these forms. As early larval forms 
represent the first line of immune evasion that ultimately leads to a patent and 
pathogenic S. vulgaris infection, successful vaccine strategies will likely be directed 
against epitopes of these early larval forms. In support of this, previous studies have 
demonstrated that oral vaccination with radiation-attenuated S. vulgaris L3  induces 
resistance to challenge infection for up to 9 months (Klei et al. , 1989) and prevents 
classical lesions of verminous arteritis (Klei e ta l., 1982). However, radiation- 
attenuated S. vulgaris vaccination does have its practical limitations. The protection is 
species-specific and is influenced by management practices in that vaccinated animals 
reared without anthelmintic therapy up until the time of challenge are not protected 
from challenge infections of S. vulgaris, whereas vaccinates reared with anthelminitc 
therapy are protected (Klei et a l., 1989), suggesting that ongoing parasitism interferes 
with the protective immune response induced by vaccination.
Eosinophils, though not apparendy essential in the protective immune response 
to helminth parasites (Coffman et a l., 1989; Sher et al., 1990a; Urban et al., 1991b), 
are considered a hallmark of helminth infections (Finkelman et a l., 1991) and 
eosinophilia is an IL-5 dependent phenomenon (Coffman et al., 1989). Following
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
43
infection with S. vulgaris, both circulatory and tissue eosinophilia develop. A primary 
circulatory eosinophilia occurs 3-5 weeks after infection in parasite free and 
previously infected animals (Amborski et a l., 1974; Duncan and Pirie, 1975; Hofing 
and Bennett, 1982) and corresponds temporally to establishment of larval infestation 
in the mesenteric arteries. The timing of peripheral eosinophilia in ponies parenterally 
vaccinated with larval or adult somatic extracts follows this pattern. However, both 
irradiated larval recipients (Monahan et al. , 1994) and strongyle naive ponies 
receiving immune serum (Klei, 1992) experience an anamnestic eosinophilia, which 
begins to rise on week 2  following challenge and reaches a higher maximal value than 
that of parenterally vaccinated ponies on week 4 . Primary eosinophilias have been 
shown to disappear between 6  and 8  weeks following infection, which was the case 
for parenterally and orally vaccinated ponies whose eosinophilia appeared to be 
falling by week 5 post challenge. Depending upon the immune status of the animal, a 
second peak in eosinophil numbers occurs sometime after the 8 th-10th week. This 
second eosinophilia, which tends to remain until the 2 0 th week, may be delayed in 
lightly infected animals (Bailey, 1984) and its occurrence in horses with pre-existing 
infections following experimental challenge is unclear (Amborski et al., 1974; Bailey, 
1987). Trickle infections by contrast have been shown to result in sustained increases 
in eosinophil counts (Drudge et a l., 1966; Amborski et al., 1974). Tissue 
eosinophilia, along with a neutrophilic component, tends to predominate within the 
submucosa shortly after infection ( 2  days to 1  week) but subsides until approximately 
2-4 months following infection, presumably associated with larval return to the 
intestine (Duncan and Pirie, 1972, 1975). By week 3 following infection,
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inflammatory cells of the arterial intima are primarily plasma cells, lymphocytes, and 
neutrophils with few eosinophils, though eosinophilic infiltration of the adventitia 
predominates. In other helminth systems, eosinophilia has been demonstrated in 
associations with tissue migration, following parasite death in response to 
anthelmentic therapy, and in response to tissue sequestration o f helminth antigens 
(Walls and Beeson, 1972; Schriber and Zucker-Franklin, 1975).
In addition to the anamnestic eosinophilia associated with challenge infections 
in ponies rendered immune by radiation-attenuated oral vaccination, in vitro 
determinations of eosinophil functions suggest that eosinophils may play a role in the 
protective immune response to S. vulgaris infection. Eosinophils have been suggested 
to act as effector cells in anti-parasite immunity, based on their adherence and 
cytotoxicity toward a variety of nematode parasites, including Trichinella spiralis, 
Dictyocaulus viviparus, and Angiostrongylus cantonensis (Kazura and Grove, 1978; 
Wassom and Gleich, 1979; Kazura and Aikawa, 1980; Knapp and Oakley, 1981; 
Yoshimura et al., 1984). Eosinophils from ponies with S. vulgaris induced 
eosinophilia express more Fc and complement cell surface receptors than do 
eosinophils from strongyle naive ponies (Dennis et al., 1988), and activated 
eosinophils have been shown to release cytotoxic compounds including major basic 
protein and reactive oxygen metabolites (Venge, 1990) that could lead to worm 
destruction. Serum from strongyle immune ponies has been shown to mediate 
adherence of eosinophils from strongyle sensitized but not strongyle naive ponies to 
L3  resulting in L3  death (Klei et al., 1992), and suggesting that eosinophils become
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activated during S. vulgaris infections, allowing them to function as mediators of 
cellular cytotoxicity.
Parasites that exhibit multistage lifecycles complicate investigations of the 
host's antigen-specific immune response because of the diversity of antigens that each 
stage presents. Indeed this multistage changing of the parasite antigenic blanket, as 
well as the presentation of immunodominant antigens that divert the immune response 
from other epitopes that may be critical to the parasite's survival, are considered 
virulence factors employed by parasites. Early studies of the lymphoproliferative 
response to S. vulgaris L4  and Ls extracts indicated that these extracts were mitogenic 
and that differences in the proliferative responses of infected and noninfected animals 
could not be detected (Bailey et al., 1984). Fractionation of these extracts by gel 
filtration yielded three fractions which specifically stimulated lymphocytes from S. 
vulgaris infected but not helminth free foals (Bailey, 1987; Bailey et al., 1989). One 
fraction specifically stimulated PBMC from S. vulgaris infected ponies 1-3 weeks 
post infection, but this responsiveness decreased by 7 weeks post infection and was 
abscent by the end of the prepatent period, suggesting that the response was directed 
at early forms of the parasite. Similar studies of naturally infected equines indicated 
that the lymphproliferative responses were inversely correlated to larval burdens, 
being more responsive in animals with less severe infections, whereas experimental 
infections did not reveal differences in the proliferative responses of ponies receiving 
innoculae of 200 or 700 L, (Bailey, 1984). Specific proliferative responses to soluble 
adult 5. vulgaris antigens (SAWA) have been characterized in ponies with oral 
radiation-attenuated L3  vaccine induced resistance to challenge (Klei, 1992). These
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initial attempts failed to detect significant differences in the proliferative responses of 
resistant and non-resistant ponies, both before and after challenge infection. Specific 
proliferative responses to SAWA have been demonstrated in infected ponies and in 
ponies receiving trickle infections o f 50 L, per week for 25 weeks, both with and 
without the benefit of anthelmintic therapy (Dennis et al., 1992; Klei, 1992). 
Proliferative responses of PBMC from ponies receiving trickle infections were 
examined prior to challenge and on weeks 7, 25 and 27 into challenge. PBMC from 
all ponies, regardless of anthelmintic therapy, failed to proliferate on week 7 of 
challenge but developed a significant proliferative response to SAWA by week 25 of 
challenge, which was decreasing by week 27. Lymphocytes derived from the 
mesenteric and mediastinal lymph nodes of these ponies at week 27 indicated that 
mesenteric lymph nodes from ivermectin treated ponies were more reactive to SAWA 
than nontreated ponies, although this difference was not statistically significant. 
Mediastinal lymph node derived lymphocytes from ivermectin treated, untreated, and 
uninfected control ponies were equally unresponsive, suggesting a compartmental- 
ization of the antigen-specific immune response.
In addition to the specific lymphoproliferative reponses of S. vulgaris 
sensitized ponies, liberation of an eosinophil chemotactic factor or factors from 
SAWA stimulated PBMC of S. vulgaris sensitized ponies confirms the generation of 
cytokines in antigen-specific responses to S. vulgaris infections (Dennis et al., 1993). 
Supemates from SAWA stimulated PBMC of S. vulgaris sensitized but not S. vulgaris 
naive ponies exhibited an eosinophil chemotactic activity. This chemotactic activity 
was specifically stimulated by S. vulgaris in that S. vulgaris sensitized PBMC
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stimulated with S. edentatus antigen preparations did not induce eosinphil chemotactic 
activity. Though the chemotactic factor(s) was only partially characterized as a 
protein exceeding 8000 kDA that was heat labile and contained essential carbohydrate 
moieties, its production following in vitro antigen stimulation of PBMC that were 
sensitized to S. vulgaris in vivo suggests the presence of an eosinophil chemotactic 
factor that could contribute to the blood and tissue eosinophilia that is characteristic of 
S. vulgaris infection.
In part due to the complexity of the S. vulgaris system, in which antibodies 
evoked by the different larval stages suggest an array of epitopes that often cross react 
both with other larval stages of not only S. vulgaris but other parasite species as well, 
the role of antibodies in the protective immune response to S. vulgaris has been 
poorly characterized. Circulating P-globuIins increase following S. vulgaris infection, 
primarily due to an increase in IgG(T) production (Patton et a l., 1978) and S. 
vulgaris-specific antibodies have been demonstrated in response to infection (Bailey et 
al., 1989). The nature of the immunodominant proteins associated with infection 
appears to vary with the type of exposure to S. vulgaris (reviewed in Klei, 1992). 
Western blot analysis of adult antigen preparations identified 110, 100, 8 8 , and 79 
kDa proteins as immunodominant in one foal with naturally acquired resistance 
induced by trickle infectious of S. vulgaris, while a 21 kDa protein was recognized 
with serum from orally vaccinated foals that were protected from challenge infections 
by ivermectin treatment. 22 and 23 kDa bands were recognized by sera from all 
ponies vaccinated or previously infected and subsequently challenged with virulent Lj.
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To date, the reactivity of larval antigen preparations with immune horse serum has 
not been examined by western blot analysis.
Several findings heighten interest in antibodies specific for early S. vulgaris 
larval stages. When compared to parenteral vaccination with adult or larval somatic 
antigen homogenates, which did not confer resistance to challenge infection, oral 
radiation-attenuated L3  vaccinated ponies which were protected from challenge had 
higher prechallenge antibody titers specific for L3  surface antigens, as identified by 
indirect fluorescent antibody testing, which remained higher than those of parenterally 
vaccinated groups for two weeks following challenge (Monahan et al., 1994). These 
L3 -specific antibodies appear to be both species and stage specific in that antibodies 
from vaccinates did not cross react with L3  of the closely related S. edentatus parasite, 
but did react with both S. vulgaris and S. edentatus L4  (Klei et al., 1993). Antibodies 
directed at L4  stages were also higher in irradiated larval vaccinates prior to challenge 
but converged with those of parenterally vaccinated ponies by 2  weeks following 
challenge. In vitro assays also demonstrate that an anti-L^ antibody in immune sera 
promotes adherence of eosinophils from strongyle sensitized but not strongyle naive 
ponies to S. vulgaris L3 , but not L3  of closely related S. edentatus, resulting in L3  
death (Klei et a l., 1992) and suggesting that anti-L^ antibodies may function in 
antibody dependent cellular cytotoxicity mechanisms. These findings, in conjunction 
with in vivo findings that irradiated L3  vaccinates lack arterial lesions associated with 
migration of late larval and adult forms (Klei et al., 1982), while animals acquiring 
natural resistance sustain small numbers of later stage larval parasites in the face of an 
immune response that rejects newly acquired infections (Duncan, 1973; Amborski,
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Bell et al., 1974; Klei, 1986), suggest that antibody to early larval stages may play a 
role in the protective immune response generated by both natural immunity and 
irradiated larval vaccines. However, humoral factors adoptively transferred from 
immune ponies were not sufficient to protect nonimmune ponies when administered in 
conjunction with or prior to oral challenge with S. vulgaris L3  (Klei, 1992). In fact, 
the presence of high antibody titers in these adoptively transferred ponies, as well as 
titers induced by parenteral immunization with larval or adult somatic extracts in 
conjunction with Ribi adjuvant (Monahan et al., 1994), which also did not protect 
from challenge infections, actually resulted in an exacerbation of lesions normally 
associated with larval migration. This exacerbation of lesions seen with high 
circulating titers does not necessarily rule out a role for antibodies in the protective 
response to S. vulgaris but may suggest that additional factors, such as timing of the 
induction of certain epitope-specific antibodies, activation of cellular immune 
mechanisms, or differences in the local secretion pattern of antibodies within the 
lumen of the intestines may be significant in the protective immune response to S. 
vulgaris.
Helminth infections are characteristically associated with eosinophilia and 
elevated IgE production (Finkelman et al., 1991), traits that also characterize the 
Type II or TH2 response initially described in cloned mouse cells (Mosmann et a l., 
1986; Mosmann and Coffman, 1989b). Type II responses, identified by the 
production of IL-4 and IL-5, which are integral to the generation of IgE (Snapper and 
Paul, 1987) and eosinophilia (Coffman et al., 1989) respectively, have been shown to 
play a significant role in the protective immune response to metazoan helminths
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(reviewed in Mosmann and Coffman, 1989a; Cox and Lieu, 1992; Urban et al.,
1992). Though the role of IgE in equine S. vulgaris infection has not been examined 
because equine-specific reagents have not been made commonly available, S. vulgaris 
infections are characterized by the generation of a peripheral and tissue eosinophilic 
response. As previously described, following oral vaccination with radiation- 
attenuated S. vulgaris, the eosinophil response is induced in an amanestic fashion and 
eosinophil chemotactic activity has been found in the supernatants of S. vulgaris 
stimulated PBMC from immune but not nonimmune ponies (Dennis eta l., 1993). 
These findings suggest that differential cytokine production, perhaps similar to that 
seen in classical Type II responses to helminth parasites may play a role in the 
immune response to S. vulgaris.
Cytokine Quantitation
To date, no single surface marker has allowed Thl and Th2 clones to be 
distinguished so that identification in cloned cells (Mosmann et al., 1986), purified CD4+ 
T-cells (Swain et al., 1991), and more recently nonhomogeneous cellular populations 
(Yamamura et al., 1991; Robinson et al., 1992) has hinged on the ability to detect 
differing relative amounts o f the characteristic Thl or Th2 cytokines. Early studies 
examined supernatants from in vitro stimulated CD4+ T cells for cytokine activity using 
bioassays (Mosmann et al., 1986). However, assay cell lines typically respond to more 
than one cytokine and there are often positive and negative interactions between the 
activities of different cytokines. Additionally, supernatants from stimulated cells contain 
a variety of cytokines, many with effects on more than one cell type, making such assays 
unreliable and, when panels o f neutralizing antibodies were used in attempts to eliminate
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cytokine cross-reactivity, cumbersome. Thus, rigorously monospecific bioassays for 
cytokines are difficult to establish.
Enzyme linked immunosorbent assays (ELISAs) are especially useful for 
cytokine quantification in liquid samples, such as supemates, because they are 
quantitative, not subject to cytokine cross-reactivity, and easily adaptable to large sample 
throughput. However, two drawbacks to quantification of cytokine proteins by ELISA 
are that cytokine-specific antibodies must be generated, and samples for ELISA analysis 
are most commonly derived from cell culture, which introduces its own set o f biases.
Cherwinski et al. (1987) demonstrated that analysis of cytokine mRNA from 
ConA stimulated Thl and Th2 clones using northern hybridization correlated with the 
activity of the cytokine protein as determined in bioassays of supernatants. Furthermore, 
northern hybridizations were more efficient at detecting differences in cytokine 
production between Thl and Th2 clones then previously utilized bioassays. These and 
other findings confirmed that cytokines are transcriptionally regulated (Brorson et al., 
1991; Ye et al., 1997). Additionally, due to the advent of the polymerase chain reaction 
(PCR), generating molecular reagents for the quantification of cytokine mRNA is much 
less laborious then generating anti-cytokine antibodies. For these reasons, cytokine 
mRNA quantification has become the most commonly utilized method to identify 
cytokine profiles that characterize the Thl or Th2 phenotype.
A variety of methods have been utilized to quantify cytokine mRNA These can 
roughly be divided into northern hybridizations and PCR based methods. A quick scan of 
the literature suggests that northern hybridization methods, though still utilized, have 
fallen out of favor. My experience with a variety of northern based methods, including
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dot blotting methods using both radio- and fluorescently labeled DNA and RNA probes, 
as well as the RNase protection assay which is a solution based hybridization method, 
suggests the following reasons for this trend. First, PCR methods are far more sensitive 
(in the range o f 3-5 molecules) than the most sensitive northerns, which are solution 
hybridization northerns using 3 2  P-Iabelled RNA probes. Second, radioisotopes must be 
used to achieve the sensitivity required for cytokine quantification using northern 
analysis but need not be utilized in PCR based quantitative methods. Third, though labor 
intensive in their own right, PCR based methods require fewer manipulations with RNA 
which is highly susceptible to environmental RNase contamination. Finally, PCR 
methods require substantially less RNA with PCR based methods commonly requiring 1  
pg o f total RNA for a complementary DNA (cDNA) reaction that allows quantification 
of a large number of cytokines versus 20 to 100 pg of RNA for the quantification of a 
single cytokine in northern based methods.
The polymerase chain reaction (Saiki et al., 1985) provides a highly sensitive 
method for the detection of nucleic acids. In the case of cytokine mRNA quantification, 
RNA is first reversed transcribed (RT) to cDNA and cDNA serves as the template for 
PCR amplification. Barriers to accurate quantification that occur in this step can be due 
to inaccurate spectrophotometric readings during RNA quantification, including 
inaccuracies due to sample impurities, and tube to tube variations in RT reaction 
efficiency. Accordingly, RNA extraction and cDNA synthesis are the first site at which 
investigators differ in their methods. The quantity and type o f RNA total vs poly A  as 
well as the nature o f cDNA priming can be varied. Many investigators utilize 1 pg of 
total RNA and Oligo d(T), as opposed to sequence specific priming for their RT
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reactions because it allows for the amplification of several cytokines from a single cDNA 
reaction. Some investigators spike their extractions and/or RT reactions with known 
quantities of RNA o f a specific sequence that contains priming sites common to the 
PCR target(s) o f interest (Wang et a i, 1989). Spiking prior to extraction is useful for 
intersample comparisons in which total RNA entering the cDNA reaction is not 
quantified. RNA spikes are labor intensive but provide the best control in reverse 
transcription followed by PCR (RT-PCR) based quantitative PCR (QPCR) systems 
because the spike serves as an internal control for both the efficiency of the RT reaction 
and the PCR reaction. However, the internal standard RNA may compete with the target 
mRNA in the PCR when both are present in disproportionate concentrations in the initial 
simultaneous RT reaction, necessitating, multiple simultaneous RT reactions with 
varying amounts o f internal standard RNA (Babu et al., 1993).
Following reverse transcription, target cytokines are amplified from RT reactions 
using PCR. The PCR has three phases: a negligible lag phase in which amplification is 
initially non-exponential, an exponential amplification phase, and a linear or stationary 
phase in which the amplification product gradually stops accumulating exponentially 
(Saiki, 1989). Amplification (N) is characterized by the equation N=N0 (l+efficiency)“, 
where N0  is the initial amount of target and n is the cycle number. Thus, minor variations 
in starting template or reaction conditions that alter efficiency are magnified during the 
exponential phase. The onset of the plateau phase appears at different stages depending 
upon the initial target concentration and characteristics of the primers (Linz et a i, 1990; 
Robinson and Simon, 1991). Though its mechanism is not fully understood (Morrison 
and Gannon, 1994), the practical consequence of plateau is that samples of differing
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initial template concentration can appear equivalent or even inversely related. This does 
not appear to be as much o f  a problem for competitive reactions in which co­
amplification o f different concentrations of different targets into the plateau phase has 
been shown to result in retention of the initial targetrcompetitor proportions (Morrison 
and Gannon, 1994) (within certain limits discussed later).
The simplest approach to quantification of RT-PCR products is measurement of 
the amount o f amplified product in the exponential phase by reference to a dilution series 
of an external standard (Ferre, 1992; Clementi et al., 1993; Foley et a l 1993; Cross,
1995). This technique has two major drawbacks. First, preliminary experiments must be 
utilized to determine conditions that allow the PCR to remain in its exponential phase, 
and second, this technique is also the most susceptible to amplification induced errors. 
Modifications in which internal standards are amplified in the same tube have been 
utilized to overcome the latter drawback (Coutlee et al., 1995). Limiting dilution 
techniques have also been applied to QPCR, but these techniques are extremely labor 
and reagent consuming (Sykes eta l., 1992; Luque etal., 1994).
The most accepted PCR based method for cytokine quantification is quantitative 
competitive RT-PCR (QC-RT-PCR) and is based upon the competitive co-amplification, 
in a single reaction tube, o f  the target sequence, together with known concentrations of 
an added internal standard, resulting in a series of tubes containing a fixed amount of 
target and varying amounts o f internal standard (Wang et al., 1989; Zimmermann and 
Mannhalter, 1996). The internal standard is designed to share primer recognition sites 
with the target sequence but differs from the target either by size or an altered restriction 
digest site that allows it to be distinguished from the wild type target. Following
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amplification, the number o f target copies in the sample is calculated by determining the 
equivalence point for competitor and target on a regression plot created by plotting 
log(1 0 )[signal intensity competitor/signal intensity target] vs quantity of internal standard 
template (Piatak et al., 1993). The term quantitative PCR has come to be almost 
synonymous with QC-RT-PCR, while all other methods are often considered semi- 
quantitative.
Once standardized, QC-RT-PCR is quite powerful but has several drawbacks.
The internal standard must amplify with the same efficiency as the wild type. The internal 
standard as well as the target must be able to be analyzed separately, and signal 
corrections are required as competitors commonly differ in size from wild type (Piatak et 
al., 1993). QC-RT-PCR is laborious and reagent intensive, requiring a large series of 
reactions with different competitor concentrations for the quantification of a single 
sample. Because o f this, replicate samples are rarely done. Amplification efficiency of 
competitors can vary significantly from that of wild type target due to size differences or 
the formation of competitor/wild type heteroduplexes (Becker-Andre and Hahlbrock, 
1989; Kanangat et al., 1992; McCulloch et al., 1995; Henley et a i, 1996; Souaze et al.,
1996). Most significantly, QC-RT-PCR is limited to a narrow linear dynamic range 
where the targetrcompetitor ratios remains between 0.66 to 1.5 (Arnold et al., 1992; 
Raeymaekers, 1993; Souaze et al., 1996).
A number o f methods have been utilized to generate competitors for QC-RT- 
PCR (Zimmermann and Mannhalter, 1996) and are not germane to this discussion. 
However, in addition to competitors which serve as controls for the errors inherent in 
the PCR amplification phase o f a QC-RT-PCR assay, a "housekeeping gene" is generally
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quantified. Housekeeping genes have been shown to be useful as normalization factors 
for intersample differences in RNA input and RT efficiency during cytokine 
quantification (Babu e ta l., 1993). However, corrections utilizing housekeeping genes 
are error prone due to the presence of processed pseudogenes in the genome, which are 
related to some o f  the commonly used transcripts of housekeeping genes (Raff et al.,
1997). In theory a housekeeping gene should be constitutively expressed equally among 
different tissues o f  an organism, at all stages of development, for both control and 
experimentally treated cell types. Unfortunately, there is no single RNA species that 
meets these criteria, and the best compromise is to identify a gene that comes closest to 
this ideal for the cell types being studied. P-actin was one o f the earliest mRNA species 
utilized as an internal control (Chelly etal., 1988; Kashani-Sabet eta l., 1988). It 
encodes a constitutively expressed, ubiquitous cytoskeletal protein, that is highly 
conserved in eukaryotes and expressed at moderately abundant levels (0.1% o f mRNA 
or 0.003 % of total RNA). P-actin's primary drawback is that it is expressed in much 
higher levels than cytokine mRNA. In a 10 pg sample of total RNA (approximately 5 x 
10s cells) there is approximately 300 pg of P-actin mRNA which 100-1000 times the 
expression of rare (0.3-3 pg/10 ug total RNA or 0.001% o f mRNA) mRNA species such 
as cytokines (Smith, 1995). This translates to approximately 950 molecules of P-actin 
mRNA per cell ([MW RNA= #nucleotides x 339]+60). Levels of P-actin have been 
shown to vary in cultured adipocytes, mammary epithelial cell lines, fibroblast cell lines, 
and cultured human colon carcinoma cells (Dodge et al., 1990; Bonini and Hofhamm, 
1991; Spanakis, 1993). P-actin mRNA levels have been shown to be higher in normal 
mouse spleen, brain, ovary and thymus than in liver, lung, and testes (Kimball, 1996).
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When compared using a QC-RT-PCR method, P-actin levels in mitogen stimulated 
human monocytic, promyelocytic, and lymphoma cell lines, were not significantly 
different from unstimulated cells (Kanangat et al., 1992). Other studies of T cell lines 
(Melby et al., 1993) and normal human PBMC (McCaims et al., 1984) have respectively 
demonstrated a 1.3 and three fold increase in P-actin mRNA following mitogen 
stimulation.
Other mRNA species that have been utilized as internal controls include 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Dukas etal., 1993), 
hypoxanthine phosphoribosyltransferase (HPRT) (Murphy et al., 1993), and peptidyl- 
prolyl cis-trans isomerase (Cyclophilin) (Nast etal., 1994). GAPDH is a key enzyme in 
glycolysis whose mRNA, like P-actin, is expressed at moderately abundant levels (0 .1% 
of mRNA) (Smith, 1995). GAPDH is constitutively expressed in many tissues, including 
rat and human muscle and heart (Piechaczyk et al., 1984). However, GAPDH levels 
show great variability. Levels have been shown to vary with the embryonic stage o f the 
cell and dexamethasone treatment (Oikarinen, etal., 1991), viral or oncogene 
transformation (Bhatia et al., 1994), as well as during different stages of the cell cycle in 
skin fibroblasts (Mansur et al., 1993). GAPDH levels have also been shown to vary in 
smooth muscle cells treated with vasoconstrictors and mitogens (Gadiparthi et al.,
1990), as well as in breast cell lines, and adipocytes cultured with insulin (Alexander et 
al., 1990). GAPDH expression in mouse brain, muscle, heart, and kidney, exceeds that 
of liver, spleen, lung, embryo, and hypothalamus (Smith, 1995).
HPRT is an enzyme which catalyzes the metabolic salvage of the purine bases 
hypoxanthine and guanine. mRNA is constitutively expressed in all tissues at low levels
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(Ogasawara et al., 1996). Expression in the order of 1-3 mRNA molecules per cell was 
found in normal human lymphocytes, amnion, fibroblasts, EBV-transformed lymphoid 
cell lines, neuroblastoma, glioblastoma, and melanoma cultures (Steen et al., 1990).
Brain tissues, especially the basal ganglia, have been shown to express HPRT at a higher 
level than other tissues (Jiralerspong et al., 1996), and resting lymphocytes have been 
shown to have expression that exceeds fibroblasts by at least two fold (Steen et al.,
1991). Though HPRT expression remains steady in long term lymphocyte cultures,
HPRT is not a well suited housekeeping gene for immunologic studies because mitogen 
stimulation (PHA) has been shown to increase HPRT expression by 10-20 fold in human 
lymphocytes, with levels returning to within 20% of baseline 24 hours after mitogen 
removal (Steen et al., 1990, 1991).
Cyclophilin encodes a cytoplasmic protein important in protein folding that is 
highly conserved. Cyclophilin's expression has been shown to be less abundant than P- 
actin in all mouse tissues, though it is still fairly abundant, comprising close to 0 . 1 % 
cytoplasmic RNA (Smith, 1995). Cyclophilin expression in rat brain, spleen, thymus, 
adrenal glands, ovaries, and testes exceeds that of liver, lung, and anterior pituitary 
(Danielson et al., 1988). In monkeys, expression has been shown to be lower in skeletal 
muscle than other tissues (Danielson etal., 1988), and expression in some tumor lines 
exceeds that of their normal cellular counterparts (Haendler et al., 1990). Despite the 
variable distribution of cyclophilin within body tissues, cyclophilin is a promising 
lymphocyte housekeeping gene because levels have not been altered in T-lymphocytes by 
treatment with mitogens or tumor promoters (Haendler et al., 1990).
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Following PCR, PCR targets as well as competitors in QC-RT-PCR must be 
detected and quantitatively assessed. PCR products can be divided into those that bear 
no endogenous labels, o r products which have been labeled during PCR through the use 
of radioactive, fluorescent, or biotin-labeled nucleotides or primers. In the most basic 
method, unlabeled PCR products are separated via agarose gel electrophoresis and 
stained using ethidium bromide (Piatak et al., 1993; Zimmermann et al., 1994). Bands 
are then assigned a signal strength using computerized image analysis. Gel electro­
phoresis allows not only the separation of competitors and targets that vary by size, but 
also reveals nonspecific bands resulting from PCR. To ensure accurate quantification in
the case of competitive PCR, correction factors are applied to accourrfgr^ater 
fluorescence emitted by larger fragments. In noncompetitive methods, densitometry of 
ethidium bromide (EtBr) stained gels is associated with gel to gel variations in staining 
intensities that can distort interpretations of absolute signal strength. Other methods 
including capillary gel electrophoresis (Fasco et al., 1995) and high pressure liquid 
chromatography (de Kant et al., 1994) have been utilized to separate PCR products by
size.
Methods in which labels are incorporated during the PCR process have greater 
sensitivity than methods that utilize EtBr staining. Endogenously labeled PCR products 
have been analyzed by a variety of methods depending upon the nature of the label. 
Because PCR products labeled in this manner have the drawback of labeled nonspecific 
PCR products that erroneously contribute to signal strength, they are generally separated 
by gel electrophoresis, then quantified either from excised bands using direct assessment 
of cpm (Scadden et al., 1992; Furtado et al., 1993), or from dried gels via
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autoradiography and densitometry (Dostal et al., 1994), or radioimaging (Arnold et al.,
1992). PCR products bearing biotin have been similarly separated via electrophoresis, 
blotted onto filter paper, and quantified using streptavidin conjugated chemiluminescent 
labels, autoradiography and image analysis (Su et al., 1994). Automated sequencers have 
also been employed to quantify fluorescently labeled PCR products in polyacrylamide 
gels (Cottrez et al., 1994; Michael et al., 1995).
To circumvent problems with labeled non-specific PCR products that are 
generated from labeling during PCR amplification, hybridization with sequence-specific 
probes followed by probe quantification has been adopted in some methods. These 
methods either involve membrane transfer of PCR product following electrophoresis 
(Telenti et al., 1992) or solid phase capture of PCR product onto microplates. 
Biotinylated PCR product has been captured onto streptavidin coated plates (Jalava et 
al., 1993; Lehtovaara et al., 1993, Martin etal., 1996), aminated PCR products onto 
carboxylated plates (Kohsaka et al., 1993), as well as capture via plates bearing 
covalently bound oligonucleotides (Bemdt et al., 1995). Once captured, PCR product is 
hybridized with radiolabeled or enzymatically labeled oligonucleotides and quantified by 
measuring incorporated radioactivity, fluorescence, or enzyme activated color change.
Two recent chemiluminescence based adaptations have been directed at 
automating the detection process in QPCR procedures. Both of these methods have the 
disadvantage o f requiring expensive reagents and machinery that is both expensive and 
not commonly available. In the first, a biotinylated primer is incorporated into the PCR 
reaction. An aliquot of the reaction is then hybridized in solution with a tris (2,2- 
bipyridine) ruthenium II chelate (TBR)-labeled oligonucleotide probe that is
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complementary to the biotinylated strand. The biotinylated PCR product bearing its TBR 
probe is then captured onto streptavidin coated iron beads and added to reagent assay 
buffer. In an automated process carried out within a machine known as the QPCR 
System 5000 (Perkin-Elmer, Foster City, CA), the entire reaction is analyzed and 
assigned a luminosity value proportional to the amount of TBR-bearing, hybridized, 
oligonucleotide probe that is detected. The QPCR System 5000 aspirates the iron beads 
with their attached PCR products onto a working electrode and traps them magnetically. 
The electrode is washed several times to eliminate unbound TBR-labeled probe and a 
voltage is applied to the electrode, inducing a series of redox reactions whereby 
stimulated TBR molecules emit light at 620 nm, which is then detected by a 
photomultiplier tube. This system has been adapted for use in competitive PCR by the 
use of two TBR-labeled oligonucleotide probes, one specific for the target, the other for 
the internal competitor (Wilkinsone/ al., 1995; Blok et al., 1997). In a modification of 
this system, TBR-labeled oligonucleotide can also be utilized as a complementary primer 
to the biotin-labeled primer without a hybridization step, but this method has the 
disadvantage of label incorporation into nonspecific products of the PCR reaction. Use 
of the QPCR System 500 has several advantages. The instrument's linear dynamic range 
has been determined to be between 3 and 4 orders of magnitude (Jessen-Eller et al.,
1994) and allows high sample throughput. The QPCR System 5000 has greater 
sensitivity than 3 2 P-labeled methods (Zhao et al., 1996) which have been calculated to be 
7.4 x 10"“ mole of PCR product above background (Crivello, 1997), and the ability to 
determine starting copy number over 1 0  orders of magnitude in competitive methods 
( 1 0 - 1 0 1 1  copies) with 90% accuracy (Crivello, 1997).
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The second method referred to as Taq-Man (Perkin-Elmer), is a real time QPCR 
system (Heid et al., 1996) which exploits the 5' exonuclease activity of Taq (Holland et 
a l, 1991). The reaction is carried out with three primers, two for amplification, and a 
third that hybridizes internally in the amplified region. A fluorescent dye on the 3' end of 
the internal primer (such as TAMRA, 6 -carboxy-tetramethyl rhodamine) quenches 
fluorescence from a reporter fluorescent tag on the 5' end (such as FAM, 6 - 
carboxyfluorescein) of the internal primer (Livak et al., 1995). During PCR, the 5' 
exonuclease activity of Taq degrades the 3' quenching activity on the internal primer, 
resulting in fluorescent emission which is determined during the PCR process. This 
approach is less sensitive (limit o f detection 10,000 copies) then the QPCR System 5000 
(Crivello, 1997) but allows much higher throughput because post PCR manipulations are 
not required. The system can also be easily adapted for simultaneous detection of 
competitors through the use of different fluorescent dyes.
The plethora, permutations, and drawbacks of the aforementioned methods 
should raise one resounding truth about quantitative PCR - that accurate quantification is 
difficult to achieve and that each method has its drawbacks. QC-RT-PCR, despite its 
many drawbacks, has the primary advantage of being commonly accepted. Because of 
the nature of our laboratories' work in which large numbers of samples from a 
genetically heterogeneous population of horses serve as the source of RNA, a rapid, 
labor conserving method in which replicate samples could be run became the primary 
force that governed our assay development. Our system synthesizes the use o f a dilution 
series of an external standard with solution hybridization techniques that minimize errors
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due to nonspecific PCR products. The housekeeping gene P-actin is used to correct for 
differences in initial RNA concentrations or variations in RT efficiency.
The underlying hypothesis of this study was that horses exhibit cytokine 
profiles consistent with the TH2 phenotype in response to S. vulgaris infection. The 
primary aim of this study was to determine if differences existed in the cytokine 
profiles of lymphocytes derived from immune and susceptible ponies, both in 
response to vaccination and following challenge. Lymphocytes for examination were 
collected both from the local site of parasite invasion along the large colon, as well as 
from peripheral blood, and immunity was induced by oral vaccination with radiation- 
attenuated S. vulgaris L3 . Characterization of the TH1 and TH2 cytokine profiles in 
the horse necessitated the development of molecular tools which included the cloning 
and sequencing of equine P-actin, to be used as a housekeeping gene for quantitative 
assays, and IL-10, considered a member of the TH2 cytokine family, and most 
significantly, the development o f a PCR based assay for the quantification of equine 
cytokines.
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CHAPTER 1
M OLECULAR CLONING AND SEQUENCING OF EQUINE 
IL-6 , IL-10, AND BETA-ACTIN
Introduction
Equine interleukin - 6  (IL-6 ), IL-10, and (3-actin were cloned and sequenced to 
facilitate their use as immunologic reagents in assays to quantify equine cytokines. 
IL- 6  and IL-10 are produced by Th2 cells in the murine system but this polarization is 
not always clear in human CD4+ subsets (Romagnani, 1992). IL- 6  (Robinson et 
al,. 1993) and IL-10 (McKay et al., 1995) have been examined as inflammatory 
mediators in the horse. However, neither the significance of the Thl/Th2 paradigm in 
equine disease, nor the role of IL- 6  or IL-10 in Thl and Th2 responses have been 
examined in the horse.
Materials and M ethods 
Preparation of cells
Equine peripheral blood mononuclear cells (PBMC) were isolated from venous 
blood by differential centrifugation over Ficoll-Pague (Pharmacia LKB 
Biotechnology, Piscataway, NJ). After washing in calcium and magnesium free 
phosphate-buffered saline (CMF-PBS), PBMC were suspended in media consisting of 
RPMI 1640 (Sigma Chemical Co., St. Louis, MO) supplemented with 2-mercapto- 
ethanol (100 mM), glutamine (2 mM), 100 U/ml penicillin, 100 /xg/ml streptomycin, 
and 5% heat inactivated fetal bovine serum (Hyclone Laboratories, Logan, UT). 
PBMC were incubated at a  concentration of 2 x 106/ml for 72 hours
64
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with phytohemagglutinin-M (2ptg/ml, Sigma) at 39°C in a humidified environment 
with 5% C02.
Total RNA isolation and complementary DNA (cDNA) synthesis
Small scale preparations of total RNA were isolated from 2-3 x 106  PHA 
stimulated PBMC using RNA Stat 60 reagent (Tel-Test, Friendswood, TX) and 
chloroform extraction as per the manufacturer's directions. 0.30 fig of RNA in a 
volume of 17.5 fil diethyl pyrocarbonate-treated water were heated to 65°C for 10 
minutes to denature the RNA and then chilled in ice and pulse spun in a 
microcentrifuge at 4°C. 22.5 fil of reagent master mix were then added resulting in a 
final reaction containing IX first strand buffer (Gibco BRL, Gaithersburg, MD), 0.5 
mM dNTP (Perkin-Elmer, Norwalk, CT), 1.0 fiM Oligo-dT (Promega, Madison,
WI), 10 mM DTT (Gibco), 0.075 fig/fil BSA (NEB, Beverly, MA), 60 Units RNAsin 
(Promega), and 400 units Moloney Murine Leukemia Virus Reverse Transcriptase 
(BRL). The reaction was incubated 1 hour at 40°C, then frozen at -20°C until use. 
Equine TL-6 . IL-10. and B-actin message amplification
Equine IL-6 , IL-10, and P-actin were amplified using the polymerase chain 
reaction (PCR). All PCRs were performed in 50 fi\ volumes containing 5 y\ cDNA,
IX PCR buffer (Perkin-Elmer), 2.5 units Taq polymerase (Perkin-Elmer), 200 /zM 
dNTP (Perkin-Elmer), and 10 pmoles of each 5' and 3' primer. Primers were derived 
from phylogenetically conserved regions of the respective genes using published 
nucleotide sequences (Table 1.1). The amplification steps involved denaturation at 
94°C for 30 seconds, annealing at 55°C for 30 seconds, and extension at 72°C for 1
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Table 1.1. Primer sequences used for PCR amplification and sequencing of equine IL-6 , IL-10, and P-actin cDNA.
cDNA Coding Strand Primer Noncoding Strand Primer Internal Sequencing Primers
IL- 6 5'ATGAACTCCTTCTTCACAAG3' 5' TCCTA ACGCTC ATACTTT3' 543AS: 5'CCACTCATTCTGTGAATGCAGACT3'
IL-10 5' ATGCACAGCTCAGCACT3' 5'TTCACAGAGAAGCTCAGTAAAT3' S 103: S' A AG AG A A AGGGTGTCTAC AAGCC A3'
P-actin 5'ATGGATGATGATATCGCCGCG3' 5'CTAGAAGCAnTGCGGT
GGACGATGGAGGGGCC3'
255S: 5 'TCTGGCACCACACCTTCTAC3'
5I0S: 5'CCATCCTGCGTCTGGAC3'
739AS: 5'TCGTrGCCGATGGTGATGAC3'
964AS: 5'TGATCrTCATCGTGCTGGG3’
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minute. Reactions were amplified to 40 cycles in a GeneAmp PCR System 9600 
Thermal Cycler (Perkin-Elmer).
Cloning and sequencing
The equine IL-6 , IL-10, and P-actin PCR products were purified by 
electrophoresis and excision from a 1.2% agarose (Sigma) gel using diatomaceous 
earth (Prep-a-Gene; Bio Rad, Hercules, CA). Fragments of approximately 670, 740, 
and 1150 base pairs (bp) respectively were cloned into pCRII vector (Invitrogen, 
Carlsbad, CA) using the TA cloning method according to the manufacturer's 
instructions, then transformed into competent E. coli DH5aMCR using heat shock 
(Lederberg and Cohen, 1974). Transformants were selected by ampicillin resistance 
and loss of p-lactamase gene function, then screened by restriction digest mapping.
The cloned PCR-vector products were purified from overnight cultures using 
alkaline lysis followed by CsCl gradient separation in the presence of ethidium 
bromide (Sambrook et al. , 1989) or using a commercial miniprep kit (Qiagen, 
Valencia, CA). Sequencing was accomplished using dideoxynucleotide chain 
termination from double stranded plasmid DNA. Plasmids containing IL-10 and P- 
actin were sequenced manually using alkali denaturing according to the Sequenase 
Version 2.0 kit (United States Biochemical, Cleveland, OH) followed by 
polyacrylamide gel electrophoresis. IL- 6  was sequenced using dye primer cycle 
sequencing (ABI PRISM Dye Primer Cycle Sequencing Core Ready Reaction Kit 
with AmpliTaq DNA polymerase, FS; Perkin-Elmer). Sequences were resolved using 
capillary gel electrophoresis on an ABI Prism 310 Genetic Analyzer (Perkin- 
Elmer/ Applied Biosystems Division). Sequencing primers were -48 (GeneLab, Baton
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Rouge, LA) and T7 (Promega, Madison, WI) plasmid primers, and primer pairs used 
for PCR. Intemalprimers were generated to span the middle of the IL-6 , IL-10, and 
P-actin fragments as needed from the derived sequences (Table 1.1). The sequence 
information was entered into the Mac Vector database program for subsequent 
alignment with published cDNAs for other species IL-6 , IL-10, and P-actin.
Results
Amplification of mononuclear cell mRNA
PCR amplification o f cDNA from PH A stimulated PBMC produced distinct 
745, 739, and 1128 base pair fragments for IL-6 , IL-10, and P-actin respectively 
(Figure 1.1). Because these fragments were the same size as predicted from sequence 
analysis of other species, the products were purified and cloned for sequencing. 
Sequencing of equine IL-6 . IL-10. and B-actin
The nucleotide sequences of the IL-6 , IL-10, and P-actin cDNA inserts are 
shown in Figures 1.2, 1.3 and 1.4, respectively. These sequences have been 
submitted to GenBank EMBL and bear the following accession numbers: IL-6 : 
U64794, IL-10: U38200, and P-actin: AF035774. All clones of the three cDNA 
sequences contained a single open reading frame which included a stop codon. The 
745 bp IL- 6  cDNA included the coding sequence which spans bases 1 to 627, and 118 
bases in the 3’ nontranslated region. Based upon comparisons to IL- 6  sequences of 
other species, bases 1-84 encode the hydrophobic signal peptide. The 739 bp IL-10 
cDNA included a coding sequence from bases 1-537. Bases 1-54 encode the putative 
signal peptide. The IL-10 cDNA also includes 202 bases in the 3' nontranslated 
region. The 1128 bp P-actin cDNA encodes only the translated regions of the protein.
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Figure 1.1 PCR amplification of equine IL-6 , IL-10, and P-actin. Lanes I 
and 8  contain the size marker phage X174 DNA HaelII digested (the size 
of the fragments in base pairs is given); lanes 2, 4, and 6  contain the PCR 
products from PHA stimulated equine PBMC cDNA for IL-6 , IL-10. and 
P-actin, respectively. Lanes 3, 5, and 7 are the respective PCR negative 
controls which contained water instead of cDNA template.
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1  atgaactcct tcttcacaag caccgtcact ccagttgcct tctccctggg gctgctcctg 
61 gtgalggcta ctgctttccc caccccacta cccctgggag aagatgaaac cacctcaaat 
1 2 1  ggaccactac tcaccactgc agacaaaacc aaacagcaca ttaagtacat cctcggcaaa 
181 atctctgccc tgaaaaatga gatgtgtaac aattttagca agtgtgaaaa cagcaaggag 
241 gtactggcag aaaacaacct gaatcttcca aagatggcag aaaaagacgg atgcttccaa 
301 tctgggttca atcaggagac ctgcctgatg aaaatcacca ctggtctttc ggagtttcag 
361 atatacctgg agtacctcca gaacgagttc aagggtgaaa aggaaaacat caagactatg 
421 cagatcagta ccaaagtcct ggtccagatc ctgatgcaaa agatgaagaa tccagaagta 
481 accacccctg acccaactgc aaaaagcagc ctgctggcta agctgcattc acagaatgag 
541 tggctgaaga acacaacaac tcacctcatc cttcgaagcc ttgaggattt cctgcagttc 
601 agcctgagag ctgttcggat aatgtaacct tggcatctaa gattgttgta gttcatgggc 
661 attccttcct ctggtcagaa acctgtccac tgggcacata acttatgttg ttctctatga 
721 agaactaaaa gtatgagcgt tagga
Figure 1.2: Nucleotide sequence of amplified equine EL- 6  cDNA. The nucleotide 
sequence of the cDNA insert was determined by automated cycle sequencing of 
double stranded plasmid. The coding sequence spans bases 1-627. Bases 1-84 encode 
the hydrophobic signal peptide, and bases 628-745 are in the 3 ’ nontranslated region. 
Primer sequences are represented in bold. The stop codon is underlined. The 
GenBank accession number for this sequence is U64794.
1  atgcacagct cagcactgct atgttacctg gtcttcctgg ccggggtggg agccagccga 
61 gaccggggca cccagtctga gaacagctgc acccacttcc caaccagcct gccccacatg 
1 2 1  ctccatgagc tccgagccgc cttcagcagg gtgaagactt tctttcaaat gaaggaccag 
181 ctggacaaca tgttgttgaa cgggtccctg ctggaggact ttaagggtta cctgggttgc 
241 caagccttgt cggagatgat ccagttttac ctggaggagg tgatgcccca ggctgagaac 
301 cacggcccag acatcaagga gcacgtgaac tccctggggg aaaagctgaa gaccctccga 
361 gtgaggctgc ggcgctgtca tcgatttctg ccctgtgaaa ataagagcaa ggcagtggag 
421 caggtgaaga gtgccttcag taagctccaa gagaaaggtg tctacaaagc catgagtgag 
481 tttgacatct tcatcaacta catagaagcc tatatgacaa cgaagatgaa aaactgaagc 
541 atcctaggga acgaagcatc caggacggtg actctactag actctaggac ataaattgga 
601 gatctcccaa atcccatcca gggttctggg agagctgaat cagctccttg gaaaaccctg 
661 tggtacctct ctcctgaata tttattaact ctgatacctc aactcctatt tctatttatt 
721 tactgagctt ctctgtgaa
Figure 1.3. Nucleotide sequence of amplified equine IL-10 cDNA as determined 
from double stranded plasmid using manual chain termination sequencing. The 
coding sequence spans bases 1-537. Bases 1-54 encode the hydrophobic signal 
peptide, and bases 538-739 are in the 3’ untranslated region. The stop codon is 
underlined. The GenBank accession number for this sequence is U38200.
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1 atggatgatg atatcgccgc gctcgtggtc gacaacggct ccggcatgtg caaggccggc 
61 ttcgcgggcg acgacgctcc ccgcgccgtc ttcccctcca tcgtggggcg cccccggcac 
121 cagggcgtga tggtgggcat gggccagaag gactcatacg tgggcgacga ggcccagagc 
181 aagaggggca tcctgaccct caagtacccc atcgagcacg gcatcgtcac caactgggac 
241 gacatggaga agatctggca ccacaccttc tacaacgagc tgcgcgtggc ccccgaggag 
301 caccccgtgc tgctgaccga ggcccccctg aaccccaagg ccaaccgcga gaagatgacc 
361 cagatcatgt ttgagacctt caacaccccg gccatgtacg tggccatcca ggccgtgctg 
421 tccctgtacg cctctggccg caccactggc atcgtgatgg actccggtga cggggtcacc 
481 cacactgtgc ccatctacga ggggtacgcc ctcccccacg ccatcctgcg tctggacctg 
541 gctggccggg acctgacgga ctacctcatg aagatcctca cggagcgtgg ctacagcttc 
601 accaccacgg ccgagaggga aatcgtgcgt gacatcaagg agaagctctg ctatgtcgcc 
661 ctggacttcg agcaggagat ggccaccgcg gcctccagct cttccctgga gaagagctac 
721 gagctgcccg acggccaggt catcaccatc ggcaacgagc ggttccgctg ccccgaggcc 
781 ctcttccagc cctccttcct gggcatggaa tcctgtggca tccacgaaac taccttcaac 
841 tccatcatga agtgtgacgt cgacatccgt aaggacctgt acgccaacac agtgctgtcg 
901 ggtgggacca ccatgtaccc aggcatcgcc gacaggatgc agaaggagat cacagccctg 
961 gctcccagca cgatgaagat caagatcatt gcgccccctg agcgcaagta ctccgtatgg 
1021 atcggcggct ccattctggc ctcattgtcc accttccagc agatgtggat cagcaagcag 
1081 gagtacgacg agtccggccc ctccatcgtc caccgcaaat gcttctag
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Figure 1.4. Nucleotide coding sequence of amplified equine P-actin cDNA (top 
panel) and deduced amino acid sequence (bottom panel). The nucleotide sequence of 
the cDNA insert was determined by chain termination sequencing o f double stranded 
plasmid. Primer sequences are represented in bold. The stop codon is underlined.
The GenBank accession number for this sequence is AF035774
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P-actin is a cellular cytoskeletal protein which is not secreted and therefore lacks a 
signal peptide. Nucleic acid homology of these equine sequences with the respective 
sequences in other mammalian species were analyzed using the BLAST program 
(Basic Local Alignment Search Tool, National Center for Biotechnology Information, 
National Library o f Medicine, National Institutes of Health). These homologies were 
extensive and are summarized in Table 1.2.
Amino acid analysis
The open reading frames for IL-6 , IL-10, and P-actin encode 208, 178, and 
375 amino acids, including 28 and 18 amino acid signal peptides for IL- 6  and IL-10, 
respectively. Like the nucleic acid sequences, the predicted amino acid sequences for 
equine IL-6 , IL-10, and P-actin have a high degree of similarity at the amino acid 
level with the respective sequences of other species as determined using the BLAST 
program. These similarities are summarized in Table 1.2. The predicted amino acid 
sequences for IL-6 , and IL-10, aligned to the respective human sequences, are shown 
in Figures 1.5, and 1.6. The amino acid sequence of equine P-actin is shown in 
Figure 1.4 and is identical to the human sequence.
The open reading frame for equine IL- 6  encodes 208 amino acids with a 
predicted relative mass o f 23,383. Comparison to other IL - 6  sequences suggests that 
the first 28 amino acids serve as the signal peptide which is cleaved off during 
secretion, making proline the amino terminal amino residue of mature IL-6 . The 
mature protein would consist of 180 amino acids and have a predicted relative mass 
of 20,471. The predicted molecular weights do not take into consideration any post- 
translational modifications of the polypeptide. Sequence alignments also indicate that
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Table 1.2. Comparison of equine IL- 6  and equine IL-10 nucleotide coding and 
predicted amino acid sequences with other mammalian species.
Equine IL - 6 Equine IL-10
Species Nucleotide 
identity (%)
Amino acid 
similarity (%)
Nucleotide 
identity (%)
Amino acid 
similarity (%)
Human 81.7 77.6 89.3 91.0
Pig 84.4 82.1 8 6 . 0 92.8
Dog 82.3 83.7 83.5 8 6 . 1
Cat 83.7 81.4 86.5 90.4
Sheep 80.7 74.9 87.3 92.5
Cow 80.3 70.7 86.9 90.4
Red
Deer
- - 96.4 89.7
Mouse 69.9 64.0 79.7 85.4
EHV-2
vIL-10
- - 85.1 83.6
Comparisons were made using the BLAST program of National Center for 
Biotechnology and Information, National Library of Medicine, National Institutes 
of Health (http:Wwww.ncbi.nIm.nih.gov/BLAST/)
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_______ Alpha helix A______
*  * * * * * *  * * *  *  *
Equine: MNSFFTSTVTPVAFSLGLLLVMATAFPT PLPLGED ETTS NGP - - - LLTTADKT- KQHI KYILGK 
MNSF TS PVAFSLGLLLV+ AFP  P+P  GED P LT+ + + + KQHI+YTL
Human: MNSFSTSAFGPVAFSLGLLLVLPAAFPA PVPPGEDSKDVAAPHRQPLTS S E RIDKQ -I RYILDG
1 20
   Alpha Helix B______
*  * *  * * * * * * * *  *  * *  *  * * * *
Equine: 1SALKNEMCNNFSKCENSKEVLAENNLNLPKMAEKDGCFQSGFNQETCLMKITTGLSEFQ I 
ISAL+ E CN +  CE+SKE LAENNLNLPKMAEKDGCFQSGFN+ ETCL+ KI TGL EF+ + 
Human: ISALRKET CNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNE ETCLVKI ITGLLEFEV 
40 50 60 80
_  Alpha Helix C_________________
*  *  *
Equine: YLEYLQNEFKGEKENI KTMQI STKVLV Q ILMQKMKNPE V -TT PDPTAKSSLLAKLH SQN 
YLEYLQN F+  + E  +  +Q +STK V L+Q  L +K KN + T PDPT +SLL KL +QN 
Human: YLEYLQNRFES SEEQARAVQMSTKVL I QFL Q KKAKNLDAI TTPD PTTNASLLTKLQAQN 
100 120 140 153
 Alpha Helix D___________
*  * *  *
Equine: EW LKNTTTHLILRSLED FLQFSLRA VR IM 
+ W L + +  TTHLILRS + + F L Q  SLRA+R M 
Human: QWLQDMTTHLILRSFKE FLQSSLRA LRQM 
160 180
Figure 1.5. Deduced amino acid sequence of equine IL- 6  aligned with peptide 
sequence of human EL-6. The putative signal sequences are in italics. Locations of 
structural a-helices (A-D) determined for human IL- 6  are shown (after Bazan,
1990). Cysteine residues are marked (A) at positions of putative conserved disulphide 
bridges. Arginine 179 (♦ ) and other invariant residues (*) are also shown. Amino 
acids are numbered according to the human sequence (Gen Bank accession 
M145840. Gaps (-) were inserted to maximize alignment.
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_______Alpha helix A ________
Equine: M//55ALLCKLVFLAGKC/1SRDRGTQSENSCTHFPTSLPHMLHELRAAFSRVKTFFQMKDQ 
MHSSALLC L V  L G V  AS +GTQSENSCTHFP + L P -M L  +LR  AFSRVKTFFQMKDQ 
Human: MHSSALLC CL VLLTG VRASPGQGTQSENSCTHFPGNLPNMLRDLRD AFSRVKTFFQMKDQ
1 20 40
_ helix B_  Alpha helix C __________  ____ Alpha helix D___
*  *
Equine: LDNMLLNGSLLEDFKGYLGCQALSEMIQFYLEEVMPQAENHGPDIKE HVNSLGEKLKTL 
LDN+LL SLLEDFKGYLGCQALSEMIQFYLEEVMPQAEN PDIK HVNSLGE LKTL 
Human: LDN LLLKE SLLEDFKGYLGCQALSEMIQFYLEEVMPQAENQDPD1KAHVNSLGENLKTL
60 80 100
________   Alpha helix_E__  Alpha helix F________
*  «
Equine: RVRLRR CHRFLPCENKSKAVEQVKSAFSKLQEKGVYKAMSEFDIFINYIEAYMTTKMKN 
R+RLRRCHRFLPCENKSKAVEQVK+AF+KLQEKG+YKAMSEFDIHNYIEAYMT- K+ +N  
Hum an:: R LRLRRCHRFLPCENKSKAVEQVKNAFNKLQEKGI YKAMSEFDIFINYIEAYMTMKIRN
120 140 160
Figure 1.6. Deduced amino acid sequence of equine DL-10 aligned with peptide 
sequence of human IL-10 (GenBank accession M57627). Putative signal sequences 
are in italics. Locations o f  predicted structural a-helices (A-D) are shown (after 
Walter, 1995). Putative receptor binding residues are marked (*). Cysteine residues 
are marked (A) at positions o f putative conserved disulphide bridges.
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equine IL- 6  possesses the 40 amino acids, including 4 conserved cysteine residues, 
which are invariant in humans, the domestic animal species, mice, and several sea 
mammals (King et al., 1996).
The open reading frame for equine IL-10 encodes 178 amino acids with a 
predicted relative mass o f 20,449. The N-terminal amino acid of mouse IL-10 is 
Gin22, while the N-terminus o f human IL-10 is Ser19. Equine IL-10 has a Ser1 9  and a 
Gin25. Phylogenetic analysis of equine IL-2 indicates that equine and human 
sequences are more closely related evolutionarily than equine and murine sequences 
(Vandergrifft and Horohov, 1993), making Ser1 9  the more likely N-terminal amino 
acid in the horse. With Ser 1 9  as the N-terminal amino acid, the mature equine IL-10 
would consist of 160 amino acids and have a predicted molecular mass o f 18,615, 
without post-trans.lational glycosylation.
The open reading frame for equine P-actin encodes a 375 amino acid protein. 
Beta-actin is a cytoskeletal protein and therefore lacks a signal peptide. After removal 
of the initiator methionine, the 374 amino acid equine P-actin protein has a predicted 
relative mass of 41,603.
Discussion
40 amino acid residues of IL- 6  have been shown to be invariant among a wide 
variety of species and these residues are also conserved in the equine sequence (King 
et al., 1996). This is in line with observations that cell supernatant from many 
different mammals can demonstrate biological activity in mouse bioassays. However, 
mouse IL- 6  is unable to activate human cells (Ehlers et al., 1994). The biological 
activity of IL- 6  is mediated through two different receptor components. IL - 6  first
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binds to a low affinity IL-6 R alpha (gp80) which is stabilized when bound by the 
signal transducing IL-6 R beta unit (gpl30) (Tage et al., 1989). The carboxy-terminus 
has been shown to be important for receptor binding of the functional protein 
(Kruttgen et al., 1990; Brakenhoff et al., 1990). The gp80 binding site (termed site I) 
is thought to involve an area where the carboxy-terminus of IL- 6  and a section of the 
chain at the beginning of a-helix A are in close proximity (Brahenhoff et al., 1989, 
1990). However, TPhe7 8  in the loop between the second and third a-helix has been 
shown to be critical for gp80 binding (Ehlers et al., 1996) and is conserved in the 
equine sequence. Amino acid deletions at positions 171-179 in the carboxy terminus 
of the human sequence have demonstrated that residues 177-179 contribute to the 
formation of this receptor binding site and Arg1 7 9  is required for biological activity of 
the molecule in the mouse bioassay (Fontaine et al., 1993). Residues 177-179, Ser, 
Leu, Arg, which are invariant among domestic and sea mammals are also conserved 
in the horse. The mouse has a Thr177, but this substitution has not been reported to be 
a cause of species specificity. In fact, the specificity of mouse IL- 6  activity has been 
linked to three of the four domains (van Dam et al., 1993) including residues 50-55 
which activate gpl30 (Ehlers et al., 1995).
The gpl30 binding region of IL-6 , involves regions early in the loop between 
the first and second a-helix, specifically Cys^-Glu5 5  (Ehlers et al., 1994), and regions 
at the end of the third and fourth a-helix, specifically GlnI5 3 -Hisl6S (de Hon et al., 
1995). Equine IL- 6  shares 100% and 85% similarity to the human sequence in these 
regions. Determination of the significance of specific residues in this region is an area
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of ongoing study. However, Lys5 4  is known to be critical to gpl30 activation (Ehlers 
et al., 1996) and is conserved in the horse.
IL- 6  produced by macrophages (Bauer et al., 1988, Gross et al., 1989), and 
fibroblasts (Santhanam et a l., 1989), as well as recombinant products of eukaryotic 
expression systems (Tanner et al., 1990; Schiel et al., 1990) has been shown to be 
variably glycosylated at both N - and O-linked positions. However, recombinant IL- 6  
expressed in E. coli is biologically active indicating that glycosylation is not required 
for biological activity (Skelly et al., 1994). Proper protein folding is required for 
maximal activity and IL - 6  mutants lacking the first and second cysteine residues retain 
activity similar to nonmutated IL - 6  while mutants lacking the third and fourth cysteine 
residues have a significant reduction in biological activity (Snouwaert et al., 1991; 
Skelly et al. , 1994).
IL-10 exists as a homodimer with each monomer composed of six a-helices, 
two of which intertwine to form the dimer (Walter and Nagabhushan, 1995). The 
resulting structure forms a four helix bundle motif. The molecule is predominantly a- 
helical (67%) and the putative helix regions derived from X-ray crystallographic 
structure of human IL-10 are shown in (Figure 1.6). Human IL-10 lacks detectable 
glycosylation but murine IL-10 is variably N-glycosylated near its N-terminous 
(reviewed in Moore et al., 1993). However, glycosylation is not required for activity. 
IL-10 is expressed (reviewed in Moore et al., 1993) and binds its receptor (Tan et 
al., 1993) as a noncovalent dimer. Equine IL-10 shares four conserved cysteine 
residues with human IL-10 and mouse IL-10. The first cysteine residue in the mature 
peptide pairs with the third and the second with the fourth. The reduced protein
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displays no biological activity suggesting that one or both of these bonds is critical for 
structure and function (Windsor et al., 1993).
Equine IL-10 demonstrates DNA and amino acid homology to an IL-10-like 
sequence of equine herpes virus-2 and also to a similar IL-10 like motif in the 
sequence of Epstein Barr virus termed BRCF or viral IL-10 (vIL-10). vIL-10 has 
been shown to have a specific activity 3-10 times lower than human IL-10 (Moore et 
al., 1991). Postulated functions of this molecule include the inhibition of virus 
induced T or NK cell activation, promoting the growth and differentiation of B cells 
(EBV transforms human B cells), and promoting Fc receptor-mediated uptake of the 
virus into susceptible cells (reviewed in Moore et al., 1993).
Though the X-ray crystallographic structure of human IL-10 has been resolved 
(Walter and Nagabhushan, 1995; Zdanov et al., 1996), mutagenesis studies to 
identify residues critical to receptor binding have not been reported. The 85 invariant 
amino acid residues in human, BRCF, equine herpes virus-2, murine, and porcine IL- 
10 described by Walter and Nagabhushan (1995) are also conserved in the horse.
Based on the structural similarities between IL-10, IFN-y, and growth hormone, and 
the residues critical to receptor binding in these latter two molecules, Ser14l is 
predicted to be a critical receptor binding residue for IL-10. Leu^, LeuJ3, and Ilel4S 
are also predicted to interact with the receptor. Three of these four residues are 
invariant in the equine with Leu4 6  being replaced by a biochemically similar Met 
residue. This residue is not, however, invariant and Met substitution is reported in the 
equine herpes virus type II sequence. Serl4, is also not an invariant residue among the 
published sequences.
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Equine cDNA's with considerable nucleic acid and amino acid homology to 
the IL- 6  and IL-10 sequences o f other species have been amplified using PCR and 
primers based on the consensus sequences of these genes in other species. The cloned 
equine IL- 6  bears 80-84% nucleic acid identity and 71-84% amino acid similarity to 
the IL- 6  sequences of humans and domestic animal species. Equine IL-10 exhibits 8 6 - 
89% nucleic acid identity with these species and 96% with red deer. The predicted 
IL-10 amino acid sequence similarity is in the range of 87-92% when compared to the 
previously noted species. Though functional assays are required to definitively 
determine if the proteins encoded by these sequences are biologically active, the high 
degree of sequence similarity suggests that these sequences are indeed equine IL- 6  and 
IL-10. The cloned P-actin gene shares 100% amino acid identity with human P-actin 
and therefore is identifiable as equine P-actin without functional assays of the protein.
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CHAPTER 2
A NOVEL METHOD FOR QUANTIFICATION OF EQUINE CYTOKINE 
MESSENGER RNA USING TARGET SPECIFIC STANDARD CURVES
Introduction
RT-PCR provides a powerful tool for the detection of mRNA which has been 
widely applied to quantify a variety of transcripts including cytokines. Quantitative 
competitive RT-PCR (QCRT-PCR) is accepted as a reliable method for quantifying 
differences in mRNA. However, QCRT-PCR has many drawbacks. The assay is 
labor and reagent intensive requiring competitor construction and the generation of a 
large series of reactions with differing competitor:target ratios in order to assay a 
single sample. Amplification efficiency of competitors can vary significantly from 
that of wild type target due to size differences or the formation of competitor/wild 
type heteroduplexes (Becker-Andre and Hahlbrock, 1989; Kanangat et al., 1992; 
McCullough et al., 1995; Henley era/., 1996; Souaze et al. , 1996). Post PCR 
detection generally requires signal corrections as competitors commonly differ in size 
from wild type (Piatak et al., 1993). Most significantly, the accuracy of QCRT-PCR 
is limited to a narrow range where the targetxompetitor ratio remains between 0 . 6 6  
to 1.5 (Raeymaekers, 1993; Souaze et al., 1996). Because QCRT-PCR assays are 
labor intensive, replicate determinations of the same sample are rarely done which can 
lead to overestimation of the accuracy of this technique. In fact, well established tests 
of this type by experienced scientists yield errors between 1 0 % and 2 0 % for analysis 
of replicate portions of the same sample on different occasions indicating that it is 
preferable to calculate the mean of replicate determinations of the same sample for
81
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reliable discrimination of two fold differences in copy numbers between two samples 
(Apostolakos et al., 1993; Piatuk et al., 1993; Besnard and Andre, 1994; de Kant et 
al., 1994; Zimmerman et a l., 1994; Xia et al., 1995).
Standard curves are routinely used in a variety of scientific disciplines 
including immunology to evaluate enzymatically dependent phenomenon characterized 
by an exponential rise to maximum. Standard curves derived from dilutions of cloned 
cDNA sequences have been described (Melby et. al., 1993; Martin et. al.-, 1995) and 
RNA standard curves have recently been employed to quantify mRNA in a 
competitive RT-PCR assay with excellent intra- and inter-assay precision (Tsai and 
Wiltbank, 1996). We demonstrate, using equine cytokines, that the quantity of mRNA 
can be determined via RT-PCR using standard curves generated from dilutions of 
double stranded circular plasmids encoding the transcript of interest and that by 
decreasing the cycle number and cDNA volume used for P-actin amplification, as 
compared to cytokine amplifications, P-actin is an accurate normalization factor for 
the differences that are inherent in the RT step of the assay. Advantages of this 
method include: (i) the assay has a linear dynamic range on the order of 3 logs; (ii) 
the target utilized to generate the standard curve is identical to the cDNA target 
thereby minimizing differences in amplification efficiency commonly reported with 
the use of competitor molecules; (iii) post PCR detection and analysis does not utilize 
radioisotopes or require adjustment for size of the reference molecule; (iv) the assay 
is technically straightforward and easily adaptable to any gene that has been cloned 
without subcloning or competitor construction; (v) the assay requires fewer reactions
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than QCRT-PCR assays (vi) the method accommodates high sample throughput and, 
(vii) replicate samples are easily generated to allow statistical analysis of data. 
Materials and M ethods 
Preparation of cells
Equine peripheral blood mononuclear cells (PBMC) were isolated from venous 
blood by differential centrifugation over Ficoll-Pague (Pharmacia LKB 
Biotechnology, Piscataway, NJ). After washing in calcium and magnesium free 
phosphate-buffered saline (CMF-PBS), PBMC were suspended in media consisting of 
RPMI 1640 (Sigma Chemical Co., St. Louis, MO) supplemented with 2- 
mercaptoethanol (lO- 8  M), glutamine (2mM), 100 U/ml penicillin, 100 pig/ml 
streptomycin, and 5% heat inactivated fetal bovine serum (Hyclone Laboratories, 
Logan, UT). PBMC were incubated at a concentration of 2 x 106/ml for 72 hours 
with phytohemagglutinin-M (PHA, 2pglml, Sigma) at 39°C in a humidified 
environment with 5 % C 0 2. Aliquots of PBMC (2 x 106  cells) were frozen at -70°C in 
RNAStat60 (Tel-Test, Friendswood, TX) until use.
RNA isolation and cDNA synthesis
Samples o f PHA stimulated PBMC which had been frozen in RNAStat60 
(Tel-test) were defrosted and processed to RNA using chloroform extraction as per the 
reagent manufacturer’s directions. RNA, which was quantified spectrophoto- 
metrically, consistently yielded absorbance ratios (260 nm:280 nm) on the order of 
1.9. 0.60 fig of RNA in 35 pi diethyl pyrocarbonate (DEPC)-treated water were 
heated to 65°C for 10 minutes to denature the RNA then chilled on ice and pulsed in a 
microcentrifuge at 4°C. 45 pi o f reagent master mix was then added resulting in a
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final reaction containing IX first strand buffer (Gibco BRL, Gaitherburg, MD), 
0.5mM dNTP (Perkin-Elmer, Norwalk, CT), 120 Units RNAsin (Promega, Madison, 
WI), 0.075 fig/fil BSA (NEB, Beverly, MA), 1.0 pM  Oligo-dT (Promega), 10 mM 
DTT (Gibco) and 800 Units Moloney Murine Leukemia Virus (MMLV)-Reverse 
Transcriptase (Gibco). The final reaction volume was 80pl. The reaction was 
incubated at 25°C for 10 minutes to facilitate primer annealing, then 40°C for 1 hour, 
and then frozen at -20°C until used for PCR. DEPC-treated water was substituted for 
MMLV-RT in control reactions in order to detect genomic DNA contamination.
In some experiments cDNA reactions were synthesized from serial two fold 
dilutions of RNA ranging from 2 fig to 0.0625 fig per reaction. The RNA from these 
reactions originated from the same extraction of PHA stimulated cells. This set of 
cDNA reactions is referred to as the RNA dilution series. In other experiments, three 
cDNA reactions were synthesized from identical amounts of RNA originating from a 
single extraction procedure in order to isolate variability associated with the RT 
reaction from that associated with RNA extraction and spectrophotometric 
quantification. These reactions are referred to as identical cDNA reactions. In assays 
that examine the inter- and intra-assay variation associated with RNA that originates 
from separate RNA extractions, a split sample design was utilized. Six aliquots of 
cells from a PHA stimulated culture of equine PBMCs were frozen in RNAStat60 at 
-80°C. RNA was extracted from three of the six samples and processed to cDNA on 
two separate days.
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Preparation of plasmid templates and oligonucleotides
Each cDNA encoding equine IL-2, IL-4, IL-5, IL-10, and P-actin was cloned 
into a plasmid vector and sequenced in our laboratory. The respective GenBank 
accession numbers are: IL-2:L06009, IL-4:L06010, IL-5: U91947, IL-iO: U38200, 
p-actin: AF035774. Sequences for equine IL-2 (Vandergrifft and Horohov, 1993) and 
IL-4 (Vandergrifft et al., 1994) have been published. Equine Interferon-y (IFN-y) 
was a gift from Dr. D. Antczak (James A. Baker Institute for Animal Health, College 
of Veterinary Medicine, Cornell University, Ithaca, New York). Plasmids encoding 
these cDNA sequences were purified from 50 ml cultures using CsCl 
ultracentrifugation in the presence of ethidium bromide (Sambrook et al, 1989) and 
quantified spectrophotometrically.
In order to generate standard curves, double stranded plasmids containing the 
equine cytokines and P-actin were serially diluted in one-half log increments to 
achieve eight dilutions. Cytokine plasmid dilutions ranged from 1 x 10' 1 9  to 1 x IQ'22 5 
moles (approximately 40 to 1.2 x 105  cytokine molecules for double stranded plasmid) 
of plasmid per PCR reaction. P-actin plasmid dilutions ranged from 1 x 10' 1 6  to I x 
1 0 ' 1 9 - 5  moles (approximately 1.6 x 104  to 4.8 x 107  P-actin molecules for double 
stranded plasmid) per PCR reaction.
Equine-specific PCR primers and oligonucleotide probes for hybridization 
were selected using ‘Oligo’ primer analysis software (National Biosciences,
Plymouth, MA) and were commercially prepared (Genelab, Baton Rouge, LA; Baron 
Biotech, Milford, CT). Sequences of the PCR primers, hybridization probes, as well 
as the length of the PCR products are listed in Table 2.1. PCR primers were designed
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Table 2.1 PCR primers, hybridization probes, and expected fragment size for PCR amplification and detection 
of equine EL-2, EL-4, IL-5, IL-10 and P-actin.
Amplicon Positive Strand primer 
(5'Biotin-3')
Minus strand primer 
(5,-3')
Hybridization probe 
(5'TBR-3')
Fragment 
size (bp)
IL-2 gcacctacttcaagctctaagag cacatgtgaatcttgtttcagacc ttcaattctgtggccttcttgg 303
IL-4 ctcacagatggaaagggcaagaat cacagtacagcaggtcccgttt cagcaaaggcatccgctacag 213
EL-5 cgaactctgctgataggcgatg agacaaagttttggaatagtttggcc ttggacagtttgattcttcaatgtg 216
IL-10 gactttaagggttacctgggttg tgcttcagtttttcatcttcgttg gcctggggcatcacctcct 324
IFN-y acccagatgtaggggatggtg cttccgcttcctcaggttagctt gcttgctggtgctgctgttaa 345
P-actin atggatgatgatatcgccgcg aggatgcccctcttgctctg acgatggaggggaagacggc 194
The positive strand primers were labeled with biotin at their 5' terminus. Hybridization probes were labeled with 
TBR at their 5' terminus. Labeled oligonucleotides were purified by HPLC to eliminate unlabeled oligonucleotides.
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to encompass approximately 250 base pairs of the cDNA sequence (range 194 bp to 
345 bp). Positive strand primers were biotinylated on their 5' terminus. Oligomers 
used for hybridization were complementary to the biotinylated strand and were 
labelled with tris (2,2'-bipyridine) ruthenium II chelate (TBR) on their 5 ’ terminus. 
Labelled primers and hybridization probes were purified by HPLC to eliminate non- 
labelled oligonucleotides.
Polymerase chain reaction
Reactions were optimized for the amplification of both cDNA and plasmid in 
preliminary experiments using commercially prepared buffers ( PCR Optimizer Kit, 
Invitrogen, Carlsbad, CA; 10X PCR Buffer, Perkin-Elmer) in order to achieve a 
single band of maximal intensity on a 3% NuSeive 3:1 GTG agarose gel (FMC 
BioProducts) with ethidium bromide staining. The target sequences were amplified in 
50jd reactions whose final components were IX PCR Buffer (Table 2.2), 200/xM 
dNTP (Perkin-Elmer), 2.5 units Taq DNA polymerase (Perkin-Elmer), and 0.2 fxM 
of each sense and .anti-sense primer. Unless otherwise noted, 5 /xl of the cDNA 
reaction were used to amplify cytokines and 2ptl to amplify P-actin. Cycling 
parameters were 94°C for 30 sec, 55°C for 30 sec, and 72°C for 1 minute except for 
IL-4 which annealed at 60°C for 30 seconds. Samples were cycled using a GenAmp 
9600 (Perkin-Elmer). PCR reactions were performed in triplicate and plasmids 
constituting the standard curve were included on the same plate with the unknown 
cDNA reactions using the same PCR reagent master solution.
The optimal number of PCR cycles which would maintain the targeted sample 
population in the exponential amplification phase of the PCR reaction were
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Table 2.2 PCR buffer composition.
Amplicon Buffer Composition (5X)
Tris-HCl (mM) (NH4 )S0 4  (mM) MgCl2  (mM) pH @22°C Gelatin (%) Source
EL-2 300 75 12.5 1 0 . 0 - INV(O)
IL-4 300 75 12.5 9.5 - INV(K)
IL-5 250 - 7.5 0 . 0 1 P-E
IL-10 300 75 7.5 8.5 - INV(G)
IFN-y 300 75 12.5 9.0 - INV(A)
P-actin 250 - 7.5 0 . 0 1 P-E
INV(A,G,K, or 0 ) signifies buffer designation in PCR Optimizer Kit (Invitrogen,Carlsbad, CA). 10X PCR 
buffer with MgCl2  used to amplify equine IL-5 and equine p-actin, was obtained from Perkin-Elmer (P-E).
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determined for each cytokine as well as for P-actin using cDNA from PHA stimulated 
equine PBMC. A PCR master mix that included cDNA was divided into equal 
aliquots. Tubes were amplified under conditions previously described and one tube 
was removed at 15, 20, 25, 30, 35, and in the case of the cytokines at 40 and 45 
cycles. Tubes were kept on ice until analyzed.
For plasmid standard curves, plasmids were serially diluted in half log 
increments to achieve final concentrations of 2 x I O' 2 0  to 0.2 x 10" 2 3  5  moles//d for 
cytokines and 2  x 10 1 7  to 2  xlO* 2 0  5  moles//d for P-actin. 5/d of each plasmid dilution 
were amplified in each PCR reaction. A standard curve therefore was created by the 
amplification of eight dilutions of plasmid encoding the cDNA of interest. Plasmid 
standard curves were always generated in parallel with amplifications from cDNA 
using the same PCR reagent master mix.
Quantification of PCR product
PCR targets were quantified using the QPCR System 5000 (Perkin-Elmer).
5/d of PCR product were hybridized in solution in a 50/d reaction containing 10 
pmoles of target-specific TBR labeled oligonucleotide probe and IX PCR Buffer 
without MgCU (Perkin-Elmer). The reaction was heated to 95°C for 90 seconds 
followed by a 5 minute hold at 55°C. Biotinylated PCR product was then captured by 
adding 15/d of streptavidin coated iron beads (Dynabeads, Perkin-Elmer) to the 
hybridization reaction and incubating at 55°C for 30 minutes. The entire 65 /d 
reaction was transferred to a 175 mm polypropylene tube containing 335 /d QPCR 
Assay Buffer (Perkin Elmer) and quantified on the QPCR System 5000. The QPCR 
System 5000 aspirates the iron beads with their attached PCR product bearing TBR
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labeled probe onto a working electrode. TBR on the target specific probe emits light 
at 620 nm as a  result of a series of redox reactions that are induced when voltage is 
applied to the electrode. The emissions are detected and quantified by a 
photomultiplier tube and reported as luminosity units. A plot of luminosity values vs 
initial template number was derived from plasmid amplifications. Initial template 
numbers in the cDNA reactions were then interpolated using luminosity values. These 
values were designated as copy units.
Statistical analysis
Interpolated copy units and luminosity values were compared using one way 
analysis of variance. Where data were not normally distributed, the analysis was 
performed on ranks. In the case of amplifications originating from identical cDNA 
reactions, that is cDNA reactions which were synthesized using equivalent amounts of 
RNA from the same extraction, interpolated copy units were compared using repeated 
measures analysis o f variance. Post hoc pairwise comparisons were made using the 
Student-Neuman-Keuls method. Inter-assay sample variation was compared using a 
paired t-test and the correlation between the predicted cytokine and the predicted P- 
actin copy numbers derived from the same cDNA sample was determined using 
Pearsons Product Moment analysis. Unless otherwise noted, differences are 
considered significant when P<0.05.
Results
Determination of PCR cycle number
To determine the optimal cycle number which would maintain the 
amplification of the cytokines and P-actin in their exponential amplification phase, the
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transcripts of interest were amplified in duplicate reactions to varying cycle numbers
from cDNA reactions and assayed for luminescence with sequence-specific probe. By
plotting luminosity vs cycle number, the exponential amplification phase of the
reactions could be identified. Cycle numbers 20 and 30 defined the limits o f the
exponential amplification phase during amplification of equine P-actin (Figure 2 . 1 ).
Accordingly, 25 cycles was chosen for subsequent P-actin amplifications. By contrast,
35 cycles were found to provide better sensitivity for cytokine amplification while
maintaining the reactions in their exponential amplification phase.
Generation of PCR standard curves
Using 25 cycles in the case of p-actin and 35 cycles for the cytokines, one-half
log dilutions of plasmid ranging from 1  x 10' 1 6  to 1  x 10 1 9  s moles for P-actin and 1  x
1 0 1 9  to 1  x 1 0 ' 2 2 5  moles for the cytokines were amplified to generate a standard
curve. A plot o f luminosity vs template number allowed rapid identification of the
exponential amplification and plateau phases of each reaction (Figures 2.2, 2.3, and
2.4). Because the noncoding strand of the plasmid derived sequence serves as a
template for the PCR reaction, each molecule of plasmid was considered equivalent to 
%
2 cDNA molecules when labeling the standard curve axis. A linear relationship was 
maintained for all cytokines from 1 x I O' 2 2 5  to 1 x 10' 2 0 3  moles of plasmid DNA 
indicating a three log dynamic range for input DNA. Similarly, post PCR 
quantification o f P-actin also demonstrated linearity of three logs for input DNA 
ranging from 1 x 10 1 9  3  to 1 x I O' 1 7 ' 3  moles. For brevity, amplifications from these 
series of plasmid dilutions will be referred to as a standard curve.
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Figure 2.1. Optimizing cycle number to maintain P-actin amplification in the 
exponential amplification phase of the PCR. Identical 50 ml PCR reactions 
containing cDNA from PHA stimulated equine PBMC were amplified to different 
cycle numbers as indicated. 5 ml of each PCR reaction were hybridized with 
sequence specific probe, captured onto streptavidin-coated iron beads (Dynabeads, 
Perkin-Elmer), and assayed using the QPCR System 5000. Reactions amplified 
between 20 and 30 cycles defined the exponential amplification phase of the 
reaction.
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Figure 2.2. PCR Standard Curves: Beta-actin and Interleukin-2. Luminosity 
(measured by the Perkin-Elmer QPCR System 5000) vs. differing initial quantities 
of plasmid encoding beta-actin or interleukin-2 after PCR cycles 25 and 35 
respectively. Data points represent mean and standard deviation of three replicate 
PCR reactions. Regression adjustment represents a two parameter exponential rise
to maximum fit of the data defined by the equation y=a(l-e '^x).
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Figure 2.3. PCR Standard Curves: Interleukin-4 and Interleukin-5. Luminosity 
(measured by the Perkin-Elmer QPCR System 5000) vs. differing initial quantities 
of plasmid encoding interleukin-4 or interleukin-5 after 35 PCR cycles. Data points 
represent mean and standard deviation of three replicate PCR reactions. Regression 
adjustment represents a two parameter exponential rise to maximum fit of the data
bxdefined by the equation y = a(l-e  ).
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Figure 2.4. PCR Standard Curves: Interleukin-10 and Interferon-gamma. 
Luminosity (measured by the Perkin-Elmer QPCR System 5000) vs. differing 
initial quantities of plasmid encoding interleukin-10 or interferon-gamma after 35 
PCR cycles. Data points represent mean and standard deviation of three replicate 
PCR reactions. Regression adjustment represents a two parameter exponential rise
h xto maximum fit o f the data defined by the equation y=a(l-e  ).
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Mathematical characterization of PCR standard curves
To determine the mathematical equation that accurately modeled the standard 
curves over a wide range o f input DNA, IL-4, IL-10, and P-actin were amplified 
from six cDNA reactions whose RNA content constituted serial two fold dilutions of 
RNA (2.0, 1.0, 0.5, 0.25, 0.125 and 0.0625 /xg). Standard curves encoding the 
targeted cytokine or P-actin were amplified in the same run.
Several mathematical regression models were applied to the standard curve 
data which was graphed on combinations of log and linear scales (SigmaPlot™,
Jandel Scientific, San Francisco, CA). Luminosity values from the RNA dilution 
series were then interpolated to copy units using each regression model to determine 
if two fold differences in message content were predicted (Figures 2.5, 2.6). 
Mathematical models of the standard curve included a linear polynomial (y=b+ax) 
adjustment to data graphed as log luminosity vs log copy units. A logistic 
mathematical adjustment (y=[(a-d)/(l+(x/c)b)]-fd) was applied to data graphed as 
luminosity vs log copy units where a=  signal maximum, b=slope parameter, 
c=value at inflection point, and d=signal minimum. These analyses of PCR standard 
curve data have been previously published (Melby et al., 1993; Reyes-Engel et al., 
1996). The logistic mathematical equation was also applied to data on a log 
luminosity vs log copy units scale.
Though the aforementioned adjustments sometimes provided superior 
correlation coefficients (r) and did predict dilutions of message that approximated two 
fold at the lower RNA concentrations, a two parameter exponential rise to maximum
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Figure 2.5. Mathematical characterization of the PCR standard curves. IL-4 and 
IL-10 were amplified from a series of cDNA reactions whose input RNA constituted 
serial two fold dilutions ranging from 2 pg to 0.0625 pg. Luminosity values were 
interpolated to copy units using four mathematical analyses of the standard curve and 
plotted according to the predicted fold change. Mathematical analyses included: (•) 
two parameter exponential rise to maximum (y=a[l-e'*3X]), ( o )  linear polynomial 
(y=b+ax) applied to log luminosity vs log copy units, (▼) logistic mathematical 
(y=[(a-d)/(l+(x/c)b)]+d) applied to luminosity vs log copy units and, ( v )  the 
logistic mathematical equation applied to log luminosity vs log copy units. The line
( -----  ) represents the ideal prediction of two fold changes between samples. Data
represents the fold change between the mean of triplicate PCR reactions.
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Figure 2.6 Mathematical characterization of the PCR standrd curve. P-actin was 
amplified from a series of cDNA reactions whose input RNA constituted serial 
two fold dilutions ranging from 2 pg to 0.0625 (ig. Luminosity values from the 
cDNA reactions were interpolated to copy units using four mathematical analyses 
of the standard cufve and plotted according to the predicted fold change.
Mathematical analyses included: (•) two parameter exponential rise to maximum 
(y=a[l-e ]), (o) linear polynomial (y=b+ax) applied to log luminosity vs log 
copy units, (▼) logistic mathematical (y=[(a-d)/(l+(x/c)b)]+d) applied to luminosity 
vs log copy units and, (v ) the logistic mathematical equation applied to log
luminosity vs log copy units. The line ( ----- ) represents the ideal prediction of
two fold changes between samples. Data represents the mean of triplicate PCR 
reactions. (*) indicates replicate beyond the final iteration of the standard curve. 
Luminosity values for amplifications from 2 mg of RNA were beyond the final 
iteration of the two parameter exponential rise to maximum analysis.
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regression analysis given by the equation y=a(l-e‘ta) was superior at predicting the 
expected two fold dilutions (Figure 2.7).
One way analysis o f  variance of interpolated copy units from this RNA 
dilution series indicated that the predicted two fold dilutions were significantly 
different for each of the PCR targets examined (P<0.01). Pairwise comparison of the 
RNA dilution groups indicated that differences among all groups were statistically 
significant with the exception o f the 0.0125 fig vs 0.0625 fig comparison for IL-4 
whose t-test approached significance (P=0.067). Data representing IL-4 at 2 fig and 
P-actin at 1.0 fig and 2.0 fig were not included in the statistical analysis as one or 
more values of the triplicate were within the plateau phase of the curve and therefore 
beyond the final iteration o f the mathematical model.
Reproducibility of the RT-PCR process
To determine the precision of the combined RT-PCR process, IL-2, IL-4, 
IL-10, IFN-y, and P-actin were amplified using PCR from three identical cDNA 
reactions. The identical cDNA reactions were synthesized using RNA from a common 
extraction procedure and a  common cDNA reagent master mix. Luminosity values 
from the cytokine amplifications were interpolated to copy units (Figure 2.8) using 
the two parameter exponential rise to maximum adjustment of the respective standard 
curves. Copy units for IL-4 and IFN-y could not be interpolated because their 
luminosity values were beyond the final iteration of the standard curve within the 
plateau phase of the reaction. Luminosity values for IL-4 and IFN-y amplification are 
shown in Figure 2.9.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
100
35000
30000
O 15000
10000
RNA per cDNA reaction (ng)
P-actin
RNA per cDNA reaction (jig)
Figure 2.7 Interpolated copy units from cDNA reactions whose RNA content differed 
by two fold. Following PCR, luminosity values were interpolated to copy units using 
a two parameter exponential rise to maximum fit of the standard curve given by the
equation y=a(l-e"*>x). The distribution of P-actin values among the cDNA reactions 
was positively correlated to the distribution of IL-4 and IL-10 values. All 2 pg P-actin 
replicates were beyond the final iteration of the regression. (*) indicates 1  replicate 
of the triplicate was beyond the final iteration of the regression.
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Figure 2.8. To determine the precision of the RT-PCR assay, IL-2 and IL-10 
(top panel) as well as p-actin (bottom panel) were amplified from 3 identical 
cDNA reactions. Copy units were interpolated from luminosity values using 
the appropriate standard curves. Data represents the average and standard 
error of the mean from triplicate PCR amplifications of each cDNA reaction.
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Figure 2.9. To determine the precision of the RT-PCR assay, IL-4 and IFN-y 
were amplified from 3 identical cDNA reactions. Luminosity values for these 
amplifications could not be interpolated to copy units because they were 
beyond the final iteration of the standard curve. Data represent the average 
and standard error of the mean from triplicate PCR amplifications of each 
cDNA reaction.
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The error, determined by the coefficient of variance associated with replicate 
amplifications from an individual cDNA reaction ranged from 5-10% for p-actin, and 
8-33% for the cytokines (with most values being <  10%). The error in the average 
predicted copy units from replicate cDNA reactions ranged from 7-13%. When 
subjected to repeated measures analysis of variance, the interpolated IL-2, IL-10 and 
P-actin copy units from the 3 identical cDNA reactions were not significantly 
different (P> 0.1). Similarly, luminosity values following IL-4 and IFN-y 
amplification from the identical cDNA reactions were not significantly different 
(P>0.08).
Inter and Intra-Assav Variability
To determine the inter- and intra-assay variation associated with RNA that 
originates from separate RNA extractions, IL-2, IL-4, IL-10 and IFN-y were 
amplified in triplicate PCR reactions from six cDNA reactions whose RNA originated 
from separate extractions of the same culture. As noted in the methods section, one- 
half of the RT reactions (1-3 vs 4-6) were performed on two separate days. PCR 
amplification was repeated on a second day. Standard curves were amplified from a 
common PCR reagent master solution on each day and message from the 6  cDNA 
reactions was determined by interpolation against the standard curve (Figure 2.10).
To assess inter-assay variability, interpolated copy units from the first day’s 
amplification were compared to those of the second day for each of the six cDNA 
reactions using paired t-tests. The interpolated copy units on day 1 and day 2 were not 
significantly different for IL-2, IL-4, and IL-10. Consistent with prior analyses,
IFN-y luminosity values from the 72 hr PHA stimulated cDNA samples tended to be
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Figure 2.10. Comparison of cytokine message amplified on two separate days 
(■ ■ I  day 1, andEHS day 2) from 6  cDNA reactions whose RNA originated 
from separate extractions o f the same culture. Message detected from an individual 
cDNA reaction did not differ significantly when the two days were compared but 
there were significant differences in message content among the six reactions.
(*) denotes IFN-y values which had reached the plateau phase of the reaction.
Bars represent the mean with standard error of triplicate amplifications.
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beyond the final iteration o f  the standard curve. However, one o f the six cDNA 
reactions had luminosity values that were much lower for each o f the transcripts 
examined than the other 5 cDNA reactions. The IFN-y luminosity values for this 
cDNA (#3) did fall within the exponential amplification phase o f the standard curve 
and the interpolated copy units were not significantly different on days 1  and 2 .
To assess the intra-assay variability, the interpolated cytokine copy units from 
the sue cDNA reactions were compared. As anticipated, there were significant 
differences (P<0.01) among the 6  cDNA reactions in the predicted copy units. IL-4 
values differed on day I and IL-10 on both day 1 and day 2. IL-4 values on day 2 
were not significantly different due to a single reaction (#4) whose coefficient of 
variation for the three replicates was very high (135%). Removal of this cDNA 
reaction from the statistical analysis restored normality to the sample population and 
indicated significant differences (P =0.002) between the predicted IL-4 content of the 
remaining 5 cDNA reactions. Interpolated copy units for IL-2 among the 6  cDNA 
reactions were not significantly different. The inability to resolve differences in IL-2 
input among the 6  cDNA reactions reflected the fact that, as expected for a 72 hour 
PHA stimulation, IL-2 message was extremely low and approached the lower limit of 
detection of the assay for all of the 6  cDNA samples.
P-actin as a Normalization Factor
The usefulness of P-actin as a house keeping gene for quantitative PCR has 
been questioned primarily because its expression exceeds that of cytokines by 1 0 0 - 
1000 fold such that cycle numbers optimized for detection of cytokines cause P-actin 
amplifications to enter the plateau phase of the reaction. Accordingly, in order to
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maintain P-actin amplification in the exponential amplification phase of the reaction 
cDNA samples were amplified to only 25 cycles in this protocol whereas cytokines 
were amplified to 35 cycles. To define the limitations of this approach, P-actin was 
amplified from the RNA dilutions and 6  extraction cDNA sets. cDNA samples were 
amplified in conjunction with a  standard curve from a common master mix. P-actin 
copy units from each PCR reaction were interpolated using the standard curve and a 
normalization factor which corrected each sample to 500,000 copies. (500000/average 
copy number of three P-actin replicates) was derived. The P-actin luminosity values 
from the cDNA reaction that contained 2/xg of RNA were beyond the final iteration of 
the standard curve, within the plateau phase. Due to the magnitude of the P-actin 
copy numbers, data were log transformed for statistical analysis.
Pearson’s product moment analysis of the predicted cytokine and P-actin copy 
values indicated that the cytokine values for each cDNA were positively and 
significantly correlated to P-actin values from the same cDNA reaction (Figure 2.7 
and 2.11). Thus, there was a statistically significant correlation between predicted 
cytokine copy units and predicted P-actin copy units over a wide range of input RNA 
even in the practical situation where PCR reactions resulting from multiple RNA 
extractions were compared.
To define the conditions for using p-actin as a normalization factor, 
interpolated cytokine copy units from the previous experiments were multiplied by 
their respective P-actin normalization factor and compared. In the case of the cDNA 
series whose input RNA constitute serial two fold dilutions (Figure 2.12), the 
normalized IL-4 values from each cDNA reaction were not significantly different.
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Figure 2.11. Correlation between cytokine and P-actin levels from the same cDNA 
reaction. IL-2, IL-4, IL-10 and P-actin were amplified in triplicate PCR reactions 
from six cDNA reactions whose RNA was derived from separate extractions of a 
single PBMC culture. Cytokine values for each cDNA were positively and 
significantly correlated to P-actin values from the same cDNA reaction.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
109
2500
IL-4 IL-10
Figure 2.12 Cytokine copy numbers normalized for P-actin content o f the cDNA 
reaction. Interpolated IL-4 and IL-10 values derived from PCR amplification of cDNA 
reactions that contained two fold dilutions of RNA were normalized to 500,000 copies 
of P-actin and compared. Of the two cytokines only the 1 pg amplification of IL-10 
was significantly different from the other cDNA reactions. However, 1 pg P-actin 
replicates were within the plateau phase of the reaction (*).
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However, the normalized IL-10 value for the cDNA reaction that contained 1 pig o f 
RNA was significantly different from the normalized values for the other dilutions. 
Because two fold dilutions of IL-10 were predicted at all dilutions prior to 
normalization, this finding suggested that amplification of P-actin from 1 pig of RNA 
was beginning to exceed the useful limits of the assay.
When normalized cytokine copy units for the 6  cDNA reactions that originated 
from separate RNA extractions of PHA stimulated cells were compared (Figure 
2.13), there were significant differences among the cDNA reactions for IL-2 and IL- 
10. Normalized copy units were not significantly different for IL-4 but this reflected a 
large coefficient o f variance associated with cDNA #3, a phenomenon previously 
observed with PCR amplifications on very low template concentrations. Normalized 
IL-4 values for the remaining cDNA reactions were significantly different when 
analyzed without data from cDNA #3. Though there was some overlap in the 
statistical groupings of the six cDNA using pairwise comparisons of the normalized 
cytokine numbers, there was a tendency for three groupings. Group one consisting o f 
cDNA ff6 and M . Group two consisting of cDNA #1, ft2, and ft5 . and group three 
having only cDNA ff3. Closer scrutinization of the luminosity values revealed an 
explanation for these findings. Cytokine luminosity values for cDNA #3 were at or 
below the lowest dilution of the plasmid standard curve, while the luminosity values 
for P-actin from cDNA #4 and ff6 were between the two highest dilutions of the P- 
actin standard curve at the portion of the curve entering the plateau region. Analysis 
of the data with and without values from these reactions (#3, #4, if6) determined that 
values in these ranges could not be used in comparisons of the data (Table 2.3).
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Figure 2.13. Cytokine copy numbers normalized for P-actin content of the cDNA 
reaction.The cytokine content o f six cDNA reactions derived from separate RNA 
extractions of the same culture were normalized to 500,000 copies of P-actin using 
P-actin values amplified from the same cDNA reaction. Bars represent the mean 
and standard deviation o f triplicate reactions run on ( ■ ■  ) dayl and repeated on 
C  ) day 2 .
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Table 2.3 Effect of P-actin normalization on the coefficient of variation (CV)
cDNA #1-6 cDNA #1,2,4-6 cDNA# 1,2,5 cDNA#4,6
IL-2 PCR 1
X STD CV X STD
raw 396.8 109.2 0.28 428 92.2
normalized 237.2 380.0 1.60 67.8 34.3
IL-2 PCR II
raw 576.1 158.2 0.27 611.2 150.6
normalized 256.7 371.9 1.45 91.2 40.9
IL-4 PCR 1
raw 7399.8 3708.0 0.50 8693 2542.7
normalized 1811.8 1233.2 0.68 1334.2 675.3
IL-4 PCR II
raw 9768.2 5353.9 0.55 11961 3433.5
normalized 2274.0 1331.3 0.59 1721.5 830.1
IL-10 PCR I
raw 1259.0 687.7 0.53 1480.2 491,3
normalized 287.5 197.0 0.69 207.2 88.7
IL-10 PCR II
raw 1144.8 842.3 0.56 1354.4 481.2
normalized 222.8 111.3 0.50 179.8 61.2
CV X STD CV X STD CV
0.22 341.0 38.0 0.11 438.0 17.0 0.04
0.51 92.0 19.0 0.20 28.5 0.5 0.02
0.25 549.0 214 0.38 689.0 22.0 0.03
0.45 134.5 12.5 0.09 45.0 2.0 0.04
0.29 7762.0 2066.1 0.27 10089.5 2551.5 0.25
0.51 1787.7 478.7 0.27 654.0 159.0 0.24
0.29 9532.5 1808.5 0.19 14389.5 2917.5 0.20
0.48 2510.0 320.0 0.13 933.0 180.0 0.19
0.33 1301.7 530.1 0.41 1748.0 250.0 0.14
0.43 270.0 55.7 0.21 113.0 15.0 0.13
0.36 1087.3 453.8 0.42 1755.0 51.0 0.03
0.34 223.7 37.8 0.17 114.0 2.0 0.02
The average of triplicate normalized cytokine amplifications from 6  cDNA reactions (#1-6) whose RNA originated from separate 
extractions of the same culture were grouped as noted and analyzed for their effect on the assay error. Removing data derived from 
the extremes of the standard curves (reactions 3, 4, and 5) decreased the error to 13-27%.
N>
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Values at or below the bottom of the cytokine curves and at the top of the P-actin 
curve overestimated the copy values leading to erroneously high correction factors. 
When all six reactions were analyzed, normalization did not improve the sampling 
error as determined by the coefficient of variation (CV) among the average values for 
the sue reactions and actually tended to increase it to unacceptable levels (50- 
> 100%). Removing values from cDNA #3 decreased the errors in both normalized 
and non-normalized samples from the same population but the errors were still up to 
two fold greater in the normalized than the non-normalized data. However, when the 
cDNA #4 and # 6  were removed from the analysis, the coefficients of variance (CV) 
prior to normalization ranged from 20-40% and were decreased to 13-27% after 
normalization. This confirms that when values lying outside the linear portion of the 
standard curve are excluded, P-actin is a valuable normalization factor and differences 
of + /-  2  standard deviations about the mean will adequately discriminate significant 
differences between samples.
Discussion
Amplifications from cloned cDNA of identical sequence to the wild type target 
have been previously utilized to generate standard curves for the quantification of 
PCR products (Martin et. al.\ 1995, Melby et. al., 1993). As with our experiments, 
the standard curve and unknown cDNA samples were amplified using the same PCR 
reagent master mix and were analyzed in replicates to minimize any tube to tube 
variation in the PCR reaction. This approach eliminates the need for synthetic 
templates of different sizes from wild type. This has several advantages. First, 
because the target and control sample are of identical sequence but amplified in
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different tubes, the concerns regarding different amplification efficiencies based on 
size differences ( Becker-Andre and Hahlbrock, 1989; Kanangat et al., 1992; Souaze 
et al., 1996) or the formation of competitor/wild type heteroduplexes are minimized 
(McCullough et al., 1995; Henley et al., 1996). This method is less labor intensive 
because there is no internal standard to construct nor is there a large series of samples 
with differing competitor:target ratios. Varying the competitor:target ratio is required 
for accurate quantification using competitive methods (Arnold et a l., 1992; Souaze et 
al., 1996;; Raeymaekers, 1993). Most significantly, this method is easily performed 
with very high sample throughput from cells to quantified product in replicates 
sufficient for statistical analysis of the data in a single day.
The generation of standard curves and their graphical representation of signal 
intensity (luminosity) vs copy number on a linear scale allowed identification of the 
exponential amplification and plateau phases of the PCR reaction. It is well accepted 
that in noncompetitive methods, samples must remain in the exponential amplification 
phase of the reaction for meaningful comparison because all reactions, regardless of 
starting template concentration, will reach a maximum defined as plateau (Ferre,
1992; Morrison and Gannon, 1994). Despite occasional reports to the contrary 
(Dostal et. al., 1994; Ruster et. al., 1995) competitive reactions can be run to plateau 
without adversely affecting target:competitor ratios (Bouaboula et. al., 1992; Siebert 
and Larrick, 1992; Couttrez et. al., 1994; Morrison and Gannon, 1994) Decreases in 
PCR product following plateau have been described and the reason for this 
phenomenon is not known (Personal communication, John Pfeifer, Perkin-Elmer).
The mathematical model applied to these standard curves, a two parameter
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exponential rise to maximum given by the equation y = a (l-e bx), has the advantage of 
preventing interpolations beyond the final iteration of the standard curve which lie 
within the plateau phase o f the reaction. The most commonly utilized mathematical 
model for PCR based quantifications is a linear fit where data is graphed following 
detection of PCR product as log,0 signal strength vs Iog10 copy number (Wang et. al., 
1989; Murphy et. al., 1990; Noonan et. al., 1990; Melby et al., 1993). However, a 
logistic mathematical analysis of signal strength vs logi0 template concentration has 
been shown to provide a superior fit to the curve over a wide range of template 
concentration (Reyes-Engel et al., 1996). When these models are applied to 
noncompetitive methods, because there is no mathematically imposed maximum, the 
beginning of the plateau is subjectively determined by the investigator. Experience 
with different graphical representations of our standard curve data indicated that linear 
adjustments made it difficult to appreciate the onset of plateau.
Unlike other experiments which simply utilize a mathematical adjustment that 
provides the best fit o f the standard curve data, in this instance cDNA reactions 
created from serial two fold dilutions of RNA, which should therefore contain two 
fold dilutions of cytokine template, were utilized to determine the mathematical model 
which most accurately modeled the performance of the PCR amplification. Though 
the other mathematical adjustments to the standard curves often provided superior 
correlation coefficients, the two parameter exponential rise to maximum adjustment 
was chosen because it most closely predicted the anticipated two fold dilutions of 
message with minimal variation such that the two fold dilutions were significantly 
different when subjected to analysis of variance. This also indicates that the assay is
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capable of resolving at least two fold differences in message, though the limits of 
resolution were not determined. Based on the graphical representation of the standard 
curves and amplifications from diluted RNA, the assay has a linear dynamic range on 
the order of 3 logs.
To our knowledge this is the first report of the use of double stranded (ds) 
circular plasmid to generate standard curves used for quantification of PCR product. 
Other reports have used linearized cDNA plasmid (Martin et al. , 1995) or liberated 
the cDNA fragment using restriction digests (Melby et al., 1993) but use of ds 
plasmids eliminates the need to purify the fragments from inhibitors of the PCR 
reaction following digests. Though there are reports of differences in the efficiency of 
amplification between double stranded and single stranded templates, the curves 
described here accurately predicted a two fold difference in transcript numbers from 
cDNA reactions whose input RNA varied by two fold for each of the transcripts 
examined. This indicates that, a t least over the range of these template dilutions which 
in the case of IL-10 covered most o f the linear portion of the standard curve, the 
amplification efficiency of the target sequences from double stranded circular plasmid 
and linear single stranded cDNA was equivalent.
A number of housekeeping genes including glyceraldehyde-3-phosphate 
dehydrogenase (GADPH) (Dukas et al. , 1993), hypoxanthine phosphoribosyl- 
transferase (HPRT) (Murphy et al., 1993) and peptidyl-prolyl-cistrans isomerase 
(Cyclophilin) (Nast et al. , 1994) have been utilized in PCR analysis of cytokine 
mRNA content. P-actin was chosen as the internal control for this assay because the 
equine sequence has been determined allowing the generation of sequence-specific
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oligonucleotide probes and primers. Additionally, attempts to amplify HPRT using 
published sequences (Grunig et al., 1992) were variably successful in our hands.
While 1.3 (Melby et al. , 1993) to three fold (McCairns, 1994) increases in P-actin 
message have been reported in response to mitogen stimulation using cloned T cells 
and normal human PBMC respectively, increases in HPRT production on the order o f 
10-20 fold have been demonstrated in mitogen stimulated human lymphocytes (Steen 
et al., 1990; Steen et al., 1991) making HPRT a less favorable internal control for 
immunologic studies. The primary drawback o f P-actin is that it is a moderately 
abundant transcript whose expression is several orders of magnitude greater than 
cytokines, a problem not significantly different for GADPH and Cyclophylin which 
are, respectively, moderately abundant and slightly less than moderately abundant 
species (Smith, 1995).
To address the difference in expression between P-actin and cytokine species, 
the volume of cDNA and the cycle number used for P-actin amplification were 
lowered when compared to parameters used for cytokine amplification. The premise 
that normalization should not be compromised and actually improved by this 
difference in template concentration cycle number reflects the fact that normalization 
values are based on relative differences between the samples which can only be 
resolved in non-competitive methods if all samples are within the exponential 
amplification phase of the reaction. This is well illustrated by the results of cDNA # 4 
and # 6  in the six extraction set of cDNA reactions whose P-actin values approached 
the plateau phase and whose normalized cytokine values were significantly lower than 
those of the other replicates. 25 cycles have been previously reported for p-actin
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amplifications using non-competitive methods but these reports utilized comparatively 
more RNA per PCR reaction, on the order of 0.5 fig per PCR reaction (Melby et a l.,
1993). In preliminary experiments, RNA quantities of this magnitude consistently 
pushed the PCR reaction into the plateau phase which eliminates the ability of P-actin 
amplifications to resolve the differences inherent in the RT step. The finding in this 
series of experiments that p-actin values in the region of the standard curve 
immediately preceding the plateau phase are associated with normalization errors has 
restricted use of samples whose P-actin values amplify to this level. Negative samples 
are still accurate but amplifications from samples with positive cytokine values are 
repeated on dilution. To our knowledge this is the first time that different cycle 
numbers and cDNA volumes have been used to amplify the housekeeping gene and 
cytokine targets.
By using RNA from a single RNA extraction in the synthesis of three identical 
cDNA reactions the precision of the PCR process (given by the error associated with 
repeated amplifications from the same cDNA reaction) as well as tube to tube 
differences in the efficiency of the RT reaction, were examined. The precision of this 
PCR process (10-30%) is quite good when compared to other investigators whose 
pre-normalization errors ranged from 20% to as high as 50% (Kanangat et al., 1992; 
Melby et al., 1993; Jessen-Eller et al., 1994). The fact that the average predicted 
copy numbers from these identical cDNA reactions were not significantly different 
and varied by only 5-10% indicates that there was no difference in the tube to tube 
efficiency of the RT reaction. When amplifications were made from multiple cDNA 
reactions whose RNA was derived from separate extractions of the same culture, at
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least two of the reactions had significantly less message (prior to normalization) than 
the remaining four reactions and this distribution of message was equivalent for each 
of the cytokines examined. Taken together these findings suggest that the differences 
in RT efficiency which are commonly reported (Cone et al., 1992; Jessen-Eller et al., 
1994) most likely reflect either errors in RNA quantification or, the presence of RT 
reaction inhibitors which are copurified with the RNA during extraction.
While the findings from the cDNA reactions created from RNA dilutions and 
from the identical cDNA reactions synthesized using RNA from a single extraction 
demonstrated that the use of plasmid standard curves is repeatable and accurately 
detects two fold changes in input RNA, single RNA isolations do not reflect 
laboratory practice. Using six separate cDNA reactions whose RNA originated from 
separate extractions of the same PBMC culture, there was no difference in the 
predicted copy values for each of the cytokines when amplifications from the same 
cDNA reactions on two different days were compared. This confirms that plasmid 
derived standard curves can be used to overcome day to day variability in the PCR 
reaction. There were however, as previously mentioned, differences in the predicted 
cytokine values among the six reactions prior to normalization. The relative ranking 
of the six cDNA reactions based on quantity of transcript was significant and 
positively correlated with the ranking derived from P-actin amplification for each of 
the transcripts examined. This confirmed that P-actin amplified under these conditions 
could be used to determine which reactions had significant differences in the RT step, 
suggesting that P-actin might be useful as a normalization factor.
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When P-actin was examined as a normalization factor several limitations to the 
assay were identified. While it was previously assumed that the final iteration of the 
standard curve would prevent errors due to interpolations within the plateau phase, 
instances did occur in which the final iteration of the standard curve was between the 
2  highest dilutions of the standard curve, within the plateau. P-actin luminosity values 
from cDNA reactions which were in this region were falsely overestimated, resulting 
in low normalization factors which therefore underestimated the normalized cytokine 
values. Similarly, cytokine values at or below the bottom of the curve overestimated 
the copy number causing normalization errors even when P-actin values were derived 
from the exponential amplification portion of the P-actin standard curve. Samples 
falling in these regions must therefore be re-amplified using an appropriate cDNA 
volume adjustment. It is also important to note that the luminosity values derived 
from negative controls are not equivalent to 0  copy units using this regression model 
so that comparisons with negative values must be adjusted based on the value 
interpolated from the negative control. When these contingencies are applied to 
normalized values both from the RNA dilution set and the set o f six separate 
extractions from a single culture, the corrected copy numbers are not significantly 
different despite significant differences prior to normalization. These contingencies 
are not unique but simply reiterate the need for strict adherence to the limits of the 
exponential amplification phase of the PCR reaction. Normalized values from the 
nonexponential regions o f the curves increased the assay error (defined by the 
variance when the average cytokine copy units from each cDNA reaction are
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compared) from 13-27% to 45-160% for the reactions from separate extractions and 
from 13% to 21% in the RNA dilution samples.
The objective in the development of this assay was to create a quantitative 
method for the analysis of cytokine mRNA in equine lymphocytes but not necessarily 
to achieve the highest sensitivity accessible by PCR. However, this method is readily 
adaptable to increased or decreased sensitivity by altering cycle number and/or the 
quantity of RNA utilized based on pilot studies of the population in consideration.
This method is precise, repeatable, easily resolves two fold differences in message 
(and perhaps smaller differences), and has a dynamic range on the order of 3 logs 
without the use of competitors. By strictly adhering to the limits of the exponential 
amplification phase of the PCR reaction, a range of + /-  2 standard deviations about 
the mean will predict significant differences between samples.
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CHAPTER 3
VACCINATION AGAINST STRONGYLUS VULGARIS IN HORSES: 
COM PARISON O F THE CYTOKINE, HUMORAL AND 
LYMPHOPROLIFERATTVE RESPONSES OF VACCINATES AND
NONVACCINATES
Strongylus vulgaris is considered the most pathogenic nematode parasite of 
equidae due to the severe arterial lesions it causes in the cranial mesenteric artery 
during larval migration. Infective third-stage larvae (Lj) ingested from contaminated 
pasture penetrate the mucosa o f the large intestine, molt to fourth-stage larvae (L4) in 
the submucosa, and then proceed along arterioles and arteries that supply the intestine 
to the root of the cranial mesenteric artery (Ogboume and Duncan, 1985). There 
larvae molt to become immature adults (Ls) causing severe arteritis before returning, 
again via the vasculature, to complete their life cycle in the large intestine. Arterial 
lesions include the formation o f tortuous subintimal tracts, thrombi, and in severe 
cases verminous aneurysms which can compromise perfusion of intestinal vascular 
beds. This syndrome known as verminous arteritis or thromboembolic disease is 
characterized by ischemic infarctions of the bowel which result in toxemia, abdominal 
pain, and death in severe cases (White, 1985).
Previous studies have demonstrated that oral vaccination with radiation- 
attenuated S. vulgaris L3  induces resistance to challenge infection and prevents 
classical lesions of verminous arteritis (Klei et al., 1982). When compared to 
parenteral vaccination with adult or larval somatic antigen homogenates which did not 
confer resistance to challenge infection, the protection observed in oral radiation- 
attenuated L3  vaccinated ponies correlated to both prechallenge anti-5, vulgaris
122
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antibody titers specific for surface antigens of late L3  stages and to induction of a  post 
challenge anamnestic-like eosinophilia (Monahan et al., 1994). Infections by S. 
vulgaris have been shown to activate eosinophils and neutrophils in vitro (Dennis et 
al., 1988) and eosinophils from S. vulgaris primed but not unprimed ponies kill S. 
vulgaris L3  in vitro in an antibody-dependent manner (Klei et al., 1992), indicating 
that an antibody-dependent phenomenon involving eosinophils may contribute to the 
resistance seen in immune ponies.
Helminth infections are characteristically associated with eosinophilia and 
elevated IgE production (Finkelman et al., 1991), traits that also characterize the 
Type II or TH2 response initially described in cloned mouse cells (Mosmann et al., 
1986; Mosmann and Coffman, 1989b). Type II responses, identified by the 
production of IL-4 and IL-5 which are integral to the generation of IgE (Snapper and 
Paul, 1987) and eosinophilia (Coffman et al., 1989) respectively, have been shown to 
play a significant role in the protective immune response to metazoan helminths 
(reviewed in Mosmann and Coffman, 1989a; Cox and Liew, 1992; Urban, J. F. et 
al., 1992). A cytokine or combination of cytokines which exhibits chemotactic 
activity for eosinophils has been found in the supernatant of S. vulgaris stimulated 
PBMC from immune but not nonimmune ponies (Dennis et al., 1993). This finding 
coupled with the anamnestic eosinophilia which is characteristic of immunity to S. 
vulgaris suggest that differential cytokine production, perhaps similar to that seen in 
classical Type II responses to helminth parasites may play a role in immunity to S. 
vulgaris.
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Methods
Experimental design
Ten yearling ponies were raised and maintained under parasite-free conditions 
(Monahan et al., 1997), housed in pairs on wood shavings, and fed a pelleted ration 
and water ad libitum. The experimental design consisted of three groups. Four ponies 
in group 1 (vaccinates) were orally vaccinated with 500 S. vulgaris Lj irradiated with 
90 kRads “ Co as described (Klei et al., 1982). Vaccination larvae were administered 
in tap water by syringe behind the tongue, then the syringe was rinsed and the rinsate 
administered orally as well. Immunization was repeated in this group 3 weeks after 
the first immunization. Group 2 (nonvaccinates) consisted of 4 ponies and group 3 
(controls) consisted of two ponies. Six weeks following the second immunization 
vaccinates and nonvaccinates were challenged per os with 1000 S. vulgaris L3 . 
Following challenge ponies were monitored at least twice daily for fever, signs of 
abdominal pain, depression, and anorexia. Observers were blinded to the nature of 
the ponies’ treatment and pyrexia was considered to be any rectal temperature above 
39°C. Four days prior to challenge (D-4), on the day of challenge (DO), and on days 
4 (D4) and 9 (D9) post challenge, exploratory celiotomies were performed to collect 
lymph nodes from the region of the cecum in close proximity to the ceco-colic fold, 
termed colonic lymph nodes (CLN). Blood was collected for hematologic evaluation 
and collection of peripheral blood mononuclear cells (PBMC) at these time points as 
well as fourteen days following challenge (D14). On D14 necropsy examinations 
were performed as described previously (Klei et al., 1982) for evaluation of lesions,
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collection of CLN, and recovery of larvae from cranial mesenteric artery (CMA) 
dissections.
Hematology
Blood was analyzed in a routine fashion. Total white blood cell counts were 
analyzed using a Baker 9000 analyzer (Serono-Baker, Allentown, PA). Differential 
white cell counts were determined by counts of 1 0 0  cells examined at 1 0 0  x under oil 
immersion.
Strongylus vulgaris larvae and soluble antigen
Larvae for use in the irradiated immunizations were recovered as from 
Baermann sedimentations of fecal cultures from monospecifically infected S. vulgaris 
donor ponies (McClure et al., 1994). Larvae were washed and stored in tap water at 
4°C until use. Soluble adult S. vulgaris antigen (SAWA) preparations used in ELISA 
and lymphoproliferation assays were prepared as previously described (Klei et al., 
1982) from adult S. vulgaris recovered from the intestines of horses.
Enzyme-linked immunosorbent assay (ELISA)
Circulating antibody isotypes specific for adult S. vulgaris soluble antigens 
were monitored by ELISA using serum collected on D-4 and D14. Soluble adult S. 
vulgaris antigen was diluted in buffer (0.015 M NajCC^, 0.035 M NaHC03, 0.003 M 
NaN3) to 5 /zg/ml. Antigen preparation was added to wells of 96-well flat bottom 
polystyrene microtiter plates in 50 pi volumes (Dynatech Laboratories, Chantilly, 
Virginia) and incubated overnight. Unless otherwise noted, incubations were 
performed at 37°C in a humidified incubator. Plates were washed three times with a 
solution of 0.05% Tween 20 in PBS (PBST) and nonspecific binding sites were
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blocked using 1% fish gelatin (Sigma, St. Louis, MO) in PBS (PBSG), 100 fi\ per 
well, for 1 hour at room temperature. A 1:200 dilution of serum was made in PBSG 
and added to triplicate wells in 50 fil aliquots. Serum from known high responders 
and negative responders served as standard positive and negative controls on each 
plate. Plates were incubated for 90 minutes then washed three times with PBST. 
Culture supemates from hybridoma lines specific for equine IgA, IgM, IgGa, IgGb, 
or IgG(T) (Lunn et al., 1996) were diluted 1:100 in PBSG, added to appropriate 
wells in 50 fil volumes, and incubated for 90 minutes. Following incubation, wells 
were washed three times with PBST. Affinity-purified, horseradish peroxidase- 
conjugated goat anti-mouse IgG and IgM, heavy and light chain specific (Jackson 
Immunoresearch Labs, West Grove, PA) was diluted 1:1000 in PBSG, added to wells 
in 50 fil aliquots, and incubated for 90 minutes. Plates were washed three times with 
PBST. The substrate was 3,3',5,5'-tetramethylbenzidine (TMB, Kirkeguard and 
Perry, Gaithersburg, MD) at 75 fi\ per well. Reactions were allowed to proceed for 
10 minutes for optimum color development. Optical density (OD) was recorded using 
a Dynatech MR 700 automated microtiter plate reader (Dynatech Industries) with 
absorbance set a t 630 nm.
Preparation of cells
Equine PBMC were isolated from venous blood by density gradient 
centrifugation over Ficoll Paque (Pharmacia LKB Biotechnology, Piscataway, NJ). 
After washing in calcium and magnesium free phosphate buffered saline (CMF-PBS), 
PBMC were suspended in media consisting of RPMI 1640 (Sigma Chemicals, St. 
Louis, MO) supplemented with 2-mercaptoethanol (10" 8  M), glutamine (2mM), 100
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U/ml penicillin, 100 pcg/ml streptomycin and 5 % heat inactivated fetal bovine serum 
(HyClone Laboratories, Logan,UT). Cells were isolated from colonic lymph nodes by 
disruption through sterile mesh screens. Colonic lymph node derived cells (CLNC) 
were washed twice in media, resuspended and counted. Aliquots of PBMC and 
CLNC (2 x 106  cells) were frozen at -70°C in RNA Stat 60 (Tel-Test, Friendswood, 
TX) for use in cytokine quantification assays.
Lymphoprol iferation
On D-4, D4, D9, and D14, PBMC and CLNC were seeded onto multiple 
wells of a 96 well round bottomed tissue culture plate (Costar, Assonet, MA) at a 
density of 2 xlO5  cells and incubated in 200 fil o f media containing soluble adult S. 
vulgaris antigen at a final concentration of 4 jzg/ml. Proliferation was measured by 
(3 H)-thymidine incorporation. After incubation for 5 days at 39°C with 5 % C 02,
50[il (0.5 fiCi) of 3 H-thymidine was added to each well and incubation was continued 
for 4 hours. The pulsed cells were harvested onto glass fiber filter pads with a 
Tomtech 96-well Harvester for liquid scintillation counting using a LKB Betaplate 
counter (Pharmacia).
Cytokine quantification
Samples of PBMC and CLNC which had been collected at D-4, D4, D9, and 
D14 and frozen in RNA Stat 60 reagent were defrosted and processed to RNA using 
chloroform extraction as per the reagent manufacturer's directions. RNA was 
quantified spectrophotometrically and the ratio of optical densities at 260nm and 280 
nm (O.D.2 6 0 nm:O.D.2g0nm) was consistently in the range of 1.9. 0.60 fig o f RNA in a 
volume of 35 fil DEPC-treated water were heated to 65°C for 10 minutes to denature
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the RNA, then chilled on ice for two minutes and pulse-spun at 14,000 x g in a 
microcentrifuge at 4°C. 45 fil o f reagent master mix were then added resulting in a 
final reaction containing lx  first strand buffer (Gibco BRL, Gaithersburg, MD), 0.5 
mM dNTP (Perkin-Elmer, Foster City, CA), 1.0 pM  Oligo-dT (Promega, Madison, 
WI), 10 mM DTT (Gibco), 0.075 pg/pl BSA (NEB, Beverly, MA), 120 Units 
RNAsin (Promega), and 800 units Moloney Murine Leukemia Virus Reverse 
Transcriptase (BRL). The reaction was incubated 1 hour at 40°C then frozen at -20°C 
until use.
Equine IL-2, IL-4, IL-5, IL-10, and IFN-y were quantified with the aid of the 
polymerase chain reaction (PCR) by interpolation against a standard curve as 
descrived in chapter 2. Standard curves were generated for each cytokine by 
simultaneously amplifying, from a common PCR master mix, known quantities of 
plasmids which contained the equine cytokine sequence of interest. Briefly, cytokines 
were amplified in 50 fil PCR reactions from 5 /d of each cDNA reaction using 2.5 
units of taq polymerase (Perkin-Elmer), 0.5 mM dNTP (Perkin-Elmer), and species- 
specific primers at a final concentration of 0.2 pM. Primers were commercially 
prepared (Genelab, Baton Rouge, LA; Baron Biotech, Milford, CT) from species- 
specific sequences which were determined using Oligo primer analysis software 
(National Biosciences, Plymouth, MN). Upstream primers were biotinylated on their 
5' terminus. Cycling parameters including buffer (PCR Optimizer, Invitrogen, 
Carlsbad, CA) and annealing temperatures were optimized for each cytokine. All 
cytokines were amplified to 35 cycles which was previously determined to maintain 
the reactions in their exponential amplification phase. P-actin, which was utilized as a
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housekeeping gene, was amplified from 2 pi of cDNA using 25 cycles in order to 
remain within its exponential amplification phase.
PCR products were quantified using the QPCR System 5000 (Perkin-Elmer) 
as has been described (Zhao et al., 1996; Blok et al., 1997). 5 pi of each PCR 
reaction were hybridized in a 50 pi reaction containing lx  PCR buffer II (Perkin- 
Elmer) and 10 of pmoles tris(2,2'-bipyridine) ruthenium II chelate labeled 
oligonucleotide probe whose sequence was specific to the cytokine targeted by PCR. 
Oligonucleotide probes were commercially prepared (Baron Biotech, Milford, CT) 
and purified by HPLC to eliminate non-labeled oligonucleotides. The reaction was 
heated to 95°C for 90 seconds followed by a 5 minute hold at 55°C. 15 fil of 
streptavidin-coated iron beads (Dynabeads, Perkin-Elmer) were added to each 
reaction followed by incubation at 55°C for 30 minutes. The entire 65 p 1 reaction was 
transferred to a 175 mm polypropylene tube containing 335 p 1 QPCR Assay Buffer 
(Perkin-Elmer) and quantified on the QPCR System 5000 whose output is in 
luminosity units.
Statistical Analysis
The number of days that anorexia, pyrexia, depression, and abdominal pain 
were exhibited by ponies in each treatment group in response to oral challenge with S. 
vulgaris larvae were subjected to one way analysis of variance. Lymphoproliferation 
data was subjected to one way repeated-measures analysis of variance. ELISA OD 
data was subjected to two way analysis of variance. Due to the wide distribution of 
cytokine responses displayed by this outbred population of ponies, cytokine data were 
log transformed for statistical analysis. For each day examined (D-4, D4, D9, and
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D14), differences in cytokine production among the three treatment groups were 
compared using one way analysis of variance while comparisons of daily cytokine 
production within a treatment group were made using repeated-measures analysis of 
variance. Daily cytokine production in PBMC was compared to that of CLNC for 
each treatment group using the Student's t-test. Differences were reported as 
significant when P<0.05.
Results 
Clinical signs..
Ponies in the vaccinal group exhibited significantly fewer episodes of pyrexia, 
depression, and abdominal pain than nonvaccinates (Table 3.1). Pyrexia, depression, 
and abdominal pain exhibited by vaccinates was not significantly different from that 
exhibited by control ponies. There was no difference in the number of days that 
anorexia was exhibited by ponies in the three treatment groups.
Larval recoveries
Irradiated recipients had a 100% reduction of migrating larvae compared with 
nonvaccinates (Table 3.2). Larval numbers in nonvaccinates ranged from 3 to 28 per 
pony.
Eosinophil counts
Differentials performed on peripheral blood smears from ponies on D-4, DO, 
D4, D9, and D14 following challenge demonstrated that ponies vaccinated with 
radiation attenuated larvae developed an eosinophilia by day 4 following challenge 
(Figure 3.1). In contrast, eosinophil counts from nonvaccinated ponies failed to show 
significant elevations within the two weeks following challenge.
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Table 3.1. Summary of the clinical signs exhibited by vaccinated, nonvaccinated, and 
control ponies in response to challenge with 1000 S. vulgaris L3 .
Group Anorexia Pyrexia Depression Colic
Vaccinates 8 1 0 0
Nonvaccinates 9 5* 3* 3*
Controls 2 0 0 0
Data represent the mean number of days that ponies exhibited the respective clinical 
sign. Pyrexia was considered any rectal temperatures exceeding 39°C . (*) indicates 
values are significantly higher than vaccinates and controls.
Table 3.2. Larval recoveries from vaccinated and nonvaccinated ponies following 
challenge with 1000 S. vulgaris L3 ..
Immunization Group Average Larval Recovery Percent Protection
Vaccinates 0 100 %
Nonvaccinates 16
Larvae were recovered from scrapings of the lumen of the CMA and its branches and 
counted using a dissecting microscope. Larval numbers in nonvaccinates ranged from 
3 to 28 per pony.
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Figure 3.1. Eosinophil response to S. vulgaris challenge in vaccinate, nonvaccinate 
and control ponies. Mean eosinophil counts for each group were calculated by 
multiplying the WBC count/p.1 blood, as determined by automated counting, by 
the percentage of eosinophils determined by manual counting of 1 0 0  cells viewed 
under oil immersion.
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ELISA
Levels of IgM, IgA, IgGa, IgGb, and IgG(T) specific for SAWA were 
determined using sera collected from vaccinate and nonvaccinate ponies on D-4 and 
D14 (Figure 3.2). When compared to prechallenge levels from nonvaccinates, levels 
of SAWA-specific IgGa, IgGb, and IgG(T) were significantly greater in the sera of 
vaccinates. Following challenge IgG(T) levels of vaccinates remained significantly 
greater than those of nonvaccinates but did not change significantly from prechallenge 
levels. Challenge with S. vulgaris L3  resulted in statistically significant increases in 
IgA in both vaccinates and nonvaccinates with nonvaccinate IgA levels significantly 
exceeding those of vaccinates following challenge. Nonvaccinates also exhibited a 
statistically significant increase in IgGa in response to challenge. There were no 
differences in IgM production within or among the treatment groups prior to or 
following challenge.
Lymphoproliferation
The proliferative response of PBMC and CLNC from vaccinate, nonvaccinate 
and control ponies to SAWA was determined using cells collected on D-4, D4, D9, 
and DI4 (Figure 3.3). Vaccinates and nonvaccinates demonstrated a significant 
elevation in the proliferative response of both PBMC and CLNC to SAWA on D14. 
Though differences in the lymphoproliferative responses of vaccinates and 
nonvaccinates were not statistically significant, the proliferative responses of PBMC 
and CLNC from vaccinates to SAWA exceeded those of nonvaccinates prior to 
challenge. Proliferation to SAWA in the CLNC of vaccinates continued to exceed that 
demonstrated by nonvaccinates by as much as five fold on day 4 following challenge.
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Figure 3.2. Antibody isotype response of vaccinated and nonvaccinated ponies to S. vulgaris soluble 
adult worm antigen 4 days prior to and 14 days following challenge. Serum samples were analyzed 
by ELISA in quadruplicate.
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Figure 3.3. Lymphoproliferative response of pony PBMC and CLNC to S. vulgaris 
antigen. PBMC (top panel) and CLNC (bottom panel), collected 4 days prior to 
challenge and on days 4, 9, and 14 following challenge, were incubated for 5 days 
with 4 Kg/ml soluble adult worm antigen. Proliferation was measured by thymidine 
incorporation. ( B B  v a c c i n a t e s n o n v a c c i n a t e s ,  n m  controls)
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Cytokine quantification
Differences in the levels of IL-2, IL-4, IL-5, IL-10 and IFN-y on D-4, D4,
D9, and D14 post challenge were compared within each treatment group (Figure 3.4 
and 3.5). PBMC from vaccinates demonstrated a significant decrease in IL-10 at D4 
and D9 while IL-2, IL-4, IL-5, and IL-10 increased significantly at D14. However, 
IL-2 and IL-10 did not exceed prechallenge levels (ie. fold increase <  1). PBMC from 
nonvaccinates demonstrated significant decreases in IFN-y and IL-10 at D9 followed 
by a significant rise in IL-10 on D14. Interferon-y production decreased significantly 
in the CLNC of both vaccinates and nonvaccinates on D9 followed by a significant 
increase in both groups on D14. On D9, nonvaccinates also experienced a significant 
increase in IL-4 and a decrease in IL-10 in their CLNC. Significant increases in IL-4, 
IL-5, and IL-10 were also observed in nonvaccinates on D14.
Comparisons of cytokine production among the three treatment groups on each 
day (Figure 3.6) indicated that IL-4 production in vaccinates was significantly greater 
than in nonvaccinates and controls on D4 in CLNC and on D9 in PBMC.
Comparisons of daily cytokine production in PBMC to that of CLNC for each 
treatment group indicated that on D9 IL-4 production in CLNC of nonvaccinates 
significantly exceeded that in PBMC.
Discussion
Differences in postchallenge clinical signs and larval recoveries demonstrated 
that ponies immunized orally with irradiated L3  developed a protective response to 
challenge when compared to nonimmunized ponies. In previous studies, necropsies 
performed six weeks following challenge with S. vulgaris L3  demonstrated that ponies
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Figure 3.4. Cytokine production in PBMC from vaccinated, nonvaccinated, and control ponies after 
oral S. vulgaris L3 challenge. Cytokine copy numbers were determined using a quantitative RT-PCR 
assay and were normalized for P-actin content of each cDNA. Data is represented as the fold increase 
in geometric mean over prechallenge values on the indicated days following oral challenge with 1 0 0 0  
S. vulgaris L3. (■ ■ §  Day 4, i n n  Day 9 ,H H  Day 14). (*) represents a significant decrease, and 
(A) a significant increase in cytokine production in relationship to the other days examined.
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Figure 3.5. Cytokine production in colonic lymph node derived lymphocytes (CLNC) from vaccinated, 
nonvaccinated, and control ponies after oral S. vulgaris L3 challenge. Cytokine copy numbers were determined 
using a quantitative RT-PCR assay and were normalized for P-actin content of each cDNA. Data is represented 
as the fold increase in geometric mean over prechallenge values on the indicated days following oral challenge 
with 1000 S. vulgaris L3 Day 4, m u )  Day 9 ,H B  Day 14) . (*) represents a significant decrease, 
and C) a significant increase in cytokine production in relationship to the other days examined.
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Figure. 3.6. IL-4 and IL-5 production in vaccinated and nonvaccinated ponies after oral 
S. vulgaris L3 challenge. Copy numbers for each cytokine from PBMC (top panel) 
and CLNC (botton panel) as determined using a quantitative RT-PCR assay were 
normalized for 3 -actin content of each sample and are represented as the geometric 
mean of values for ponies in each treatment group on the indicated days following 
oral challenge with 1000 virulent S. vulgaris L3. ’“Represent significant differences 
among treatment groups ( v a cc in a t e s , n o n v a cc i n a t e s ,a m  controls).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
140
vaccinated with irradiation-attenuated L3  did not develop lesions of verminous arteritis 
but instead had significant periportal fibrosis, suggesting that the protective response 
is generated within the intestinal submucosa and that larval antigens are cleared via 
the portal system prior to L4  migration into the intestinal vasculature (Monahan et al
1994). Blocking parasite entrance to the intestinal arterioles in vaccinates should both 
limit peripheral exposure to parasite antigens and prevent arterial lesions resulting in 
the significant reductions in fever, depression and abdominal pain we observed in 
vaccinates relative to nonvaccinates. Massive killing of larvae within the wall of the 
intestine in vaccinates should, however, be expected to trigger the cascade of 
inflammatory mediators responsible for pyrexia including tumor necrosis factor-a, 
IL-1, and IL-6 . It has been postulated that clearance of killed larvae and inflammatory 
mediators by the portal system, which is by virtue of its network of vessels of 
expanding diameter, mechanically less susceptible to procoagulant effects and 
thrombus trapping then intestinal vasculature, could also contribute to the decrease in 
both pyrexia and abdominal pain observed in vaccinates as compared to nonvaccinates 
(Monahan et al., 1994).
Following challenge with S. vulgaris, vaccinates developed an anamnestic 
eosinophilia which began to rise on D4 and appeared to be peaking at D9. The 
kinetics of this response preceded those previously reported (Monahan et al., 1994) 
and may be the result o f a larval challenge which exceeded previously published 
doses, or perhaps improved viability of either the vaccinal or challenge larvae leading 
to more robust stimulation of the eosinophilic response mechanisms. IL-5 is required 
for the eosinophilic response to helminth parasites (Coffman et al., 1989; Sher et al.
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1990b). Levels of IL-5 in both the PBMC and CLNC of vaccinates exceed those of 
nonvaccinates by at least four fold prior to challenge and on D4 and D9 following 
challenge. Though not statistically significant, these findings appear to be 
physiologically significant with greater IL-5 production prechallenge and on D4 post 
challenge correlating to the more rapid increase in eosinophil numbers observed in 
vaccinates relative to nonvaccinates.
Though the magnitude of the IL-5 response in PBMC from nonvaccinates on 
D14 actually exceeded that of vaccinates, this change was not statistically significant. 
However, analysis of the fold increase in IL-5 produced by PBMC of nonvaccinates 
over prechallenge levels indicated that the IL-5 response on D14 was statistically 
significant. Significant increases in IL-5 production were also observed in the CLNC 
of nonvaccinates on D14. In previous experiments, eosinophil responses in 
nonvaccinates lagged behind that observed in vaccinates by approximately one week 
(Monahan et al., 1994). Accordingly, the slight increase in eosinophil counts 
observed in nonvaccinates on D14 which correspond temporally with significantly 
elevated IL-5 levels may signal the beginning of the eosinophilic response in this 
group.
Though cytokine regulation of murine IgG isotypes is well characterized, 
allowing one to correlate antigen-driven isotype production to cytokine profiles 
consistent with either Type I or Type II responses, both cytokine regulation of equine 
immunoglobulin production and the relationship between the equine and murine IgG 
isotypes have not been characterized. IgE production, a hallmark of helminth
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infection, was not quantified because equine-specific reagents have not been made 
commonly available.
Prior studies have demonstrated that following immunization with radiation- 
attenuated S. vulgaris L,, vaccinates develop a small increase in total immunoglobulin 
directed against soluble adult S. vulgaris antigen and that following challenge with S. 
vulgaris L3 , this SAWA-specific antibody production displays an anamnestic 
response, converging with that of nonvaccinates by 3 weeks post challenge (Monahan 
et al. 1994). We examined the differences in immunoglobulin isotypes specific for 
SAWA in vaccinates and nonvaccinates in response to challenge with S. vulgaris. Our 
data indicate that the previously described increase in SAWA-specific immuno­
globulin titers seen in response to vaccination are at least in part due to production of 
isotypes IgGa, IgGb, and IgG(T) in response to vaccination. Following challenge, 
SAWA-specific IgG(T) remained significantly greater in vaccinates compared to 
nonvaccinates but was not significantly different from prechallenge levels. Increases 
in IgG subclasses in response to S. vulgaris infection have been previously 
demonstrated with IgG(T) showing the greatest increase (Patton et al., 1978). 
However, to our knowledge, this is the first data to demonstrate the antigen- 
specificity of this elevation in IgG subclasses. Challenge resulted in significant 
increases in SAWA-specific IgA production in both vaccinates and nonvaccinates. 
SAWA-specific IgA titers observed in nonvaccinates following challenge were 
significantly greater than those of vaccinates indicating that vaccination was associated 
with a blunting of the antigen-specific IgA response to adult parasite antigen. 
SAWA-specific IgGa also increased significantly in the sera of nonvaccinates but not
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vaccinates following challenge. Though no changes in SAWA-specific IgM were 
noted, only day D14 serum samples were assayed and given the acute nature of 
antigen-specific IgM responses, it is likely that earlier samples might have detected a 
difference in SAWA-specific IgM. Serum from D4 and D9 is available and 
characterizing SAWA-specific isotype responses on these days is a focus of ongoing 
study
Stimulation of PBMC from ponies infected with S. vulgaris has produced a 
specific proliferative response to SAWA that is absent in uninfected ponies (Dennis et 
al., 1992). However, attempts to demonstrate differences in the proliferative response 
to adult worm antigens between resistant and non-resistant ponies before and after 
challenge infection were not successful (Klei, 1992). Though not statistically 
significant, in this experiment the prechallenge proliferative responses of PBMC and 
CLNC from vaccinates exceeded those of nonvaccinates suggesting that some 
component of the larval vaccine was able to prime these individuals for a secondary 
response to adult antigen. Following challenge, both vaccinates and nonvaccinates 
respond similarly demonstrating statistically significant increases in the proliferative 
responses of both PBMC and CLNC that were not significantly different between 
vaccinates and nonvaccinates.
Statistical analyses of cytokine data was complicated by the wide range of 
responses seen in this outbred population as well as the limited number of controls. 
Significant increases in IL-4 production were noted in the PBMC of vaccinates on 
D14. Unlike IL-5 which tended to increase (though not significantly) in the PBMC of 
each nonvaccinate pony, IL-4 showed minimal response in the PBMC of
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nonvaccinates over the course o f the experiment and in feet the small response on 
D14 reflected that of a single individual with a disproportionately high IL-4 response. 
In contrast to the IL-4 response o f PBMC from nonvaccinates, IL-4 production was 
significantly elevated on D9 and D14 in nonvaccinate CLNC. Vaccinates also 
demonstrated a daily increase in CLNC IL-4 levels throughout the duration of the 
experiment but these changes were not statistically significant.
IL-4 was unique among the cytokines in that it's production by vaccinates on 
D4 in CLNC and D9 in PBMC significantly exceeded that of nonvaccinates and 
controls. This was not the case for IL-2, IL-5, IL-10 and IFN-y production. Though 
not statistically significant, prechallenge IL-4 levels in the CLNC of vaccinates tended 
to exceed those of nonvaccinates. These differences between vaccinates and 
nonvaccinates, namely greater IL-4 production in prechallenge CLNC and 
significantly greater IL-4 production occurring first at the local site of parasite 
invasion followed by an increase in peripheral IL-4 production by PBMC constitute 
an anamnestic IL-4 response presumably associated with priming during 
immunization of vaccinates that is of course absent in nonvaccinates. Nonvaccinates, 
however, did demonstrate a significant increase in IL-4 production which lagged 
behind the response of vaccinates temporally, being first detected in CLNC on D9. 
Though the role of IL-4 in IgE production by memory B-cells is unclear (Le Gros et 
al., 1996; Levy et al., 1997), IL-4 is required for the generation and maintenance of 
secondary antigen-specific IgE responses in vivo (Finkelman et al., 1990). Therefore, 
anamnestic IL-4 production might be associated with an antigen-specific anamnestic 
IgE response in vaccinates following challenge. Elimination of the IgE response with
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anti-IL-4 has been shown to reverse protection in both Heligmosomoides polygyrus 
immune mice (Urban, J. 1. et a l., 1991b) and primary Trichuris muris infections 
(Else et al., 1994). A synthesis of these findings leads to the hypothesis that 
anamnestic IL-4 production, possibly leading to an anamnestic antigen-specific IgE 
response may be one component of the immune response that differentiates S. 
vulgaris immune from susceptible ponies.
Though further characterization of the differences in IL-4 production in CLNC 
and PBMC associated with vaccination and challenge are warranted, it is clear that 
both vaccinates and nonvaccinates respond to challenge with S. vulgaris by producing 
IL-4, and that at least in immune animals, this production of IL-4 is not restricted to 
the CLNC. Though further studies are warranted to confirm that IL-4 production 
varies in its magnitude and site of initial production in S. vulgaris immune ponies, 
significant increases in IL-4 production in vaccinates relative to nonvaccinates at the 
CLNC on D4 and PBMC on D9 suggest that the occurrence of a local immune 
response characterized by the production of the Type II cytokine IL-4 which spreads 
to a peripheral immune response in which IL-4 also plays a role may differentiate 
susceptible and immune ponies. This difference in peripheral IL-4 production was 
unique to the vaccinates and could reflect a peripheral recognition event present in 
vaccinates but absent in nonvaccinates that contributes to the protective immune 
response.
We observed statistically significant decreases in IFN-y on D9 in the CLNC 
and PBMC of nonvaccinates as well as in the CLNC of vaccinates. Depression of 
IFN-y production was also observed in the PBMC of vaccinates though this was not
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statistically significant. Nonetheless, unlike the other cytokines assayed, IFN-y 
production was consistently lower on D-4, D4, and D9 in the CLNC of vaccinates 
and nonvaccinates as compared to controls. In light of the association between 
decreased IFN-y production and the increased TH2 response, these findings are 
certainly noteworthy.
In the TH1/TH2 paradigm inhibition of IFN-y production is often attributed to 
IL-10. Though IL-10 was originally described as a product of mouse TH2 clones, it is 
now clear that IL-10 is also secreted by TH1 cells (especially in humans) and 
activated macrophages (Somasse et al., 1996; Martinez et al., 1997). IL-10 is a 
potent inhibitor of IFN-y production (Fiorentino et al., 1989; Urban, J. J. et al., 
1991b). However, in our experiments a temporal relationship between increased IL- 
10 levels and decreased IFN-y levels was not clear. All groups exhibited a decrease in 
IL-10 production following challenge which was significant on D4 and D9 in the 
PBMC of vaccinates and D9 in the PBMC and CLN of nonvaccinates. Significant 
increases in IL-10 which were noted on D14 in the PBMC of vaccinates and the 
PBMC and CLNC of nonvaccinates were relative to the depression on D9 and were 
not significantly different from prechallenge levels. It is important to remember that 
while IFN-y is capable of directly inhibiting the TH2 response, IL-10 inhibition of 
IFN-y production is indirect, acting on antigen presenting cells to reduce their ability 
to stimulate cytokine secretion by TH1 cells. Other cytokines including IL-3 and IL-4 
(Liew et al., 1989), IL-11 (Leng and Elias, 1997), IL-13 (Doherty et al., 1993), and 
TGF-P (Hausmann et al., 1994) have been shown to interfere with macrophage 
activation. Statistically significant elevations in IL-4 production were observed in the
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CLNC of vaccinates on D4 which could account temporally for the significant 
decrease in IFN-y production seen on D9 in these individuals.
IFN-y and IL-2 tended to increase by D14 in PBMC and CLN of both 
vaccinates and nonvaccinates. These increases were significant for IL-2 in the PBMC 
of vaccinates, and IFN-y in the CLNC of vaccinates and nonvaccinates and may 
reflect a Type I response associated with an inflammatory response to dead parasites 
from the challenge dose.
It appears from this data that the immune response of both naive susceptible 
and vaccinated immune ponies to S. vulgaris may involve the generation of a  classical 
Type II response rather than being dramatically polarized as seen in Type I and Type 
II responses that define susceptibility and resistance, respectively, to murine helminth 
parasites. Both S. vulgaris immune and susceptible ponies showed similar 
lymphoproliferative and antibody responses to adult worm antigen following 
challenge and both groups exhibited characteristics of a Type II response producing 
IL-4 and IL-5 in response to challenge. However, the timing of the immune response 
to challenge infections of S. vulgaris in vaccinates appears to precede that of 
nonvaccinates. Natural exposure to S. vulgaris L3  is known to induce resistance to 
further infection (Ogborune and Duncan, 1985) and our data support the notion that 
oral vaccination with radiation-attenuated larvae may simply induce this resistance 
quicker than natural exposure, thereby protecting animals from pathology. Prior to 
challenge vaccinates exhibited greater antigen-specific proliferative responses and 
produced more IL-4 and IL-5 in CLNC than did nonvaccinates, though these 
differences were not statistically significant. Following challenge IL-4 production by
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nonvaccinates lagged behind vaccinates. Vaccinates produced significantly more IL-4 
in response to challenge then nonvaccinates first in CLNC at D4 and then in PBMC at 
D9 while IL-4 production in the CLNC of nonvaccinates increased significantly by 
D9. Thus the ability to generate an anamnestic IL-4 response to S. vulgaris either at 
the site of parasite invasion and/or perhaps in peripheral blood appears to be one 
component of the protective immune response generated by vaccination with 
radiation-attenuated S. vulgaris Lj.
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SUMMARY
The purpose o f this dissertation was to create reagents for the study of equine 
Type I and Type II responses, to develop an assay for the quantification o f equine 
cytokine mRNA, and to apply this assay in order to examine the cytokine responses of 
control ponies and ponies vaccinated with radiation-attenuated Strongylus vulgaris 
larvae during the generation o f their immune response to challenge with S. vulgaris L3 . 
In order to develop reagents for the study of cytokine responses of the horse, equine 
IL-6 , IL-10 and p-actin were cloned from mitogen stimulated equine PBMC using 
reverse transcription followed by polymerase chain reaction amplification (RT-PCR) 
with primers based on consensus sequences of these cytokines in other species.
Equine IL - 6  cDNA comprises 745 bases including 118 bases in the 3' 
untranslated region. The cDNA shares 82% nucleotide identity with human IL-6 . The 
open reading frame for equine EL- 6  encodes 208 amino acids including a 28 amino acid 
signal peptide. The mature protein would consist of 180 amino acids and have a 
predicted relative mass of 20,471, without post-translational modification. The predicted 
amino acid sequence of equine IL- 6  shares 78% similarity with human EL- 6  and includes 
the residues which have been shown by other investigators to be critical for biological 
activity of the protein (Brakenhoff eta l., 1989, 1990; Kruttgen et al., 1990; Fontaine et 
al., 1993; van Dam et al., 1993; Ehlers et al., 1994, 1995, 1996; de Hon et al., 1995; 
King et al., 1996). The GenBank accession number for equine EL- 6  is U64794.
Equine EL-10 cDNA comprises 739 bases including 202 bases in the 3' 
untranslated region. The cDNA shares 89% nucleotide identity with human EL-10. The
149
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open reading frame for equine IL-10 encodes 178 amino acids including an 18 amino 
acid signal peptide. The mature protein would consist of 160 amino acids and have a 
predicted relative mass o f  18,615 without post-translational modification. The predicted 
amino acid sequence o f equine IL-10 shares 91% similarity with human IL-10 and 
includes the residues which are postulated to be significant in receptor binding based on 
the X-ray crystallographic structure o f human recombinant IL-10 (Walter et al., 1995). 
Equine IL-10 shares 85% nucleotide identity with an IL-10-like sequence in the genome 
of Equine Herpes Virus-2. The GenBank accession number for equine IL-10 is U38200.
The cloned equine P-actin comprises a single open reading frame of 1128 bases. 
The cDNA shares 94% nucleotide identity and 100% amino acid identity with human P- 
actin. The mature protein has a predicted relative mass of 18,615 without post- 
translational modification. The GenBank accession number for equine P-actin is 
AF035774.
A RT-PCR based assay was utilized to quantify cytokine message in cDNA 
samples by comparison to a standard curve. To generate the standard curve, known 
concentrations of plasmid encoding the cDNA of interest were amplified in conjunction 
with the unknown cDNA samples in triplicate PCR reactions. PCR product was detected 
using a luminescence based assay in which sequence-specific probes were hybridized to 
the PCR products in solution and detected using a Perkin-Elmer QPCR System 5000.
The message content of the unknown samples was determined by interpolation against 
the standard curve using a two parameter exponential rise to maximum analysis of the 
standard curve data. P-actin was used as a normalization factor by altering the cycling 
parameters to maintain its amplification within the exponential amplification phase o f the
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reaction. The assay resolves 2 fold changes in cytokine message, has a linear dynamic 
range on the order of 3 logs, and is precise with errors most commonly in the range of 
10% for replicate amplifications from the same sample. The error between replicate 
samples whose RNA was derived from separate extractions of the same cell population 
following P-actin normalization was 13-27%. This assay was utilized to determine the 
effect of oral vaccination with radiation-attenuated S. vulgaris larvae on the cytokine 
response to oral challenge with S. vulgaris.
1 0  ponies were reared in a parasite free environment and divided into three 
groups. Four ponies were orally vaccinated with 500 S. vulgaris third-stage infective 
larvae (vaccinates) which had been radiation-attenuated with 90 krads from a “ Co 
source. Vaccinations were performed 9 and 6  weeks prior to oral challenge with 1000 
non-attenuated L, on day 0. Four other ponies were not vaccinated (nonvaccinates) and 
were also challenged with 1000 L3  on day 0. Control ponies were neither vaccinated nor 
challenged. Four days prior to challenge, as well as on days 4 (D4) and 9 (D9) post­
challenge, peripheral blood as well as lymph nodes from the region of the cecum (CLN) 
were collected. Peripheral blood and CLN were also collected at necropsy on day 14 
(D14) post-challenge.
Oral immunization with radiation-attenuated S. vulgaris L, provided protection 
from challenge. Ponies immunized with irradiated L3  developed anamnestic 
eosinophilias, had fewer episodes of pyrexia, depression, and abdominal pain, and were 
1 0 0 % protected from larval migration when compared to nonvaccinated ponies.
Soluble adult S. vulgaris antigen-specific antibody isotypes from vaccinates and 
nonvaccinates were compared on D-4 and D14. Vaccination caused significant increases
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in SAWA-specific IgGa, IgGb, and IgG(T). IgG(T) remained significantly greater in 
vaccinates than nonvaccinates on D14 but was not significantly different from D-4 
values. Challenge significantly increased IgA in vaccinates and nonvaccinates.
Vaccination blunted the SAWA-specific IgA response. IgGa also increased significantly 
in the sera of nonvaccinates but not vaccinates by D14.
The proliferative response o f PBMC and CLNC from vaccinate, nonvaccinate, 
and control ponies to SAWA was determined on D-4, D4, D9, and D14. Prior to 
challenge, the proliferative responses of PBMC and CLNC from vaccinates exceeded 
those of nonvaccinates but these differences were not significant. By D14 vaccinates 
and nonvaccinates demonstrated a significant elevation in the proliferative response of 
both PBMC and CLNC to SAWA.
Total RNA from PBMC and CLN derived cells (CLNC) was assayed for IL-2, 
IL-4, IL-5, IL-10, and IFN-y message in the aforementioned RT-PCR assay. Prior to 
challenge, vaccinates produced more IL-4 and IL-5 than nonvaccinates, though these 
differences were not statistically significant. Following challenge, both vaccinates and 
nonvaccinates demonstrated a Type II cytokine pattern with significant elevations in EL- 
4 and IL-5 production. Vaccinates demonstrated significant increases in IL-2, IL-4, IL-5, 
and IL-10 production in PBMC on D14 post-challenge though IL-10 production initially 
decreased significantly on D4 and D9. Nonvaccinates demonstrated significant decreases 
in IL-10 and IFN-y production on D9 and a significant increase in IL-10 production on 
D14 in their PBMC. In CLNC, only nonvaccinates demonstrated significant increases in 
IL-4 and IL-5 production in response to challenge. Vaccinates also demonstrated 
increases in IL-4 and IL-5 production in CLNC in response to challenge but these
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increases were not significant because of the higher pre-challenge levels o f IL-4 and IL-5 
in their CLNC. Vaccinates did exhibit a significant decrease in IFN-y production on D9 
followed by a significant increase on D14. Nonvaccinate CLNC exhibited significant 
decreases in IFN-y and IL-10 message on D9 followed by significant increases in IL-4, 
IL-5, IL-10 and IFN-y by D14. When groups were compared, vaccinates produced 
significantly more IL-4 in response to challenge then nonvaccinates or controls, first in 
CLNC at D4 and then in PBMC on D9. There was not a significant difference in the 
production of IL-2, IL-5, IL-10, or IFN-y between groups.
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CONCLUSIONS
Equine IL- 6  and IL-10 exhibit significant nucleic acid homology (>80%) and 
amino acid similarity (>70%) with the respective sequences of other domesticated 
mammals. The sequences include putative receptor binding residues and are therefore 
likely to be biologically active. Expression and determination of the biological activity of 
the recombinant proteins is a focus o f continuing research.
Cytokine messenger RNA can be quantified using RT-PCR in the exponential 
amplification phase of the reaction by interpolation against a plasmid standard curve 
derived from known dilutions o f plasmids encoding the cytokines o f interest. Analysis of 
the standard curve using a two parameter exponential rise to maximum analysis of the 
data graphed on linear scales, given by the equation y=a(l- e'bx), provides superior 
prediction of two fold dilutions in RNA content of cDNA reactions when compared to 
other published analyses of the standard curve. This also indicates that amplification 
from double stranded plasmid can accurately model the amplification efficiency of 
cDNA. Using triplicate amplifications from the same cDNA, the assay resolves 2 fold 
changes in cytokine message and is precise with errors most commonly in the range of 
1 0 % for replicate amplifications from the same sample which is in line with the results 
achieved with quantitative competitive RT-PCR methods. The dynamic range o f this 
assay is on the order of 3 logs, exceeding the dynamic range achieved by competitive 
methods.
Despite its 1 0 0 - 1 0 0 0  fold greater expression, equine P-actin, whose amino acid 
sequence is identical to that of human P-actin, is useful in normalizing inter-sample
154
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variability in the RNA extraction and reverse-transcription steps of the RT-PCR assay 
provided its values fall within the exponential amplification portion of the standard 
curve. Under these conditions the error between replicate samples whose RNA was 
derived from separate extractions o f the same cell population following normalization 
was 13-27% which is in line with the errors using quantitative competitive methods.
As previously demonstrated, oral immunization with radiation-attenuated S. 
vulgaris L3  protects ponies from challenge infections, preventing larval migration and 
significantly decreasing clinical signs associated with challenge including pyrexia, 
depression, and abdominal pain. Vaccination is associated with the development of an 
anamnestic eosinophilia which is known to be a Type II dependent response though a 
temporal relationship between elevated IL-5 production and eosinophilia was not 
established.
Vaccination induced significant increases in SAWA-specific IgGa, IgGb, and 
IgG(T). Challenge induced significant increases in IgA in vaccinates and nonvaccinates 
and significant increases in IgGa in nonvaccinates. Though cytokine regulation o f murine 
IgG isotypes is well characterized, allowing the correlation of antigen-driven isotype 
production to cytokine profiles consistent with either Type I or Type II responses, both 
cytokine regulation of equine immunoglobulin production and the relationship between 
equine and murine IgG isotypes have not been characterized so that the relevance of 
Type I and Type II cytokine responses to equine isotype production cannot be 
established.
Though not statistically significant, the prechallenge proliferative responses of 
PBMC and CLNC from vaccinates exceeded those of nonvaccinates suggesting that
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some component of the larval vaccine was able to prime these individuals for a 
secondary response to adult antigen. Challenge sensitized both vaccinates and 
nonvaccinates to adult antigen.
Both vaccinates and nonvaccinates exhibited characteristics of a Type II cytokine 
response producing significant IL-4 and EL-5 in response to challenge and indicating 
that equine species generate Type H responses to gastrointestinal nematodes. However, 
the timing of the immune response to challenge infections in vaccinates appears to 
precede that of nonvaccinates. Thus, the ability to generate an anamnestic IL-4 response 
either at the site of parasite invasion and/or perhaps in peripheral blood appears to be 
one component of the protective immune response generated by vaccination with 
radiation-attenuated S. vulgaris L, indicating that the protective immune response to S. 
vulgaris probably involves the induction of a Type II cytokine response.
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